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Abstract 
 
Ever increasing applications of nanomaterials (materials with one or more dimension 
less than 100 nm) has raised awareness of their potential genotoxicity. They have 
unique physico–chemical properties and so could have unpredictable effects. Zinc oxide 
(ZnO) and titanium dioxide (TiO2) are widely used in a number of commercial 
products. There are published studies indicating that some forms of these compounds 
may be photo-clastogenic in mammalian cells. What has not been investigated before is 
the effect of nanoparticles from these compounds in human germ cells.  Thus the 
present study has examined their effects in the presence and absence of UV light in 
human sperm and compared responses to those obtained with human lymphocytes using 
the Comet assay to measure DNA damage. The effect of nanoparticles (40-70nm range) 
was studied in human sperm and lymphocytes in the dark, after pre-irradiation with UV 
and simultaneous irradiation with UV. The studies do provide some evidence that there 
are photo-genotoxic events in sperm and lymphocytes in the absence of overt toxicity.   
 
The cytotoxic and genotoxic potentials of ZnO and TiO2 as well as their effect on 
phosphotyrosine expression, were examined in the human epithelial cervical carcinoma 
cells (Hela cells). This was done to try and determine the underlying molecular events 
resulting from their exposure to ZnO and TiO2 nanoparticles occurring at the same time 
as DNA is damaged.  Concentration- and time-dependent cytotoxicity, and an increase 
in DNA and cytogenetic damage with increasing nanoparticle concentrations were 
reported in this study. Mainly for zinc oxide, genotoxicity was clearly associated with 
an increase in tyrosine phosphorylation.  
 
Nanotechnology has raced ahead of nanotoxicology and little is known of the effects of 
nanoparticles in human systems, let alone in diseased individuals.  Therefore, the effects 
of TiO2 nanoparticles in peripheral blood lymphocytes from patients with respiratory 
diseases (lung cancer, chronic obstructive pulmonary disease (COPD) and asthma) were 
compared with those in healthy individuals using genotoxic endpoints to determine 
whether there are any differences in sensitivity to nano-chemical insult between the 
patient and control groups. The results have shown concentration dependent genotoxic 
effects of TiO2 in both respiratory patient and control groups in the Comet assay and an 
increasing pattern of cytogenetic damage measured in the micronucleus assay without 
being statistically significant except when compared with the untreated controls of 
healthy individuals.  Furthermore, modulation of ras p21 expression was investigated. 
Regardless of TiO2 treatment, only lung cancer and COPD patients expressed 
measurable ras p21 levels that showed modulation as the result of nanoparticle 
treatment.  
 
Results have suggested that both ZnO and TiO2 nanoparticles can be genotoxic over a 
range of concentrations without either photoa-ctivation or being cytotoxic. 
 
Key words, Nanoparticles, TiO2, ZnO, Sperm, Lymphocyte, Comet assay, Tyrosine 
phosphorylation, Micronucleus assay, Respiratory diseases, lung cancer, COPD, 
asthma, healthy controls and ras oncoprotein. 
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1. Introduction  
Nanotechnology as defined by the Centre for Responsible Nanotechnology (USA) is 
“the engineering of functional systems at the molecular scale. It is referred to the future 
ability to construct items from the bottom up, using techniques and tools being 
developed today to make complete, high performance products” 
(http://www.crnano.org/whatis.htm). 
The U.S. National Science Foundation perspective for nanotechnology is as follows: 
“Imagine a medical device that travels through the human body to seek out and destroy 
small clusters of cancerous cells before they can spread or a box no larger than a sugar 
cube that contains the entire contents of the Library of Congress or materials much 
lighter than steel that possess ten times as much strength”. 
(http://www.scribd.com/doc/18303519/Nanotechnology-for-Communications) 
The outlook for nanotechnology is to be a general-purpose technology (as it was called), 
because it will have significant effect on all other technologies and industries. The 
outcome because of nanotechnology as expected is that everything will become better.  
Medicines that are more effective enhanced stronger buildings, and cleaner safer water 
supply.   
Nanotechnology is a wide field, incorporating applied physics, chemical engineering, 
biological engineering, etc. A nanoparticle is a small particle with a dimension generally 
less than 100 nm. Nanotechnology is used to manufacture polymers and in computer 
chip design, but the real commercial applications are in suntan lotions, cosmetics, drug 
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delivery and protective coatings (Hofmann-Amtenbrink et al., 2010; Nesseem, 2010; 
Osmond and McCall, 2010) 
 
1.1 History of nanotechnology 
It is now been realized that nanoparticles (NPs) have a very long history; they were used 
in the 9th century by artisans for the glittering effects or lustre on the surface of pottery. 
Lustre originated from films that contained copper and silver nanoparticles dispersed in 
a glassy matrix of ceramic. The nanoparticles used in lustre were created by adding 
copper and silver oxides to salts, vinegar, ochre and clay on the surface of glazed 
pottery then heated to 600ºC.  Heat would soften the glaze and make copper and silver 
migrate to the outer surface. The low pressures prevent the ions transforming back to 
the metal form and help to give the formed nanoparticles colour and optic effects.  The 
lustre technique originated first in the Islamic world as Muslim men were forbidden 
from wearing gold, so they found lustre as a way to get a similar effect without using 
real gold. 
 
The first scientific description of nanoparticles and their optical properties was provided 
by Michael Faraday in a paper in 1857 entitled “Experimental relations of gold (and 
other metals) to light” (Faraday 1857).  
 
The first idea of nano-technology came from a talk given by an American physicist 
called Richard Feynman at the American Physical Society on December 1959. Feynman 
described a process by which smaller sets of atoms and molecules can be produced from 
manipulating larger ones (Taniguchi, 1974). Although, the term nanotechnology was 
defined by Professor Norio Taniguchi from Tokyo Science University in 1974 as the 
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process of separation, consolidation, and deformation of materials by one atom or by 
one molecule (Taniguchi, 1974) 
 
In the early 1980s, nanotechnology and nanoscience started and with it came the 
invention of the scanning tunnelling microscope (STM). This development led to the 
discovery of fullerenes in 1985 and carbon nanotubes. In the year 2000, the United 
States National Nanotechnology Initiative was founded to coordinate Federal 
nanotechnology research and development (Guzman et al., 2006; Tinkle, 2010). 
 
1.2. Properties of nanoparticles 
Nanoparticles are a bridge between bulk material and atomic structures.  Bulk materials 
have constant physical and chemical properties regardless of their size but materials 
reduced to the nano-size can suddenly show completely different properties (Ehrman, 
1999; Hutter and Maysinger, 2010; Perrier et al., 2010; Pouliquen et al., 1991).  
 
Agglomeration or aggregation is another definite characteristic of nanoparticles, 
because nanoparticles are held together by both weak and strong forces, including van 
der Waals and electrostatic forces, and sintered bonds.  The binding force of 
agglomerates affects the solubility of the component of the particles under different 
conditions (Allouni et al., 2009; Poizot et al., 2000; Wokovich et al., 2009).  Another 
property of nanoparticles is that as the size of the material decreases, the number of 
physical properties changes and subsequently becomes dominant as the nanometer size 
is reached. One example is the increase in surface area to volume ratio that acts as a 
driving force for diffusion and greater reactivity, especially at high temperatures.  It also 
reduces the melting temperature of nanoparticles and alters most of the physical 
properties of the material including thermal and catalytic properties (Buffat, 1976) . 
 
 1.2.1 Photo-properties of ZnO and TiO
TiO2 and ZnO nanoparticles, 
cosmetics and sunscreens
sunscreen, because they ac
against solar radiation.   The industry took advantages of their scattering properties and 
small size to improve the homogeneity of distribution in cosmetics and sunscreens.  
Although, TiO2 reflects a
the total UV (Dunford et al., 1997)
 
Both TiO2 and ZnO are considered as photo
which uses light to activate a substance that in return modifies the rate of a chemical 
reaction without being involved itself and a photo
modify the rate of a chemical reaction using l
2010; Wang et al., 2010a; Zhang et al., 2008)
photo catalyst. The main difference between chlorophyll and a nano photo
that chlorophyll converts water and carbon dioxide into oxygen and glucose in the 
presence of sun light, however, nanoparticles create a strong oxidation agent and 
electronic holes to break down the organic matter to carbon dioxide and water with the 
formation of an intermediate free radical, which could be harmful.
 
 
 
 
 
TiO2 
2 
with sizes between 50 – 500 nm, are
, mainly in the sun protection factor (SPF) fraction of 
t as nano-mirrors reflecting UV light and as UV filters 
nd scatters UVB and UVA in sunlight, it absorbs about 70% of 
. 
-catalysts.  The photo-
-catalyst is the substance, which can 
ight irradiation (Akyol and Bayramoglu, 
. Chlorophyll of plants is a typical natural 
Chlorophyll 
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1.3 Applications of nanotechnology 
Nanomedicine is a large industry that deals with medical applications of 
nanotechnology. Its sales were 6.8 US billion dollars in 2004 and with over 200 
companies and 38 products worldwide (Emerich and Thanos, 2003). The uses of 
nanomedicines include drug delivery by using nanoscale particles to maximize 
bioviability of a drug at a place where it is most needed and for a prolonged time.  
However, the current problems for nanomedicine involve understanding the toxicity of 
nanoparticles (Amiji, 2010; Jin et al., 2006; Lammers et al., 2010; LaVan et al., 2003; 
Sheng and Huang, 2010).   
In cancer, the very small size of nanoparticles (10–100 nm) and high surface area to 
volume ratio are very useful in cancer diagnosis for example in MRI imaging (due to 
size tunable light emission), where nanotechnology can produce more detailed higher 
contrast and lower cost images of the tumour site (Kubik et al., 2005).  In addition, the 
small size of the NPs allows them to preferentially accumulate at the tumour sites due to 
lack of effective lymphatic drainage. This is a property which could be used to attach 
nanoparticles to future trial cancer therapies to target specific tumour cells efficiently 
and replace chemo and radiotherapies (Leary et al., 2006).  Scientists are also 
investigating the possibility of manufacturing multifunctional nanoparticles which could 
detect, image then “cook” the tumours with radio waves that heat only the nanoparticles 
and their tumour cells (Brown et al., 2010; Korelitz and Sommers, 1975; Richard et al., 
2008). 
 
Other speculative claims for future medical uses of NPs include photo-dynamic therapy 
(Yamakoshi et al., 1999), surgery (Matteini et al., 2010), nanorobots e.g. computational 
genes (Cheng et al., 2010) and cell repair (Moghimi et al., 2005). However, 
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commercially significant uses of nanoparticles are uses in consumer products e.g. TiO2 
and ZnO nanomaterials in sunscreens, cosmetics, food products, as a white paint,  
outdoor furniture varnishes, surface coating and paint (Parlini, 2008).  Other current and 
speculative household uses of nanotechnology include coating, easy to clean surfaces, in 
optics e.g. antireflective ultra thin sunglasses; in food for sensing and detection of 
biochemical changes and in textiles, nano fibres to make clothes which are stain and 
water repellent or wrinkle free. 
 
Nano-filtration is another large scale product of nanotechnology through which water is 
produced and could be used in the developing countries which lack access to reliable 
water sources (Bai et al., 2010; Hillie and Hlophe, 2007; Lazarova and 
Spendlingwimmer, 2008). 
 
1.3.1 Titanium dioxide (TiO2) and Zinc Oxide (ZnO) nanoparticles 
 
Titanium dioxide is a naturally occurring oxide of titanium, also known as titanium IV, 
Titania, or pigment white 6 or titanium white when used as a pigment. The chemical 
formula is TiO2.  It occurs in three forms rutile, anatase and brookite.  It is used, as a 
white pigment because of it is brightness, as a reflective optical coating, in papers, foods 
and medicines (pills and tablets).  It is widely used as a sunscreen because of its UV 
resistant properties and acts as a UV absorber, transforming destructive UV energy light 
into heat. 
 
Nano- size ZnO has possible future uses as transparent coatings to protect against 
ultraviolet and infrared radiation similar in concept to the sunscreen. It could also be 
used in electronic applications such as photo-printing and electro-photography.  
Commercial uses of ZnO are: anti-corrosion coatings on steel (galvanizing), 
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construction material, brass, pharmaceuticals, cosmetics, and as micronutrients for 
humans, animals and plants. 
 
 
1.3.2 Pulmonary applications of nanomedicines 
Current, rapid advances in nanotechnology and nanoscience offer means of new 
methods of diagnosing and treating many diseases.  Accordingly, in the USA, the 
national heart, lung, and blood institute (NHLBI) arranged a working group on 
nanotechnology that recommended the creation and development of research centres for 
applications of nanotechnology and nanoscience for heart, lung, blood, and sleep 
(HLBS) diseases and encouraged investigators and small businesses to develop 
nanotechnology-based approaches to clinical problems (Buxton et al., 2003). 
Gene therapy for the treatment of lung cancer has shown promise in the laboratory and 
in clinical trials. However, at present its use is limited to treatment of localized lung 
tumours because of host-immunity in opposition to the viral gene delivery vector. 
Accordingly, there is a remarkable effort to develop alternative gene delivery vectors 
that are capable of delivering tumour suppressor genes to metastatic lung cancers and at 
the same time to be non-immunogenic and efficient for systemic therapy. The 
preclinical trials with 1,2-dioleoyl-3-trimethylammonium-propane cholesterol 
nanoparticles (DOTAP: Chol), which are NPs complexed to DNA (DNA-nanoparticles) 
have been found to be an effective such non viral alternative vector for gene delivery 
(Gopalan et al., 2004; Ramesh et al., 2004). 
 
Chemotherapeutic studies have found that alginate nanoparticles used in aerosols to 
encapsulate the anti-tuberculous drugs isoniazid (INH), rifampicin (RIF) and 
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pyrazinamide (PZA) was an ideal carrier for the controlled release of anti-tuberculous 
drugs, because it has increased the bioavailability of all three drugs encapsulated 
compared to the oral free drugs. In addition, all drugs were detected 15 days post- 
nebulisation in the lungs, liver and spleen while the free drugs not detected after one day 
of administration (Ahmad et al., 2005; Alvares et al., 2008). 
The use of an aerosolized nanostructure itraconazole, as prophylaxis against invasive 
pulmonary aspergillosis caused by Aspergillous fumigatus, has been investigated in 
mice.  The nanoparticle drug itraconazole has been found to significantly limit the 
invasiveness of the disease and to improve mouse survival (Hoeben et al., 2006).  
A novel method for systemic delivery of drugs via the lungs was reported using lecithin 
based nanoparticles of less than 300 nm in size in a pressurised aerosol inhaler. The NPs 
deposited in the alveolar space, which is an ideal deposition site for more effective 
results (Dickinson et al., 2001; Nyambura et al., 2009). 
Another major respiratory problem that was targeted by nanomedicines is respiratory 
syncytial virus (RSV) infection, which is a most important cause of respiratory tract 
infection that has no vaccine or treatment so far existing. It is commonly associated with 
bronchiolitis especially in infancy with a higher risk of developing asthma later in life. 
Chitosan /DNA nanoparticles are synthetic polysaccharide nanoparticles commonly 
used in gene transfer therapy because it can release the incorporated drugs for long 
term. Chitosan DNA nanoparticles containing plasmid DNAs encoding all RSV 
antigens were used for intranasal gene transfer into mice, which have resulted in a 
significant induction of RSV-specific antibodies in the mice lungs with a subsequent 
reduction to the viral antigen load and titres following acute RSV infection.  Chitosan-
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DNA nanospheres were also found to reduce allergic airway inflammation similar to 
asthma in mice (Kumar et al., 2003). 
 With regard to the advances in imaging and diagnostic applications of NPs in lung 
imaging, these include advances in delivery of NPs imaging agents to specific tissues or 
cells of concern, nanoprobes for molecular imaging of the disease pathway and the 
enhancement in contrast agents (Buxton, 2007; Pison et al., 2006). 
1.4 The lung 
The main role of the respiratory system is to take oxygen from the external environment 
in exchange for waste gases mainly carbon dioxide, which requires the lung to work 
with maximum efficiency and optimise usage of the large surface area for gas diffusion.  
Although around 10000 litres of air are inhaled every day, the inspired air has low flow 
and turbulence, which facilitates particle deposition in the lungs (Coates et al., 2005; 
Peterson et al., 2008) .  
1.4.1 Smoking and DNA damage  
Various compounds in cigarette smoke can directly form radicals and produce DNA 
single-strand breaks; however, the procarcinogens must be activated first by P-450 
cytochromes before producing single-strand breaks in the DNA, as such this could 
explain how mutations in some members of cytochrome P-450 are linked to lung cancer 
(Miller, 1978). 
In vitro studies have linked tobacco smoke to DNA damage (Au et al., 1991; Bond et 
al., 1989; El-Zein et al., 2010; Hopkin and Evans, 1979; Hopkins and Evans, 1980; 
Song et al., 2010; Willey and Harris, 1990).  Furthermore, an in vivo study has detected 
an increase in 8-hydroxy-2'-deoxyguanosine (which is a product of a reaction between 
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an oxidant and DNA) activity level in smokers’ lymphocytes and lung epithelial cells 
(Kiyosawa et al., 1990; Leanderson and Tagesson, 1992a).  Additionally, human 
respiratory tract epithelial cells treated with gas-phase cigarette smoke produced DNA 
strand breakage as well as guanine and adenine base deamination in all four DNA bases,  
that  pattern of DNA damage was suggestive of oxygen radicals (Spencer et al., 1995).  
Other radicals in cigarette smoke such as hydroquinone and semiquinone have also been 
found to produce DNA damage which could lead to mutations and carcinogenesis 
(Adler et al., 1990; Yoshie and Ohshima, 1998).  The damaging effect of cigarette 
smoking on DNA was suggested due to its ability to produce mutations in certain genes 
which are regarded as unique such as p53 and K-ras genes and are considered as 
fingerprints of oxidative stress to DNA and their association with higher rate and bad 
prognosis of lung cancer in cigarette smokers (Slebos et al., 1991). 
1.4.2 Lung cancer 
In the USA lung cancer is the leading cause of cancer deaths in both men and women  
(Greenlee et al., 2000).  Lung cancer could be of primary origin from the lung cells or of 
secondary origin that due to metastasis from other organs such as breast, colon, prostate, 
cervix, etc. It is commonly presented as a persistent cough.  
 
There are two main histological categories of lung cancer.  Non–small cell lung 
carcinoma is accounting for about 85 % of lung cancers.  It grows more slowly than the 
small cell lung carcinoma, and by the time of its diagnosis, 40% of the patients have 
metastases. The most common types of non–small cell lung carcinoma are 
adenocarcinoma, large cell carcinoma and squamous cell carcinoma (Trushkowsky, 
1991).  Small cell lung carcinoma (oat cell carcinoma), accounts for 13 % of all lung 
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cancers. It is very aggressive form of cancer and by the time of diagnosis the majority of  
patients have metastases (Goossens and De Greve, 2010).  
 
Cigarette smoking is a major cause of lung cancers, responsible for 85% of all lung 
cancer and 10% of all smokers eventually develop lung cancer (Wang et al., 2010b).  
However, lung cancer also occurs in 10% of people who never smoked. Recent studies 
have found that non smokers who develop cancer have mutations in the epidermal 
growth factor receptor (EGFR) gene (Cappuzzo et al., 2007; Lee et al., 2010). Other risk 
factors include exposure to passive smoke or other carcinogens such as asbestos and 
radiation.  
Lung cancer prognosis is always poor. People with advanced non–small cell lung 
carcinoma (NSCC) can survive only for 6 months.  The 5-year survival rate of patients 
with extensive small cell lung cancer or advanced non–small cell lung cancer is less than 
1% (Sawabata et al., 2010).  
 
1.4.2.1 Genetics of lung cancer  
Although there is no evidence that lung cancer has an inherited form, it has been 
frequently associated with some genetic mutations such as the p53 gene which is 
involved with Li-Fraumeni syndrome and the retinoblastoma gene (RB1).  Such 
individuals have a higher risk of developing lung cancer or it could develop at early age.  
Carriers of germ-line mutations in the retinoblastoma gene are also at an increased risk 
(Wikenheiser-Brokamp, 2006).  Additionally, a meta-analysis suggested that lung 
cancer incidence increases with family history of lung cancer.  It more likely to occur if 
more than one family member has been affected and if it was diagnosed at a younger 
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age (Matakidou et al., 2005).  However, less than 10% of all cancers are considered to 
be linked to genetic traits (Ludwig and Weinstein, 2005). 
As some non-smokers (as well as a large minority of smokers) do develop lung cancer, 
genetic influences could be a possible factor of the disease.  As for example mutations 
in some members of cytochrome P-450, GST and NAT gene families which have been 
found to influence detoxification of tobacco smoke constituents (Bouchardy et al., 
2001) .  In addition, malfunctioning of the DNA repair mechanism has also been 
reported in in vivo studies on lung cancer patient cells compared to controls (Breuer et 
al., 2005).  
Varying mutational patterns in K-ras and p53 genes have also been reported in Chinese 
lung cancer patients. Such variation was reported between smokers and non-smokers 
and between different lung cancer cell types that suggest other environmental factors 
than smoking could be involved in the pathogenesis of lung cancer (Gao et al., 1997). 
 
1.4.2.2 Lung cancer biomarkers 
Lung cancer has become a worldwide problem as its occurrence is increasing in 
addition to failure of the chemo- and radio-therapeutic and surgical methods.  It 
constantly has bad prognosis, which gives importance to the chemo-prevention 
therapies that are natural or synthetic small molecules targeting specific sites of 
mutations e.g. inhibitors of ras and epidermal growth factors, as such they can delay, 
prevent or modulate the carcinogenesis process (Soria et al., 2003). 
 
Clinically available lung cancer biomarkers include carcinoembryonic antigen (CEA)  
(Afrikian et al., 1982) and oncofetal antigen that is elevated especially in adeno and 
large cell carcinomas (Boghaert et al., 2008).  However, many oncogenes have been 
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observed and implicated in lung cancer including K-ras, EGFR and Myc genes (Soria et 
al., 2003; Sy et al., 2004; Wong et al., 2002).   
 
 
 
1.4.3 Chronic obstructive pulmonary disease (COPD) genetics 
COPD is a chronic inflammatory disease of the lower airways and lung parenchyma, 
which is enhanced during exacerbations. The pathological changes of COPD consist of 
emphysema (lung parenchyma destruction), airways inflammation, airflow limitation 
(reduced FEV1) and increase in mucus-producing cells. COPD is a worldwide health 
problem that mostly affects people over the age of 40 years.  As the disease progresses 
slowly most patients with symptomatic COPD are middle age or elderly and it 
particularly has a higher incidence in developing countries (Barnes, 2003).  However, 
there is still a fundamental lack of knowledge about the cellular, molecular, and genetic 
causes of COPD, and no therapies are currently adequate to reduce COPD progression 
and mortality. 
1.4.3.1 ROS and COPD  
The oxidative stress from environmental pollutions, noxious gases and particle 
inhalation such as cigarette smoke has been found to play a significant role in the aging 
process of the lungs that leads to COPD (Buist et al., 2007; Harman, 2006; Ito and 
Barnes, 2009).  Additionally, accumulation of ROS that formed during normal 
metabolism has been found to damage the DNA that can lead to aging.  Such 
explanation is in line with the free radical theory of aging which has been supported by 
many subsequent studies (Galaris et al., 2008; Percy et al., 2008; Reeve et al., 2008). 
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1.4.3.2 Predisposing factors to COPD  
Smoking is the key factor in COPD, 15% of smokers will develop COPD and smoking 
is responsible for 90% of COPD.   The symptoms of COPD include, coughing, sputum 
production and breathlessness accompanied by rapid lung function deterioration.   Air 
pollution from indoor stoves used for cooking was also reported as risk factor for COPD 
(Liu et al., 2008).  COPD is also associated with occupational pollutants such as silica, 
coal miners and construction workers (Mukherjee et al., 1993). 
A well-established genetic cause of COPD is alpha-1 antitrypsin  (AAT) deficiency.  
Alpha-1 antitrypsin deficiency is a rare genetic disorder that is inherited as an autosomal 
recessive gene (DeMeo et al., 2009). The normal function of the lung is dependent on 
the elastic fibres that composed of elastin protein and surround the bronchi and the 
alveoli. The elastase enzyme is found in small amount in normal lungs however, its 
secretion increases in cigarette smokers and subsequently breaks down the elastin lung 
fibres and damages the bronchi and alveoli. The AAT is normally produced by the liver 
and is present in normal lungs to block the damaging effects of elastase. 
The AAT deficiency leads to unopposed destruction of the elastic lung tissues by 
elastase and subsequently earlier onset of COPD which cigarette smoking may 
accelerate (Kellermann et al., 1991; Mangione et al., 1991). 
1.4.4 Bronchial asthma 
 
The alveolar surface of the lungs is directly in contact with the external environment. 
Bronchial asthma is characterized by reversible airway obstruction, increased bronchial 
reactivity and airway inflammation. Asthma results from complex interactions among 
inflammatory cells, their mediators, airway epithelium, smooth muscles and the nervous 
system. In genetically susceptible individuals, these interactions can lead the patient 
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with asthma to symptoms of breathlessness, wheezing, cough, and chest tightness 
(Bush, 2002).  The allergic response in the airway is the result of a complex interaction 
of mast cells, eosinophils, T lymphocytes, macrophages, dendritic cells and neutrophils. 
Inhalation-challenge studies with allergens reveal an early allergic response (EAR), 
which occurs within minutes and peaks at 20 minutes following inhalation of the 
allergen. Clinically, the manifestations of the EAR in the airway include bronchial 
constriction, airway oedema and mucous plugging. These effects are the result of mast 
cell–derived mediators. Four to ten hours later, a late allergic response may occur, 
which is characterized by infiltration of inflammatory cells into the airway and is most 
likely caused by cytokine-mediated recruitment and activation of lymphocytes and 
eosinophils.  In developed countries the prevalence of asthma has increased steadily 
over the last century.  Current estimates suggest that about 300 million people 
worldwide suffer with asthma.  Some reports suggest the prevalence of asthma is 
increasing by 50% every decade worldwide.  In the United Kingdom this is more than 
15% (Eder et al., 2006).  Prognosis of asthma is generally good; mortality from asthma 
is rare and usually caused by under treatment and delay in delivering appropriate 
therapy.  Associated phenotypes with asthma include bronchial hyper responsiveness 
and atopy. No asthma genes have yet been known, although, genetic studies pointed out 
that several genes are involved in the pathogenesis of asthma. More than 25 genes have 
been found to be associated with asthma or atopy (Ober and Hoffjan, 2006). 
 
1.5 Toxicity of nanoparticles 
Although free nanoparticles in the environment tend to quickly agglomerate, there still 
are considerable possible environmental and medical dangers because of their 
unpredictable behaviour especially their high surface to volume ratio which makes the 
particles very reactive and able to pass through cell membranes and interact with the 
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biological system (Bharali and Mousa, 2010; Lu et al., 2007; Maurer-Jones et al., 2010; 
Moore, 2006; von der Kammer et al., 2010).  Nanomaterials can enter human tissues 
through different ports, for example, via the lungs after inhalation (Oberdorster, 2001), 
through the digestive system (Jung et al., 2000) and possibly through the skin 
(Kreilgaard, 2002; Lademann et al., 1999). Nanoparticles have also been found to reach 
the olfactory bulb and the cerebellum crossing the blood–brain barrier (Borm and 
Kreyling, 2004; Oberdorster et al., 2004).  NPs could also cross the blood-testis barrier 
(Braydich-Stolle et al., 2005; Jani et al., 1990).  
 
1.5.1 Nanoparticles and generation of oxidants 
 
The genotoxicity of NPs in general could be primary and inflammation-independent 
(Schins, 2002; van Maanen et al., 1999) or secondary to inflammation (Greim et al., 
2001).  NPS could induce ROS and RNS which lead to DNA damage (Marnett, 2000) 
as well as to oxidative attack of the DNA, and therefore leading to structural changes in 
the DNA, for example to deletions, insertions or base pair mutations which are common 
in mutated oncogenes such as ras p21 and tumour suppressor genes (Wiseman and 
Halliwell, 1996).  
As such, persistent formation of oxidants that occurs as the result of inflammations that 
are induced by various particles is considered as a major factor in nanoparticle induced 
genotoxicity.  The major oxidants that are inducing as a result of NPs are hydroxyl 
radicals (●OH) because they are produced mainly as a result of the Fenton reaction 
which involves hydrogen peroxide and transition metals.  The (●OH) are the most potent 
ROS that could react with the four DNA bases and generate new products (Lloyd et al., 
1998; Pryor, 1988). 
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1.5.1.1 The lung and generation of oxidants 
Previous studies have shown  the ability of the lung epithelial cells to generate ROS 
after exposure to quartz particles, fly ash or PM through processes involving 
mitochondrial respiration and activation of NADPH (Deshpande et al., 2002; Driscoll et 
al., 2001; Li et al., 2003; Shukla et al., 2000; Voelkel et al., 2003). Nanoparticles may 
also activate intracellular oxidant formation within the lung such as ROS and RNS 
which are endogenously generated by the lung epithelial cells or vascular endothelial 
cells (Arroyo et al., 1990; Guo et al., 1995; Kinnula et al., 1991). However, the most 
important ROS/RNS generating system in the lung is the influx of inflammatory 
phagocytes during particle exposure (Porter et al., 2002; Schapira et al., 1995).  In 
addition to phagocytes, neutrophils and macrophages could also be activated involving 
NADPH in a process in which oxidase activation has demonstrated in studies with 
asbestos, silica, coal fly ash and ambient particulate matter (PM) (Becker et al., 1996; 
Gusev et al., 1993; Hedenborg and Klockars, 1989; Leanderson and Tagesson, 1992b; 
Prahalad et al., 1999). 
 
1.5.2 Mechanisms of toxicity of nanoparticles  
Reactive oxygen species (ROS) are believed to play a major role in the primary 
genotoxicity of nanoparticles as they generate free radicals in cells and cause oxidative 
stress.  These contribute to their ability to cause cell injury, inflammation, and 
genotoxicity. Excessive and persistent formation of ROS from inflammatory cells is 
considered the hallmark of genotoxicity of nanoparticles. For example, studies on coal 
fly ash have shown a role of particulate size and ion release in  radical generation and 
oxidative DNA damage (Kleinjans et al., 1989). 
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Particle size, shape, crystallinity (e.g., silica), solubility and interaction with the cell 
division process (e.g., asbestos) are other factors besides, the presence of mutagens 
carried with the particle (e.g., diesel exhaust particles, DEP), are additional factors 
related to the primary genotoxicity of nanoparticles. 
 
Photo-mutagenicity, which is the alteration of a non-mutagenic chemical into another 
which is likely to cause mutation after or during exposure to UV light, is another 
mechanism of the toxicity of nanoparticles.  The best known photo-mutagens are the 
furocoumarins especially 8-methoxypsoralen or 8-MOP (Ashwood-Smith et al., 1982; 
Borges et al., 1998; Kim et al., 2000; Miolo et al., 1999; Mizuno, 1981; Song and 
Tapley, 1979).  
 
The nanoparticle’s small size is the most studied contributor to NPs toxicity.  For 
instance in a study that supported the size mechanism of NPs toxicity, treatment of a 
human bronchial epithelial cell line with anatase TiO2 (10 and 20 nm) resulted in DNA 
damage, lipid peroxidation and micronuclei formation in the absence of photo-
activation through oxidative stress induction, however; treatment of the same cells with 
anatase-sized (200 and > 200 nm) particles did not induce oxidative stress (Gurr et al., 
2005).  In a study in bacteria that was comparing toxicity of nano size metal oxides, 
titanium dioxide, zinc, aluminium and silicon to that of their counterpart larger size 
particles, the nano-scaled ZnO have been found to cause bacterial mortality of up to 
100% to all three tested bacterial strains, followed by alumium and silicon but not 
titanium dioxide. Such toxicity was species specific and higher in the nano-scaled than 
the bulky counterparts; the study suggested that toxicity has occurred as response to the 
dissolved particles oxide that could explain the lesser toxicity of TiO2 because it tends to 
aggregate (Jiang et al., 2009). Additionally, earlier studies have shown that lung 
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epithelial cells exposed to different nano-sized particles induced cell proliferation which 
was related to small particles and the bigger particles failed to induce inflammation, it 
was suggested that the special surface properties developed as a consequence of the 
extremely small size of the particles was responsible for the cell proliferation (Baulig et 
al., 2003; Brunsgaard, 1998; Unfried et al., 2008). 
 
Particle solubility has also contributed to NPs toxicity.  For example in vitro 
cytotoxicity tests, evaluating the effect of seven industrial nanoparticles on human 
mesothelioma and in a rodent fibroblast cell line, it was found that solubility strongly 
influenced NPs cytotoxicity (Schrand et al., 2010). In a different  in vitro study 
involving metal oxide toxicity, it was found that cytotoxicity could be contributed to by 
the dissolved metal ions (NPs dissolution) before or after the NPs entered the cell for 
example Zn2+ (Brunner et al., 2006). 
 
1.5.3 Pulmonary toxicity of nanoparticles 
Occupational and environmental exposure to many particles has been related to an 
increasing risk of lung diseases and lung cancer such as crystalline silica and asbestos 
fibres. The mechanism of nanoparticle genotoxicity to the lung could be due to reactive 
oxygen species generated primarily by NPs through different mechanisms such as 
mitochondrial activation by the NPs or secondary through induction of an inflammatory 
response, as well as NPs carrying adsorbed carcinogenic components into the lung. 
Pulmonary effects of inhaled NPs are attributed to the ease of their translocation from 
the lung into the blood stream due to their small size and their capacity to produce 
inflammatory responses in the lung.  
There are many NPs to which the lung could be exposed. A substantial number of 
nanoparticles are already in consumer products such as sunscreens, cosmetics, and many 
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more to follow. There is great potential for the respiratory system to be open to 
countless unique nanoparticles. In vivo studies of dispersed single-walled carbon 
nanotubes (SWCNT) have been found to rapidly be incorporated into the alveolar 
interstitium and subsequently increased collagen deposition (Mercer et al., 2008).  The 
kinetics of distribution of intravenous administered TiO2 in male Wister rats treated for 
1, 14, and 28 days distribution, then assessed for  toxicity and distribution has found 
that, TiO2 has maximum availability in the liver, followed by spleen, lung, and kidney 
with no toxic effect and not detected in blood cells or brain (Fabian et al., 2008). 
In vivo studies in rats exposed to aggregated ultra fine TiO2 and carbon black, have 
found that both compounds induced lung tumors in rats at considerably lower 
gravimetric lung burdens than larger sized TiO2 (Bermudez et al., 2002; Oberdorster, 
1996) .  In another in vivo study, rats developed more lung  inflammation with a nano 
size TiO2 compared to that produced by larger particles (Donaldson et al., 2002; 
Oberdorster et al., 2000).  Yet another in vivo study, has found that rats exposed to 
ultra-fine P25 TiO2 for a period of time,  produced lung tumours in 16-30% of the 
studied rats which indicates that chronic inhalation of the studied nanoparticles can be 
carcinogenic (Heinrich et al., 1995).   
Significant species differences too have been reported in the pulmonary responses to 
inhaled TiO2 particles, for example rats developed a more severe and persistent 
pulmonary inflammatory response than mice or hamsters and were also unique in the 
development of progressive fibro-proliferative lesions and alveolar epithelial metaplasia 
in response to exposure to a high concentration of TiO2 particles (Bermudez et al., 
2002).  As regards to the  photo-genotoxic effects of TiO2  to the lungs, TiO2 have been 
found to induce
 
clastogenicity in Chinese hamster lung cells (Nakagawa et al., 1997) in 
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the Comet assay, but positive responses were generally only at toxic doses.  However, 
TiO2 was found not to exhibit photochemical genotoxicity in the same system in another 
study (Theogaraj et al., 2007).  
 
Environmental studies have suggested that low exposure to ambient particulate matter 
(PM), contributes to lung cancer, even after correction for other risk factors such as 
cigarette smoking, diet, occupational exposure and other individual risk factors (Abbey 
et al., 1999; Pope et al., 2002).  PM is a mixture of particulate matter from different 
sources therefore, PM is  subject to continuous variation in  composition and activity 
but it is not clear which of  the PM components could be responsible for its 
carcinogenicity (Salvi and Holgate, 1999). In addition, nanomaterials are increasingly 
emitted in the environment due to the large scale of nanomaterials production which has 
been shown to be responsible for many acute and chronic disorders including neoplasia. 
Different mechanisms have been suggested to contribute to NPs induced lung diseases 
including particle accumulation followed by inflammatory cell influx and subsequently 
cell proliferation.  Also NPs directly or indirectly through inflammatory cell production 
can cause genetic damage or the production and release of oxidants which could lead to 
proliferative or mutational effects to their target cells.  Accumulation of mutated cells 
could eventually cause malignant diseases particularly if protective mechanisms such as 
DNA repair and selective apoptosis fail.  The 8 hydroxydeoxyguanosine (8-OHdG), 
which is an oxidized nucleoside of DNA that occurs upon DNA repair, was found to be 
increased in the lung tissues of rats exposed to diesel exhaust inhalation (Ichinose et al., 
1997; Seiler et al., 2001).  In addition, in vivo studies in rats exposed to carbon black or 
to crystaline silica have shown enhanced HPRT mutations in alveolar epithelial cells 
(Driscoll et al., 1997). 
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Oxidative stress is now considered as a mechanism underlying inflammatory, 
proliferative and genotoxic responses as well as regulating cellular signalling due to 
ability of the particles to generate reactive oxygen species (ROS) and reactive nitrogen 
species (Fubini and Hubbard, 2003; Schins, 2002). 
 
1.5.4 Toxicity to other systems    
       
1.5.4.1 Dermatological toxicity 
Skin plays a critical role in the testing for toxicity of nanoparticles, as sunscreens 
constitute most of the commercial use of nanoparticles as part of the sun protection 
factor (SPF), which contain up to 25% of either ZnO or TiO2. On testing TiO2 (anatase 
and rutile) and ZnO extracted from different sunscreens in cultured human fibroblasts, 
the results showed that illuminated TiO2 induced DNA strand breaks, and there was 
some evidence that hydroxyl radicals may have played a part in the observed DNA 
effects.  This was because DMSO and mannitol suppressed the DNA damage, and the 
conclusion of the study suggested possible health hazards with TiO2 if it can enter 
viable cells after penetrating the stratum corneum (Dunford et al., 1997).  Studies 
carried out in vitro and in vivo on human cells, found that TiO2 caused  formation of 
hydroxyl (●OH) radicals with subsequent DNA damage (strand breaks) through the 
generation of free radicals by photo-catalytic reactions . 
 
 However, in a second but contradictory study, human volunteers and skin biopsies were 
tested for dermal penetration of coated TiO2 micro particles, the result showed that the 
deeper the skin the more the skin free from NPs.   The TiO2 concentration as well was 
decreased with
 
increasing depth of the stratum corneum (Lademann et al., 1999).  In a 
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third contradictory study in which different skin samples were used, electron 
microscopy results showed that in healthy skin the nanoparticles penetrated into the 
deepest corneocyte layer of the skin, but never reached the vital layer (Kertész et 
al.2004). In addition, on testing dermal uptake of nano TiO2 and determining it is 
localization in the skin using transmission electron microscopy (TEM), TiO2 was found 
only in trace amounts in the upper part of the follicle as clear agglomerates without any 
evidence of uptake into follicular epithelium.  The study concluded that follicles are not 
a relevant route of penetration for TiO2  (Pflucker et al., 1999). 
 
1.5.4.2 Haematological and cardiovascular toxicity 
Nanoparticles of gold and polystyrene have been shown to cause haemolysis and blood 
clotting.  Combustions e.g. diesel soot and diesel particles injected into hamster lungs 
caused clear cardiovascular effects and thrombosis (Nemmar et al., 2001).  
Additionally, inhaled nanoparticles, were also found to interfere with the heart pace 
maker directly, causing heart rate alteration and arrhythmias in hypertensive rats 
(Campen et al., 2003).   Furthermore, carbon black nanoparticles directly injected into 
the blood of healthy mice, induced platelet accumulation in hepatic micro vessels with 
prothombotic changes (Khandoga et al., 2004).   
 
 1.5.4.3 Central nervous system (CNS) toxicity 
After inhalation, NPs can bypass the blood brain barriers and reach the brain through 
the olfactory epithelium (Lockman et al., 2004), or could be carried out wrapped in low 
density lipoproteins (Kim et al., 2007).  A healthy blood brain barrier (BBB) protects 
the brain from the effects of nanoparticles but some diseases, as for example 
hypertension, distort BBB defences and increase their permeability of the barriers.  Also 
the surface charges of nanoparticles alter the BBB rendering it more permeable and less 
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effective and subsequently nanoparticles can get easy access to the brain (Lockman et 
al., 2004).  Additionally, studies in mice exposed to nanoparticles showed activation of 
pro-inflammatory cytokines in the brain (Fabian et al., 2008; Shin et al., 2010). 
 
 
 
1.5.4.4 Germ cell toxicity 
 DNA damage to somatic cells can give rise to cancer but damage to germ cells can not 
only give rise to cancer, but can also cause congenital defects in future generations. 
Studies in Chinese hamster ovary (CHO) cells treated with ZnO under various 
illumination conditions, found that ZnO has photo-clastogenic properties which were 
four-fold greater in the presence of UV light, but less than the photo-genotoxic effect of 
8-MOP (Dufour et al., 2006) .   
In addition, a separate study has found that gold nanoparticles had spermatotoxic effects 
after gold nanoparticles mixed with human spermatozoa lead to gold penetration into 
the sperm heads and tails and as a result, 25% of sperm lost their motility.  The effect of 
different types of nanoparticles was also investigated in mouse spermatogonial germ 
line stem cells and demonstrated a concentration-dependent toxicity for silver, 
molybdenum and aluminium nanoparticles tested, whereas the corresponding soluble 
salts had no significant effects (Braydich-Stolle et al., 2005). 
 
1.5.4.5 Bactericidal effect of nanoparticles 
 
The bactericidal action of photo-activated TiO2 particles have been demonstrated on 
contaminated dental implants and metal pins used for skeletal traction (Tsuang et al., 
2008).  In addition, TiO2, SiO2 and ZnO suspended in water have been found to be 
cytotoxic towards all tested bacteria (B. subtilis and E. coli) and the eukaryotic Daphnia 
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magna.  In addition, the toxicity of NPs increased with the particle concentrations and 
decreased from ZnO to TiO2 to SiO2 (Adams et al., 2006a; Adams et al., 2006b). 
 
On the other hand,  several studies have reported that fullerenes nC60 have bactericidal 
effects on gram negative and gram-positive bacteria and other studies reported  almost 
complete elimination of bacteria  from water by using nC60 (Fortner et al., 2007; Lyon 
and Alvarez, 2008).  Not all nanoparticles are bactericidal, but modified fullerenes are 
used as antimicrobial agents. 
   
In addition, Z-MITE powders, which are inorganic zinc oxide nanoparticles, are used 
commercially as antibacterial and antifungal and they confirm the cytotoxic effect of 
ZnO. 
 
1.5.4.6 Toxicity to environmental aquatic species  
There is a great concern regarding the environmental impact of nanoparticles, in the 
form of adverse effects on wildlife. Studies showed harmful and damaging effects to 
wild life creatures.  A study examined water-soluble fullerene (nC60) and it has been 
shown to induce lipid peroxidation and oxidative stress in the brain of the juvenile 
largemouth bass (LMB) fish (Oberdörster, 2004). Water-stirred-nC60 was found to 
elevate lipid peroxidation in the brain and gill of aquatic fish significantly causing 100% 
mortality (Zhu et al., 2006).  The aquatic toxicity screening studies in a 72h acute test 
involving the green algae Pseudokirchneriella subcapitata have concluded that  ultra-
fine TiO2  has a low hazard potential (Warheit et al., 2007a).  However, (Zhu et al., 
2008) have studied developmental toxicity of metal oxide nanoparticles, and the results 
demonstrated that ZnO is very toxic to zebra fish embryos and larvae.  Photo-activated 
TiO2 extracted from different sunscreens, have been reported to catalyse DNA damage 
both in vitro and in human cells (Dunford et al., 1997).     
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1.5.4.7 Cellular effects of nanoparticles  
Previous studies have shown that Chinese Hamster V79 cells exposed to micronised 
ZnO, developed structural chromosomal aberrations. The researcher concluded their 
findings as a positive clastogenic activity of ZnO under the study conditions (Theogaraj 
et al., 2007). In another study, 130 µg/ml of TiO2 in the absence of UV light, were found 
to be highly toxic to WIL2-NS cells (Wang et al., 2007b).  The potential use of TiO2 in 
the photo killing of malignant cells in the presence of photo-irradiation (photodynamic 
therapy), was investigated in HeLa cells treated with illuminated ultra fine TiO2 powder 
, the  researchers reported that HeLa cells were completely killed after TiO2 exposure 
and the resulting cytotoxicity was due to free radical formation (Ito and Barnes, 2009). 
 
1.6 DNA repair mechanisms 
DNA damage results in chromosomal breakage, alteration in the gene transcription of 
the cell to which that specific DNA encodes and induction of mutations in the cell 
genome. Therefore, the DNA repair mechanisms are essential to maintain the genome 
stability and integrity, thus the DNA repair is a continuously active process through 
which the cell identifies and corrects the damage to the DNA in its genome.  In human 
cells,   as many as 1000 - 1 million lesions per cell occurs every day as a result of 
normal metabolic activities or environmental factors such as UV light, radiation and 
other genotoxins (Browner et al., 2004).  The cell responds to genotoxic insults by 
activating different pathways such as cell-cycle arrest, apoptosis or DNA repair.  Many 
factors govern the rate of DNA repair, these include the cell age and type. Subsequently 
the cell that has a great amount of  accumulated DNA damage, or the cell that cannot 
repair the DNA damage effectively  can either enter a state of senescence (which is a 
state of  irreversible dormancy, apoptosis or undergoes uncontrolled cell division with 
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neoplastic formation especially if it occurred in critical genes as for example the tumor 
suppressor genes. The DNA damage repair genes protecting the DNA and as such 
influence the life span. 
 
 
 
1.6.1 Single strand DNA repair 
For single strand breaks (SSBs), the repair mechanism involve one strand to be used as 
a template for the correction of the damaged strand through different excision repair 
mechanisms mostly  by replacing the damaged nucleotide with an undamaged 
complementary nucleotide from the undamaged DNA strand (Watson and Losick, 
2004).  The base excision repair (BER) is an example of the excision repair mechanism, 
which repairs damage to a single DNA base that damaged through a different 
biochemical processes.  The damaged part is removed by a DNA glycosylase, the 
endonuclease then recognise the missing base which is then resynthesized by DNA 
polymerase, and sealed up by DNA ligase (Watson and Losick, 2004).  Mismatch repair 
(MMR), is another repair mechanism that corrects undamaged but mispaired 
nucleotides due to errors of DNA replication and recombination (Watson and Losick, 
2004).  
 
1.6.2 Double strand DNA repair  
DNA repair is also critical for cell survival after mammalian cells exposure to genotoxic 
agents that cause DNA damage especially DSBs. The double-strand breaks and DNA 
crosslinkages that occur as the result of failed normal repair system and or apoptosis are 
particularly dangerous because they can cause genome rearrangements (Acharya, 1972; 
Bjorksten et al., 1971). 
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The DNA repair mechanisms for double-strand breaks (DSBs), includes two pathways, 
in the first pathway the DNA broken ends aligned and joined together by sequence 
homology, in the second pathway the broken ends rejoined without sequence homology: 
1) Non-homologous end joining (NHEJ):  In NHEJ, DNA Ligase IV together with 
cofactor XRCC4 act together to directly joins the two broken DNA ends (Wilson et al., 
1997) and for accurate repair, NHEJ rely on a short homologous sequence 
(microhomologies)  at the ends of a single-strand tail to be joined. If these 
microhomologies are compatible, they usually give accurate repair although it can 
accidentally produce mutations for example deletion due to loss of the damaged 
nucleosides during repair (Burma et al., 2006)  
2) Homologous recombination  requires the presence of identical or semi-identical 
sequences because that sequence will be used as a template for the damaged 
chromosome repair through a sister chromatid  which would be available in G2 
(Watanabe et al., 2009). 
Defects in DNA repair (faulty DNA repair) can leads to accumulation of mutations and 
genomic rearrangements that promote carcinogenesis or various hereditary genetic 
disorders such as hereditary cancers e.g. breast  and hereditary nonpolyposis colorectal 
cancer (HNPCC), xeroderma pigmentosum and all accelerated aging diseases in which 
their sufferers appears old and suffer from geriatric diseases at young age.  Inherited 
DNA repair genes mutations are associated with high cancer risk for example  BRCA1 
and BRCA2 genes which  are tumour suppress genes that helps in DNA repair , BRCA1 
and BRCA2 mutations leads to hereditary breast cancer (Boulton, 2006). 
1.7 The cell cycle controls and cancer 
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Autosomal cell cycle normally pass through four phases: S phase which is the DNA 
synthesis and replication phase and M phase (mitosis) or cell separation phase.  The S 
and M phases are separated by two gap phases G1 and G2 and the non dividing cell rest 
at G0 phase the whole cell cycle machinery is dependent on cycline kinases (CdKs) 
activation or inhibition (Hamel and Hanley-Hyde, 1997).  
 
Tumours can be either benign or malignant "cancer". Malignant tumours grow 
aggressively and invade other tissues of the body (metastasis), as the result tumour cells 
enter into the bloodstream or lymphatic system and then invade other sites in the body. 
All cancers result from an abnormality in the balance system of the cell growth. 
Normally, balance between cell growth and cell death is maintained so that the cells 
division to produce new cells occurs only when new cells needed. Disruption of the 
control system that checks and balance cell growth results in an uncontrolled cell 
division and eventually tumour formation.  Mutations which enhance cell proliferation 
and that inhibit apoptotic signals leads to cancer. 
In the last decades, a number of mutated genes have been identified in human cancer 
cells, and categorized into: proto-oncogenes, tumour suppressors and DNA repair genes.  
Mutational changes in these genes by activation of proto-oncogenes or inhibition of 
tumour suppress genes can lead to uncontrolled cell growth, proliferation and 
immortality.  In addition, mutation of DNA repair gene can lead to inactivation and 
accumulation of mutations. 
1.7.1 Ras proteins 
Human ras genes code for small proteins those contain 189 amino acids, with a 
molecular weight of 21,000 Daltons (p21).  The ras proteins are members of  GTPases 
family (G proteins), that include proteins involved in  signal transduction in which  ras 
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act as a molecular switch because it alternate between an inactive form guanosine 5'-
diphosphate (GDP) and an active guanosine 5'-triphosphate (GTP) form (Boguski and 
McCormick, 1993).  Ras is synthesized as a biologically inactive (Pro-ras) and localized 
to the inner surface of the plasma membranes (Hancock et al., 1989; Hancock et al., 
1990; Pearson, 1979).   Ras genes which have yet been identified are structurally and 
functionally similar three ras oncoproteins named H-ras gene, which is homologous to 
the oncogene of the Harvey murine sarcoma virus, the K-ras gene (homologous to the 
oncogene of the Kirsten murine sarcoma virus and the N-ras gene (Mulcahy et al., 
1985).   
1.7.1.1 Ras role in the cell cycle regulation 
Previous studies have shown that stimulation of ras p 21 expression in quiescent mouse 
fibroblasts lead to cell cycle entry, and an antibody to ras prevents S phase entry (Stacey 
and Kung, 1984).  Ras proteins were shown to influence cells proliferation, 
differentiation, transformation, and apoptosis by signalling mitogenic and growth 
signals into the cell cytoplasm and nucleolus (Khosravi-Far and Der, 1994).  During the 
cell cycle ras have been found to become activated in the mid G1 phase (Taylor and 
Shalloway, 1996), it  also involve in  multiple steps of transition between G1 and S 
phases (Dobrowolski et al., 1994).  For normal cell growth to occur, it needs balance 
between growth stimulation and growth inhibition pathways.  Malfunction of numerous 
pathways is needed for malignant transformation.   
1.7.1.2 Ras p21 and cancer 
The ras p21 protein encodes by the ras gene which was the first oncogene shown to 
cause human cancer (Barbacid, 1987) through single base changes in the ras gene which 
turn ras proteins to transforming protein (p21). Ras p21 contains substitution of single 
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amino acids at position 12, 13, and or 61 (Croce, 2008) in the wild-type,  which are 
critical positions in the polypeptide chain (Bos, 1989; Pincus, 2004).   The ras 
oncogenes in different human tumors contain such point mutation, which leads to their 
transforming activity that can induce neoplasm in experimental animals (Chie et al., 
1999; Stanley, 1995). 
 Mutated ras genes have been found in around 30% of human malignancies, with the 
highest incidence of ras gene mutations reported in K-ras genes, which was detected in 
80-90% of pancreatic malignancies (Ballas et al., 1988; Smit et al., 1988) and in 30-
60% of colorectal carcinomas (Husgafvel-Pursiainen et al., 1992; Rodenhuis et al., 
1997; Rodenhuis and Slebos, 1992; Sagawa et al., 1998; Suzuki et al., 1990).  Many 
studies targeted ras in the last two decades to have better understanding of the 
mechanism by which mutated ras gene confer into cells neoplasia which could help in 
the production of more effective and less toxic cancer therapeutic.   In quiescent normal 
cells GTPase regulatory activating proteins (GAPs) help to keep most p21 ras in an 
inactive GDP, over expression of non-mutated ras could lead to GAPs regulatory 
proteins saturation with subsequent deregulation of ras activity and oncogenic 
transformation (Ahmadian et al., 1996). 
 
1.7.1.3 Ras and other signalling pathways  
The non-mutated ras genes (wild type) play a key role in the regulation of many 
physiological processes, such as a role as intermediates in other signal transduction 
pathways that act as shuttles between the cytosol and the nucleus (Adler et al., 1995; 
Adler et al., 1996).  These signalling pathways include receptor tyrosine kinase and 
other protein kinase which control many cellular processes, such as cellular growth and 
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differentiation and apoptosis (Barbacid, 1987; Boguski and McCormick, 1993; Bos, 
1989; Lowy and Willumsen, 1993; Ruta et al., 1986) 
 Activated, ras p21 stimulates wide range of essential proteins that regulates different 
nuclear and cytoplasmic processes, such as growth factors (e.g. epidermal growth factor) 
and hormones e.g., insulin (McCormick, 1994).  For ras to induce mitosis, it must 
activate other proteins that end in the nucleus, typically, tyrosine kinase is the cell-
surface receptor for these growth factors which in return promote autophosphorylation 
(Bos, 1989; Khosravi-Far and Der, 1994; McCormick, 1993; Pazin and Williams, 
1992).  However, the most important of such proteins is Raf which becomes activated 
after it binds to ras-p21 in the cell membrane, Raf in return activates many 
phosphorylation reactions which includes activation Mitogen-activated protein kinase 
(MAPK).  
1.7. 2 Phosphotyrosine and the cell cycle 
Tyrosine is a non- essential amino acid, which, is normally used by the cell for protein 
synthesis.  It is also called (Tyr or Y) or 4 hydroxyphenylalanine, tyrosine is found 
naturally in casein and acts as a precursor of important hormones and enzymes e.g. 
adrenaline and thyroxin.  Most importantly it has a key function in the signal 
transduction process as it acts as a receiver of phosphate groups by protein kinases 
(receptor tyrosine kinases).  Phosphorylation of the hydroxyl group changes the activity 
of the tagged protein (phosphorylated) and is referred to as phosphotyrosine. 
 
 Various tyrosine kinases (TK) are turned on during cell division while non-
proliferating cells have very low levels of tyrosyl phosphorylated proteins. As such 
phosphotyrosines are a very important subset of proteins that mediates a variety of 
cellular processes, including cell differentiation, growth, adhesion, motility, death, and 
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metabolism. Disturbances or dysregulations of tyrosine phosphorylation is implicated in 
the development of many human diseases, such as diabetes and cancer (Krause and Van 
Etten, 2005).  Phosphotyrosine play a key role in a variety of cellular functions and have 
been the targets for investigation of specific signalling pathways as well as for the 
development of therapeutic drugs. 
 
1.8 Methods for the study of genotoxic effects 
 
1.8.1 The Comet assay 
 
The Comet assay or single cell gel electrophoresis assay is a sensitive method compared 
that can detect double strand breaks (DSB), single strand breaks (SSB), alkali labile 
sites (ALS) and cross-links.  It is a reliable, rapid method for DNA damage detection 
that can reliably assesses and determine in vitro and in vivo environmental genotoxins 
(Collins and Horvathova, 2001; Singh et al., 1988; Tice et al., 2000).   
 
The alkaline Comet assay with pH ≥13  for DNA unwinding and electrophoresis, has 
advantages over the neutral Comet assay (pH 8-9) as it allows the detection of double 
DSB, SSB as well as ALS, while the latter can mainly detect DSB (Singh et al., 1988) 
and only some SSB from the relaxation of super coiled loops.  The alkaline comet tail is 
formed of SSB and alkali labile sites but mainly single strand breaks (Collins, 2004).  
 
Many chemicals, medicines as well as foods were investigated for their genotoxicity in 
lymphocytes and sperm either on their own (Anderson et al., 1997), or combined with 
antioxidants (Anderson et al., 2003). Some chemicals for example, ethylene glycol 
mono ethyl ether produced positive responses in sperm but not in lymphocytes, which 
was thought to be due to lack of repair in sperm compared to lymphocytes (Anderson et 
al., 1997).  
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The US Food and Drug Administration (US FDA), and the UK Committee on 
Mutagenicity of Chemicals in Food, Consumer Products and Environment have 
approved the use of the Comet assay for in vivo bio-monitoring of genotoxins 
(Burlinson et al., 2007). For example in mice herbicides like bentazon were investigated  
(Garagna et al., 2005) and in rats cyclophosphamide (Anderson et al., 1996).  The 
Comet assay has also been used in sperm to test people exposed to occupational hazards 
from pesticides (Xia et al., 2008). 
1.8.1.1 Comet assay on lymphocytes 
Lymphocyte cells are routinely used as surrogate to test for different chemicals and 
other genotoxic materials.  All lymphocytes should be tested for viability after treatment 
to exclude cytotoxic effects of the chemicals, and   viability of ≥ 75% in the trypan blue 
dye exclusion test should be produced for the tested compound to avoid false positive 
results on the Comet assay (Henderson et al., 1998) . Viability varies and 50% viable 
cells in trypan blue are considered as viable by the World health organization (World 
Health Organization, 2001).  However, 75% was prefers as a cut-off point to avoid false 
positive (Henderson et al., 1998).  Untreated lymphocytes can show between 0-10% 
DNA in the tail (Collins, 2004) and sperm can show up to 20 % DNA in the tail 
(McKelvey-Martin et al., 1997).   
 
1.8. 1.2 Comet assay on sperm 
To investigate repro-toxins with the Comet assay, sperm have more advantage over ova 
as they are easier to obtain by simple non invasive methods, also sperm production is 
continuous and renewable throughout most of human life (Baumgartner et al., 2009). 
 
Compared to lymphocytes, sperm chromatin contains nine fold more single strand 
segments which subsequently could become ALS.  Also, sperm nuclei contain more 
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than double the SSB compared to lymphocytes (Muriel et al., 2004).  Sperm chromatin 
is 6 times more compacted than metaphase chromosomes (Ward and Coffey, 1991).  
Sperm from fertile men are more resistant to toxicants than infertile samples 
(McKelvey-Martin et al., 1997) , which has been indicated by completed questionnaires 
from donors, including their reproductive history, according to the WHO criteria (World 
Health, 2001).  Sperm DNA also contains highly condensed nuclear chromatin 
stabilized by intra- and intermolecular disulphide bonds (Hughes et al., 1996). Breaking 
the disulphide bond during lysis is an important step for a successful alkaline Comet 
assay (pH ≥ 13) (Singh et al., 1989). In the alkaline Comet assay (pH ≥ 13) human and 
mouse sperm can yield up to 106 -107 SSB due to the presence of numerous alkali 
labile sites which is a functional characteristic of sperm, and does not occur under 
neutral conditions nor in lymphocytes  (Singh et al., 1989).  Depending on the 
conditions used, sperm freezing can affect sperm chromatin structure and morphology 
due to ice crystal formation or severe osmotic changes (Hammadeh et al., 1999).  It can 
also increase membrane rigidity and decrease viability to ≤ 45%. However other studies 
found no differences between fresh and frozen sperm samples (Steele et al., 2000). 
1.8.2 Western blotting method 
Western blotting or immunoblotting allows the determination, with a specific primary 
antibody, the relative amounts of the protein present in different samples. Tyrosine 
phosphorylation of proteins is difficult to detect unless external stimuli are present; even 
then, many proteins are phosphorylated only in response to one stimulus (Ignatoski, 
2001). 
1.8.3 The cytokinesis-block micronucleus assay (CBMN)  
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The cytokinesis-block micronucleus assay (CBMN) in human lymphocytes is a 
commonly used assay for measuring DNA damage that occurs as a result of different 
genotoxic and cytotoxic insults (Fenech, 2007), in determining safety of 
pharmaceuticals and chemicals and in preventive medicine (Bonassi et al., 2007; Fenech 
et al., 2005; Kirsch-Volders et al., 2003; Lee et al., 2003).  The many advantages of 
CBMN compared with other cytogenetics methods lead to it being preferred over the 
other cytogenetic methods.  These advantages include that it is a quick, inexpensive 
method  and it is easier to score micronuclei compared with chromosome aberrations  
(Fenech, 2002b).  It is also easy to identify the cells that have successfully completeted 
one nuclear division, because micronuclei, nucleoplasmic bridges and nuclear buds are 
dependent on and only expressed after completion of nuclear division (Umegaki and 
Fenech, 2000). 
The CBMN can be carried out in human blood or lymphocytes after the cell cultures are 
stimulated for cell division (PHA).  It could also carried out or cell lines.  Measurements 
should be carried out in cultured and/or mammalian cells because scoring is restricted 
BN cells that denotes dividing cell (Carter, 1967; Fenech, 2000).  
In the CBMN, the DNA damage is measured in a divided binucleated (BN) cells and the 
measurements include scoring the number of  micronuclei (MN) which are biomarkers 
of chromosome breaks or whole chromosome loss, nucleoplasmic bridges (NPBs) 
which are  a biomarkers of DNA misrepair that measure chromosome rearrangement 
and  nuclear buds are  biomarker of amplified DNA repair complexes, in addition to 
apopotetic and necrotic cells (Shimizu et al., 2000).  The mechanism of MN, NPBs and 
nuclear buds occurs at the anaphase of nuclear division, chromosome fragments or 
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whole chromosomes that lag behind give rise to micronuclei (Fenech, 2000; Heddle, 
1973; Schmid, 1975).  
In this assay, the dividing cell cytokinesis is blocked with cytochalasin B (Cyto B), 
which is an inhibitor of microfilament ring assembly that is essential for the completion 
of the cell division therefore the  cell division is blocked in the binucleated stage 
(Fenech, 2000; Fenech and Morley, 1986).  The micronuclei originate during cell 
division as a result of chromosome fragments or whole chromosomes that failed to 
accompany the mitotic spindle, accordingly it lags behind and therefore, expressed as 
micronuclei.  Additionally, prevention of anaphase bridges breakage as a result of 
cytokinesis inhibition by cyto B makes it accessible to score nucleoplasmic bridges 
(NPBs) that originate through a variety of mechanisms.  Nucleoplasmic bridges could 
originate from centromeres of dicentric chromosomes or chromatid that pulled to the 
opposite end of the cell leading to asymmetrical chromosome rearrangement or DNA 
strand breaks misrepair (Thomas et al., 2003) or telomere end fusions that occurs as a 
consequence of telomere shortening accompanied aging process (Blasco, 2005; 
Stewenius et al., 2005).   Moreover, detection of nuclear buds, which is a marker of 
possible gene amplification and an indicator of genotoxic insult similar to MN and 
NPBs, is another advantage of CBMN assay (Fenech, 2002a; Serrano-Garcia and 
Montero-Montoya, 2001). 
1.9 Aims and objectives: 
• In spite of the fact that ZnO and TiO2 are widely used in many consumer 
products, none of the investigations has focused on the effects of these 
nanoparticles on human germ cells.  Therefore the first plan was to investigate 
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the effect of ZnO and TiO2 (anatase form) in human sperm and lymphocytes in 
the presence and absence of UVA irradiation using the Comet assay.   
• Different mechanisms of ZnO and TiO2 toxicity were previously considered in 
many studies however, tyrosine phosphorylation which is a major signalling 
pathway that mediates cell growth, differentiation, host defence, and metabolic 
regulations, was never investigated before. Hence the second strategy was to 
investigate the tyrosine phosphorylation events in the presence of different ZnO 
and TiO2 concentrations in HEp-2 cells (HeLa).  Additionally, to investigate 
their cytotoxic (using MTT and NRU assays) and genotoxic (using Comet and 
CBMN assays on the same cell line.  
• Given the scale of nanotechnology production, therefore, it is inevitable that the 
waste of nanotechnology products will accumulate and contaminate the 
environment.  The respiratory pathway is the main route of entry of 
environmental pollutant particles to the body through inhalation. Accordingly, it 
is necessary to understand how engineered TiO2 NPs interact with human cells 
following exposure of the more vulnerable respiratory disease patients compared 
to the healthy individuals.  Therefore, the objective was to compare the effects 
of TiO2 nanoparticles in peripheral blood lymphocytes from patients with 
respiratory diseases and healthy individuals using genotoxic endpoints (Comet 
and CBMN assays) and to determine whether the respiratory disease patients 
had a specific mechanism, which could contribute to TiO2 potential toxicity.  
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2.1 Materials 
 
The following chemicals were used in the work, obtained from suppliers indicated. 
 
Table 2.1: Chemicals and their suppliers  
 
Chemicals, Reagents And Media Supplier 
Acetic acid BDH, Poole, UK 
Acrylamide / Bis solution 30% Bio-Rad, Hertfordshire, UK 
Agarose normal melting point Invitrogen, Paisely, UK 
Amersham Hyperfilm ECL GE Healthcare, Buckinghamshire , UK 
Ammonium persulphate(APS) Sigma, Poole, Dorset, UK 
Anti-biotin, HRP-linked antibody Cell signalling, Hitchin, Hertfordshire, UK 
Anti mouse IgG, HRP-linked antibody Cell signalling, Hitchin, Hertfordshire, UK 
Biotinated protein ladder Cell signalling, Hitchin, Hertfordshire, UK 
Bovine serum albumin Invitrogen Ltd, Paisley, UK 
Bromophenol blue Sigma, Poole, Dorset,UK 
Coumaric Acid (p-) Sigma, Poole, Dorset, UK 
Cytochalasine B Sigma, Poole, Dorset, UK 
DC Protein Assay Kit Bio-Rad, Hertfordshire, UK 
Dimethyl sulfoxide (DMSO) Sigma, Poole, Dorset, UK 
Dithiothreitol (DTT) Sigma, Poole, Dorset, UK 
EMEM- EBSS  culture medium  Invitrogen Ltd, Paisley, UK 
Ethanol BDH, Poole, Dorset, UK 
Ethidium bromide Sigma, Poole, Dorset, UK 
 EDTA BDH, Poole, Dorset, UK  
Fetal calf Serum Invitrogen Ltd, Paisley, UK 
Formaldehyde Merck, Nottingham, UK  
GADPH Abcam, Cambridge, UK 
Giemsa staining solution BDH, Poole, Dorset, UK 
Glutamine Gibco, Paisley, UK 
Glycerol Sigma , Poole, Dorset, UK 
HEp-2 (HeLa derivative) ECACC, Porton Down, Salisbury, UK 
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Histamount Fisher scientific, Loughbrough, UK 
Hybond-P (PVDF membrane) GE Healthcare, Buckinghamshire, UK 
Hydrogen peroxide Sigma, Poole, Dorset, UK  
Laemli sample buffer 2X concentrate Sigma, Poole, Dorset, UK 
Low melting point agarose Sigma, Poole, Dorset, UK 
Luminol Sigma, Poole, Dorset, UK 
Lymphoprep Axis Shield, Oslo, Norway 
Mitomycin C Sigma, Poole, Dorset, UK 
2-Mercaptoethanol Sigma Aldrich, York, UK 
Methanol Sigma, Poole, Dorset, UK 
Non Essential Amino Acids Gibco, Paisley, UK 
Pan ras p21 primary antibody Abcam, Cambridge, UK 
Phosphatase inhibitor cocktail 2 Sigma, Poole, Dorset, UK 
Phospho-tyrosine mouse mAb  Cell signalling, Hitchin, Hertfordshire, UK 
Protease inhibitor cocktail Sigma, Poole, Dorset, UK 
Phytohaemaglutinin (PHA) Invitrogen Ltd, Paisely, UK 
Ponceau S, practical grade Sigma, Poole, Dorset,  UK 
RPMI medium 1640  Invitrogen, Paisley, UK 
Sodium dodecylsulphate Sigma, Poole, Dorset, UK 
Sodium Chloride BDH, Poole, Dorset, UK 
Sodium Hydroxide BDH, Pool, Dorset, UK 
Supported nitrocellulose membrane 0.45 µm Bio-Rad, Hertfordshire, UK 
SW 480 cell lysates Abcam, Cambridge, UK 
Titanium dioxide iv (anatase) Sigma, Poole, Dorset, UK 
N,N,N’,N’-Tetramethylethylenediamine (TMED) Sigma, Poole, Dorset, UK 
Triton X-100 Sigma, Poole, Dorset, UK 
Trizma base Sigma, Poole, Dorset, UK 
Trypan blue Sigma, Poole, Dorset, UK 
Trypsin Sigma, Poole, Dorset, UK 
Tween 20 Sigma, Poole, Dorset, UK 
Zinc oxide Sigma, Poole, Dorset, UK 
 
Table 2.2 Equipment and other materials  
 
Equipments and other Services Company / Distributor 
Centrifuge Mistral 3000 MSE, Albertville, USA 
Centrifuge (biofuge 28 RS) Heraeus, Sepatech, Germany 
CCD camera Hitachi KPMI/EK Monochrome, Japan 
Coplin jar VWR, Lutterworth, UK 
Cover glass VWR, lutterworth, UK 
Cryovials Sarstedet, Numbercht, Germany 
Culture flasks (25&75 Cm3) Corning Incorporated Co star®, NY, USA 
Dry incubator (37º C) LKB  BIOCHROM Leec LTD, Nottingham, UK 
Electrophoresis power supply Consort (E861), Belgium 
Electrophoresis tank (HU20) Scie-Plas, Renfrewshire, UK 
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Falcon tubes BD, Swindon, UK 
Freezer -20º C Sanyo, Ultra low, Japan 
Freezer -80º C Sanyo, Ultra low, Japan 
Fluorescent microscope Leica, Weztler, Germany 
Fume cupboard Milton, UK 
Fume hood ray air Maiche Aire, Bolton, UK 
Ice maker (Scotsman AF 100) Namur, Belgium 
Incubator 37º C with 5% CO2 Hera cell 150, Heraeus, Germany 
Light microscope Nikon, Japan 
Liquid nitrogen tank Biostar, UK 
Komet 4 soft ware Kinetic Imaging, Nottingham, UK 
Magnetic stirrer SMI Stuart Scientific, Essex, UK 
Microcentrifuge MSE GMI, Alberville, USA 
Microcentrifuge MSE Sanyo, Bucks, UK 
Microplate reader Dynex technology, Sussex, UK 
Microscope (ortholux) Leitz, Sturttgart, Germany 
Mini protein 11 gel electrophoresis  Bio- Rad, Hertfordshire, UK 
MSE 150 WATT ultrasonic disintegrator MK2   MSE technical, Bucks, UK. 
Pipettes Gilson, Middleton, WI, USA 
pH meter  Dunmow, UK 
Power pack supply Pharmacia LKB, Uppsala, UK 
Quanta 400 scanning electron microscope FEI, Netherlands 
Quartz Cuvete Vector, Peterbrough, England 
Quartz Cuvete reader Pharmacia Biotech Ltd,,Cambridge, UK 
Spectrophotometer Biochrom ultrospec 11 LKG 
Super frost slides VWR, Lutterworth, UK 
Ultra spec 2000 spectrophotometer Biochrom 
ultrospec 11 
Pharmacia Biotech Ltd,,Cambridge, UK 
UV light Lamp UVitec, Cambridge, UK 
Water bath Grant instruments, Cambridge, UK 
Zeta sizer-nano Malvern instruments, UK 
 
2.2 Methods: 
2.2.1 Methods for effect of zinc oxide and titanium dioxide nanoparticles in the 
Comet assay with UVA photoactivation of human sperm and lymphocytes study 
 
 
2.2.1.1 Preparation of ZnO and TiO2 nanoparticle stock suspensions 
Zinc oxide (ZnO) CAS 1314-13-2, Sigma Aldrich) and titanium (IV) oxide nano-
powder 99.7%, anatase (CAS 1317-70-0 Sigma Aldrich), were suspended in DMSO and 
used to make serial dilutions.  After suspension of Zinc oxide (ZnO) and titanium 
dioxide (TiO2 anatase) nano-powders in DMSO, They were sonicated using a MSE 
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ultrasonic disintegrator (MK2 -150 Watt) for 5 min (1 min on and 30 seconds off). 
Before filtration the optical density (OD) at optimum wavelengths of 370 nm for ZnO 
and 340 nm for TiO2 was measured using a spectrophotometer. The suspensions were 
filtered through a 0.2 µm syringe filter and the OD of the filtrate measured. Using the 
OD before and after filtration, the concentrations of the filtrate were determined. To 
prepare the stock suspensions that were used in the experiments, the filtrates were 
processed through serial dilutions. Four concentrations were used for each of the 
compounds tested. For ZnO, the concentrations used were 11.5, 46.2, 69.4 and 92.3 
µg/ml and for TiO2 the concentrations used were 3.73, 14.92, 29.85 and 59.7 µg/ml. 
Concentrations were different due to the differential solubility of these two compounds 
in DMSO.  The particle size was ascertained using photon correlation spectrometry 
(Zeta analyser, Malvern instruments) and scanning electron microscopy (SEM). For 
SEM analysis a drop of nano-suspension of the ZnO and TiO2 was placed and air dried 
on separate mesh Formvar carbon coated (adhesive carbon stubs) and then used for 
SEM. The particle size was observed to be between the 40 nm and 70 nm range. 
2.2.1.2 Blood sample collection and lymphocyte isolation  
 
The collection of lymphocytes had been approved by the University of Bradford 
Subcommittee for ethics in research involving human Subjects Ref no. 0405-8. Blood 
samples were collected in 10 ml heparinized tubes from healthy non-smoker individuals 
after signing a consent form.  Following blood sample collection, the following method 
was used to isolate the lymphocytes 
1. The blood sample was diluted 1:1 in 0.9% NaCl and mixed gently 
2. LymphoprepTM (3 ml) was placed in 15 ml Falcon tubes. 
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3. Each 3 ml LymphoprepTM were then overlaid gently and carefully (so as not to mix 
the phases) with 6 ml of the diluted blood. 
4. Falcon tubes were centrifuged at 1900 rpm (800g) for 20 minutes. 
5. In the meantime, 10 ml of 0.9% NaCl (w/v) were placed in 50 ml universal tubes  
6. Four layers of different blood consistencies were formed and the cloudy layer 
(lymphocytes) was collected from the interface by a Pasteur pipette and transferred to 
50 ml Universal tubes. 
7.  The Universal tubes were then centrifuged at 1500 rpm (400g) for 15 minutes at 
20ºC. 
8. The supernatant was removed and the pellet was resuspended in 900 µl warm foetal 
bovine serum (FBS) and placed in a cryovial supplemented with 100 µl DMSO. The 
cryovials were placed at -20º C for 2 hours and transferred to -80º C overnight and 
lastly placed in liquid nitrogen.  
2.2.1.3 Single cell gel electrophoresis (SCGE)/ Comet assay 
The alkaline Comet assay PH ≥ 13 was used in all experiments according to the 
methods by Tice and Singh (Singh et al., 1988; Tice et al., 2000).  In this technique 
DNA damage is measured cell by cell using a micro gel electrophoresis technique. The 
image/ shape of the damaged migrating DNA under the microscope resemble a comet. 
The alkaline Comet assay pH ≥13 for DNA unwinding and electrophoresis was first 
introduced by Singh in 1988.  It is a sensitive, reliable and rapid  and can detect double 
strand breaks (DSB), single strand breaks (SSB), alkali labile sites (ALS) and cross-
linked DNA damage (Wang et al., 2000). Additionally it can reliably assesses and 
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determine in vitro and in vivo lifestyle and environmental genotoxins (Baumgartner et 
al., 2009).   
 
In the alkaline Comet assay, the comet tail is formed of SSB and ALS and mainly SSB 
(Collins, 2004) and has advantages over the neutral Comet assay (pH 8-9) as it allows 
detection of double DSB, SSB as well as ALS, while the latter can mainly detect DSB 
and only some SSB from the relaxation of super coiled loops (Singh et al., 1988). 
 
Table 2.3 Chemicals and reagents for the Comet assay 
 
Buffers/Reagents Chemical constituents of reagents 
Low melting point agarose (LMP) 0.5% (w/v) low melting point agarose in PBS 
1% (w/v) low melting point agarose in PBS 
2% (w/v) low melting point agarose in PBS 
Normal melting point  agarose 
 
1% (w/v) normal melting point agarose in 
ddH2O2 
 
Lysing buffer 2.5 M NaCl, 8g NaOH, 100 mM EDTA, 10 mM 
Trizma base dissolved in ddH2O2 then the pH is 
adjusted to 10. Triton X-100 and DMSO added 
later. 
Sterile PBS 1n one litre ddH2O2 dissolve the following 8g 
NaCl, 0.2g, KCl, 1.44g Na2HPO4, 0.24g 
KH2PO4, and adjust pH to 7.4 with 0.1M HCl, 
then autoclaved. 
 
Neutralizing buffer 0.4 M Trizma adjust pH to 7.5 with 
concentrated HCl 
Staining solution 20 µg/ml ethidium bromide (EtBr) 
Electrophoresis buffer 10 M NaOH , 1 mM EDTA (pH 10 with NaOH 
or HCl 
 
2.2.1.3. 1 Alkaline Comet assay on lymphocytes 
2.2.1.3.1.1 Treatments and viabilities 
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All membrane integrity/ viabilities were measured by trypan dye blue exclusion to 
avoid false positive responses due to toxicity. The cut-off point used was 75% viable 
cells that exclude trypan blue dye due to their intact membranes which indicate viability 
(Henderson et al., 1998). For lymphocytes: Viabilities were measured in freshly 
collected as well as thawed samples. However, the viabilities for sperm were measured 
only in fresh samples, as it is difficult to obtain viabilities after freezing.  Different 
concentrations of all chemicals used in this study were tested for their cytotoxicity after 
treatment and before applying such concentrations; only cells showed viability of ≥ 75% 
were used.  The steps followed for trypan exclusion test were as follows: 
 
After treatment and before performing the Comet assay or adding LMPA, all treated 
cells were tested for viability at the concentrations chosen to exclude cytotoxic effects. 
The viability was determined by the trypan dye exclusion test (10µl of 0.05% trypan 
blue was added to 10µl of cell suspension) and the percentage of cells which excluded 
the dye (indicating an undamaged cell membrane) was estimated using a 
haemocytometer under a microscope.  Only concentrations with viability  of ≥ 75% in 
the trypan blue dye exclusion test were considered for the test  compound to avoid false 
positive results (Henderson et al., 1998).  Different concentrations of ZnO, TiO2 H2O2 
were prepared, and then tested on lymphocytes and sperm for viability.  Only 
concentrations that gave viability > 75% were used in all experiments whenever H2O2 
used (Henderson et al., 1998) . 
 
2.2.1.3.1.2 DNA damage and repair of H2O2 in lymphocytes  
Different H2O2 concentrations were prepared and tested on lymphocytes viability by 
trypan blue exclusion test only H2O2 concentrations that gave lymphocytes viability of  
≥ 75% was selected for the experiment. The experiment was carried out as follows: For 
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lymphocytes resustation, PBS was prepared in a universal tube; lymphocytes were 
thawed quickly and added to PBS.  The cells were washed in PBS by centrifugation at 
1600 rpm for 5 minutes to remove DMSO and FCS, because DMSO is an antioxidant 
and FCS proteins are also protective to the cell and act as a protein shield around the 
cell.  The supernatant was discarded and the pellet re-suspended in PBS. 
 
Phosphate buffered saline (PBS) 890 µl was used as a solvent, 10 µl treatment solution 
(1%) and 100 µl lymphocyte solution were mixed in Eppendorf® tubes and incubated at 
37ºC for 30 minutes. After incubation the Eppendorf® tubes were centrifuged at 4000 
rpm  for five minutes, then 900 µl of supernatant was discarded, the cell pellet was re-
suspended and mixed with an equal volume of 1% low melting point agarose 
(Invitrogen: 15517-022) and layered on super frost slides. The layer was allowed to gel 
on an ice block.  A third layer of 0.5% low melting point agarose was added on top and 
also allowed to gel on an ice block, the Comet assay was then carried out.  
 
 For the repair kinetics study, 900 µl of the supernatant were removed and replaced with 
RPMI 1640.  The cells were gently resuspended and incubated at 37ºC for different 
times up to 20 hours.  There after slides were prepared and Comet assay was carried out. 
 
2.2.1.3.1.3 UVA irradiation of lymphocyte cells 
 
Three sets of 6 well cell culture plates (CLS 3516: Corning® Incorporated Co Star® 
NY, USA) were used for each experiment. The UVA radiation dose was provided using 
a lamp which consisted of two Waldmann F15/T8-PUVA tubes (Villingen-
Scwenningen, Germany) in a casing (Wavelength range : 320-410 nm with peak 
emissions at 351 nm). In each set, a negative control with PBS in place of the chemicals 
and a positive control (80µM H2O2) were included for comparison. Each experiment 
was carried out with 3 independent repeats.  In each experiment the following chemical 
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concentrations were used: for ZnO, (0, 11.5, 46.2, 69.4 and 92.3 µg/ml) and 80 µM 
H2O2 (as a positive control) and for TiO2 the concentrations used were (0, 3.73, 14.92, 
29.85 and 59.7 µg/ml) and 80 µM H2O2 (as a positive control).   
 
Phosphate buffered saline (PBS) 890 µl was used as a solvent, 10 µl treatment solution 
(1% ) and 100 µl lymphocytes solution were mixed in Eppendorf® tubes and incubated 
at 37ºc for 30 minutes in H2O2 assays and for different times for nanoparticles 
depending on the assays. After incubation the Eppendorf® tubes were centrifuged at 
4000 rpm  for five minutes and after discarding 900 µl of supernatant, the cell pellet was 
re-suspended and mixed with an equal volume of 1% low melting point agarose 
(Invitrogen: 15517-022) and layered on super frost slides. The layer was allowed to gel 
on an ice block.  A third layer of 0.5% low melting point agarose was added on top and 
also allowed to gel on an ice block. 
 
 2.2.1.3.1.3.1 Non-irradiation of lymphocytes (D) 
 
A 6-well cell culture plate with PBS (phosphate buffered saline) and cells was floated in 
a water bath in the dark (without UVA irradiation) maintained at 37ºC for 30 min after 
which the chemical was added and further incubated in the dark maintained at 37ºC 
another 30 min. 
 
2.2.1.3.1.3.2 Pre-irradiation (PI) of lymphocytes  
The second 6-well cell culture plate with PBS and the cells was floated in a water bath 
maintained at 37ºC for lymphocytes and exposed to UV for 30 min (1.68 
milliwatts/cm2). Subsequently the chemical was added and incubated for another 30 
min in the absence of UV at 37ºC. 
 
2.2.1.3.1.3.3 Simultaneous irradiation (SI) of lymphocytes 
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The third 6-well cell culture plate with PBS and the cells was floated in a water bath 
maintained at 37ºC in the dark for 30 min. After this the chemical was added and 
exposed to UV for 30 min (1.68 milliwatts /cm2) at 37ºC.   In each set, a negative 
control with PBS in place of the chemicals and a positive control (80 mMH2O2) were 
included for comparison. 
2.2.1.3.1.4 Slide preparation  
The slides were prepared according to the protocol of (Tice et al., 2000).  Super frosted 
slides flamed in 70% ethanol were dipped in 1% normal agarose (Invitrogen: 15510-
027) and left to air dry to be used in the Comet assay.  Following incubation of 
lymphocytes with the different chemicals, the samples were centrifuged. An amount of 
900 µl was then removed from the supernatant. The remaining 100 µl of the cell 
samples (approx 104) was mixed with 100 µl of 1% LMPA.  The second layer of the 
LMPA was spread over 2 duplicate slides and immediately covered with a cover glass 
(24 x 50 mm) and left to set on ice tray for 5 minutes.  A third layer of 0.5% LMPA 
(100 µl) was applied on top of the second layer after carefully removing the cover slips 
and left to dry on an ice for 5 minutes. 
2.2.1.3.1.5 Lysis of lymphocyte cells 
The aim of the lysing step was to liberate the DNA. After removal of the cover slips the 
slides were immersed laterally in cold lysing solution.  The lysing solution contained 
high salts to accelerate cell swelling and rupture the membrane.  It consisted of 2.5M 
NaCl (BDH), 100 mM EDTA (Sigma: E 3154), 10 mM Trizma base (Sigma: T- 6066), 
10% DMSO and 1% Triton X-100. The lysing solution was prepared during the 
incubation period, for each 50 ml, 44.5 ml lysis solution, 0.5 ml Triton X-100 and 5 ml 
DMSO were used.  DMSO was used to prevent radical induced DNA damage 
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associated with iron released from erythrocytes during lysing.   The lysing step started 
after the third layer of agarose solidified, the cover slip was removed and the slides were 
immersed laterally and incubated over night in a cold final lysing solution at 4ºC which 
was chilled to maintain the stability of the agarose layers. 
 
 
2.2.1.3.1.6 DNA unwinding and electrophoresis of lymphocytes 
The slides removed from the lysing solution were rinsed carefully in electrophoresis 
buffer PH ≥13 to remove detergent and salts.  The slides were kept in an electrophoresis 
tank filled up to the level of ~ 0.25 cm above the slides with electrophoresis buffer 
[containing 60 ml of 300 mM NaOH (BDH: 301675N) and 1mM Na2 EDTA (pH ~ 
13.5)] and 1930 ml of ddH2O2 for 30 minutes at 4ºC to produce single stranded DNA 
and to express alkali labile damage. Unwinding and electrophoresis was conducted at 
4ºC for 30 minutes each for lymphocytes or 20 minutes each for sperm using a constant 
voltage of 25 volts /cm and ~ 300 mA current, which was adjusted by raising or 
lowering the buffer level and using a compact power supply.  Unwinding and 
electrophoresis were conducted inside a fridge to avoid light. 
2.2.1.3.1.7 Neutralization 
The slides were removed from the electrophoresis buffer and neutralized with three 
washes of cold Tris buffer (pH 7.5) which contained Trizma base with the final 
concentration of 0.4 M.  The aim of the neutralization step was to stop the alkaline 
buffer effect. 
2.2.1.3.1.8 Slide staining and coding  
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In this assay ehidium bromide (EtBr) which is a DNA specific dye was used to visualize 
the slides at a concentration of (20 µg/ml), 60 µl were added to each slide. All slides 
were coded by an independent person to prevent bias in scoring. 
 
 
2.2.1.3.2 Comet assay on sperm  
The collection of sperm had been approved by the University of Bradford 
Subcommittee for ethics in research involving human Subjects Ref no. 0405-8. The 
semen samples were obtained from healthy volunteers through masturbation after 
abstinence for 4 days. All donors completed a questionnaire including their reproductive 
history and conformed to the WHO criteria for collection of sperm (World Health, 
2001).  The sperm samples were deposited at the laboratory within 2 hours of 
collection. A 100 µl aliquot was used for conventional semen analysis and 50 µl of 
semen was aliquoted into Eppendorf® tubes and flash frozen in liquid nitrogen and 
stored in liquid nitrogen for future use.  Comet assay on sperm was carried out 
according to the protocol of (Anderson et al., 2003). 
2.2.1.3.2.1 Effect of H2O2 on sperm  
Different H2O2 concentrations were prepared and tested on freshly collected sperm for 
membrane integrity/viability by the trypan blue dye exclusion test.  Only H2O2 
concentrations that gave viability of ≥ 75% on sperm were selected for the experiment. 
The experiment was carried out as follows: Phosphate buffered saline (PBS), and sperm 
differ depending on sperm concentration but generally between 4-6µl, 10 µl treatment 
solution (1% ) and PBS to make a total of 1 ml, all mixed in Eppendorf® tubes and 
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incubated in a water bath at 32ºC for 30 minutes. After incubation the Eppendorf® tubes 
were centrifuged at 3000 rpm  for three minutes, then 900 µl of supernatant was 
discarded, the cell pellet was re-suspended and mixed with an equal volume of 1% low 
melting point agarose (Invitrogen: 15517-022) and layered on super frost slides. The 
layer was allowed to gel on an ice block.  A third layer of 0.5% low melting point 
agarose was added on top and also allowed to gel on an ice block, the Comet assay was 
then carried out.  
2.2.1.3.2.2 UVA irradiation of sperm cells 
Three sets of 6 well cell culture plates (CLS 3516: Corning® Incorporated Co Star® 
NY, USA) were used for each experiment.  The UVA radiation dose was provided 
using a lamp which consisted of two Waldmann F15/T8-PUVA tubes (Villingen-
Scwenningen, Germany) in a casing (Wavelength range : 320-410 nm with peak 
emissions at 351 nm). In each set, a negative control with PBS in place of the chemicals 
and a positive control (80µM H2O2) were included for comparison. Each experiment 
was carried out in 3 independent repeats. 
2.2.1.3.2.2.1 Treatment of sperm cells with ZnO and TiO2 
The amount of PBS used and the number of sperm varied depending on the sperm 
concentration, but on an average 4 µl of sperm, 986 ml PBS and 10 µl chemical were 
used.  Cells were incubated at 32ºC water bath.  After incubation samples were 
centrifuged at 3000 rpm x 3 minutes.   
2.2.1.3.2.2.2 Non-irradiation of sperm (D) A 6-well cell culture plate with PBS and 
cells was floated in a water bath in the dark maintained at 32ºC for 30 minutes after 
which the chemical was added and further incubated in the dark maintained at 32ºC for 
lymphocytes for another 30 min. 
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2.2.1.3.2.2.3 Pre-irradiation (PI) of sperm  
The second 6-well cell culture plate with PBS and the cells was floated in a water bath 
maintained at 32ºC and exposed to UV for 30 min (1.68 milliwatts/ cm2).  Subsequently 
the chemical was added and incubated for another 30 min in the absence of UV at 32ºC.  
 
 
 
 
 
 
2.2.1.3.2.2.4 Simultaneous irradiation (SI) of sperm 
The third 6 well cell culture plate with PBS and the sperm cells suspension were floated 
in the dark for 30 minutes at 32°C after which the chemicals were added and exposed to 
UV for 30 minutes (1.68 milliwatts/cm2) at 32°C, i.e. sperm received irradiation 
simultaneously with ZnO or TiO2 treatment.  
2.2.1.3.2.3 Slide preparation for the sperm assay 
The primary preparation and agarose coating for superfrost slides was similar for both 
lymphocytes and sperm.  After incubation of sperm cells with the different chemicals, 
the samples were centrifuged. An amount of 900 µl was then removed from the 
supernatant. The remaining 100 µl of the cell samples was mixed with 100 µl of 2% 
LMP.  The second layer of the LMPA was laid over 2 duplicate slides and immediately 
covered with a cover glass (24 x 50 mm) and left to set on ice tray for 5 minutes.  A 
third layer of 0.5% LMPA (100 µl) was applied on top of the second layer after 
carefully removing the cover slips and left to dry on ice for 5 minutes. 
 
2.2.1.3.2.4 Lysis of sperm cells 
 
The aim of the lysing step was to liberate the sperm DNA. After removal of the cover 
slips the slides were immersed laterally in cold lysing solution.  The lysing solution 
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contained high salts to accelerate cell swelling and rupture the membrane.  It consisted 
of 2.5M NaCl (BDH), 100 mM EDTA (Sigma: E 3154), 10 mM Trizma base (Sigma:  
T- 6066), 10% DMSO and 1% Triton X-100. The lysing solution was prepared during 
the incubation period, for each 50 ml (44.5 ml lysis solution, 0.5 ml Triton X-100 and 5 
ml ddH2O2) were used.  Two lysis steps were carried out to liberate the sperm DNA 
instead of one as for lymphocytes.  The first lysis step started after the third layer of 
agarose solidified, the cover slips then removed and the slides were immersed in a cold 
lysis solution that contained 10 mM dithiothreitol (DTT) (Sigma: D-9779) and 
incubated in the refrigerator for 1 hour, thereafter, washed in PBS for 5 minutes.  They 
were then immersed in a second lysis solution that contained 10 mg proteinase K (PK, 
Roche: 1000144) and incubated in the fridge for another hour, and washed in 
electrophoresis buffer for 5 minutes. DDT and PK were used to break the strong 
disulphide bonds in the sperm. 
 
2.2.1.3.2.5 Sperm DNA unwinding and electrophoresis 
The slides were removed from the lysing solution, then rinsed in an electrophoresis 
buffer PH ≥13, and kept in an electrophoresis tank with electrophoresis buffer. 
Unwinding and electrophoresis was conducted at 4ºC for 20 minutes each using a 
constant voltage of 25 volts and ~ 300 mA current. 
2.2.1.3.2.6 Neutralization 
 
The slides were removed from the electrophoresis buffer and neutralized with three 
washes of cold Tris buffer (pH 7.5) which contained Trizma base with the final 
concentration of 0.4 M.  The aim of the neutralization step was to stop the alkaline 
buffer effect. 
 
2.2.1.3.2.7 Slide staining and coding 
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In this assay ehidium bromide (EtBr) which is a DNA specific dye was used to visualize 
the slides at a concentration of (20 µg/ml); 60 µl were added to each slide. All slides 
were coded by an independent person to prevent bias in scoring. 
 
 
 
 
2.2.2 Methods for genotoxicity and cytotoxicity of zinc oxide and titanium dioxide 
in HEp-2 cells 
 
2.2.2.1 Cell culture of the HEp-2 cell line  
Human negroid cervix carcinoma HEp-2 cells (HeLa derivative) were obtained from the 
European collection of cell cultures (ECACC, catalogue No 86030501). Such cells have 
been the mainstay of cancer research for determining the cytotoxic effects of different 
chemicals (Campbell et al., 2005; Cole et al., 1994; Kusumoto et al., 1988; Lebret et al., 
2008). HEp-2 cells were maintained in continuous culture in pre-warmed Eagle's 
minimal essential medium in Earle’s balanced salt solution (EMEM-EBSS) 
supplemented with 1% non-essential amino acids (NEAA), 2 mM glutamine, 10% (v/v) 
fetal bovine serum (FBS), 100 units/ml penicillin and 100 mg/ml streptomycin (P/S) 
from Gibco, Paisley, UK. The medium was changed every 3-4 days and the cells were 
maintained in a humidified atmosphere of 5% CO2 at 37 ºC. Cells were passaged upon 
confluence at a ratio of 1:3 stocks of cells were routinely frozen and stored in liquid 
nitrogen. 
 
2.2.2.2 Chemicals  
(Some of these chemicals have been described in Table 2.1, but are mentioned here 
again for ease of presentation).  Zinc oxide nano-powder (ZnO; CAS 1314-13-2), and 
anatase titanium (IV) oxide nano-powder (TiO2, 99.7%, CAS 1317-70-0), low melting-
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point agarose (LMA), normal melting-point agarose (NMA), thiazolyl blue tetrazolium 
bromide [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) dye 
(CAS 298-93-1),  ; neutral red (NRU) dye (CAS 553-24-2); ethidium bromide (EtBr) 
and Triton X-100 were purchased from Sigma Aldrich, Poole, Dorset, UK. Phosphate 
buffered saline (Ca2+, Mg2+-free; PBS), Trypan blue dye solution and 10,000 U/ml of 
trypsin–EDTA were purchased from Gibco.  Acrylamide / bis-acrylamide solution 
(30%), Bio-Rad protein assay dye reagent concentrate (CAS 500-0006), buffers, 
membranes and films were purchased from Bio-Rad, Hertfordshire, UK. 
Phosphotyrosine mouse monoclonal antibody (P-Tyr-100) and anti-mouse IgG-HRP 
linked antibody were purchased from Cell Signalling Technology, Hitchin, 
Hertfordshire, UK. 
 
2.2.2.3 Particle preparation and characterization 
 
Nanoparticles were suspended in 10 ml EMEM-EBBS medium at concentrations of 10, 
20, 50, and 100 µg/ml. Suspensions were probe-sonicated at a current of 30 W for 
5 minutes on and off  then allowed to equilibrate for different times: 0, 2, 4, 24, and 48 
hours. The first two times were chosen to look at more immediate effects, the latter two 
time points to evaluate long-term effects. The resulting ZnO and TiO2 suspensions were 
measured as a function of incubation time. Prior to evaluation of the toxic potential, the 
mean size (hydrodynamic diameter) of the nanoparticles was determined using a high 
performance particle sizer (Malvern Instruments Ltd., Worcestershire, U.K.). Before 
analysis suspensions were briefly shaken to resemble the cell culture incubation 
conditions. Suspensions were placed in disposable cuvettes and three consecutive 
measurements at 25 ºC each consisting of three runs were undertaken. 
 
2.2.2.4 Cytotoxicity assays 
58 
 
2.2.2.4.1 MTT assay  
The MTT assay to evaluate the mitochondrial activity was undertaken according to the 
originally described method (Mosmann, 1983). HEp-2 cells were plated in 96-well 
plates and the cell concentration (~1.5x104) was chosen as previously successfully used 
(Khan et al., 2007; Uboldi et al., 2009). The cells were incubated for 24 hours at 37° C 
and 5 % CO2, then incubated for different time periods (2, 4, 24 and 48 hours) with ZnO 
or TiO2 nanoparticles. The MTT dye was added 4 h prior to completion of incubation 
periods. The medium from each well was discarded and the resulting formazan crystals 
were solubilized by adding 200 µl of dimethylsulphoxide (DMSO) and quantified by 
measuring absorbance at 570 nm. 
 
2.2.2.4.2 Neutral red uptake (NRU) assay  
The NRU assay was performed to determine the accumulation of the neutral red dye in 
the lysosomes of viable, uninjured cells (Borenfreund and Puerner, 1985).The medium 
was discarded and 100 µl of neutral red dye (50 µg/ml) dissolved in serum free medium 
was added to each well. After incubation at 37 °C for 3 h, cells were washed with PBS 
and the dye taken up by cells was dissolved in 200 µl of a fixative solution (50% 
ethanol, 49% ddH2O2 and 1% acetic acid) and added to each well. Absorbance was 
taken at 570 nm in MRX 11 micro-plate reader (Dynex Technologies, USA), using the 
software Revelation version 4.02. 
2.2.2.5 Comet assay on HEp-2 cells 
2.2.2.5.1 Cell viability 
Prior to the Comet assay, cells were incubated with different concentrations (10, 20, 50, 
100 µg/ml) of ZnO or TiO2 nanoparticles for 4 hours then assayed for viability using the 
Trypan blue dye exclusion test. The cut-off point was 75% as suggested by Henderson 
and colleagues (Henderson et al., 1998). 
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2.2.2.5 Comet assay on HEp-2 cells 
The sub-confluent monolayer was exposed to four different concentrations of ZnO and 
TiO2, and 2.72 µg/ml (= 80 µM) of hydrogen peroxide (H2O2) as a positive control. 
There was also a negative control using untreated cells. After an incubation of 4 hours, 
cells were washed with cold PBS and harvested with trypsin-EDTA and followed by 
centrifugation at ~180 g for 9 minutes. The pellet was finally resuspended in PBS. The 
Comet slides were prepared by the method as previously described (Tice et al., 2000). 
The cell suspension (100 µl) was mixed with 100 µl of 1% LMA, of which 100 µl was 
spread onto microscope slides pre-coated with 1% NMA. The slides were kept 
overnight at 4 °C in freshly prepared, chilled lysis solution (2.5 M NaCl, 100 mM 
EDTA, 10 mM Tris, with 1% Triton X-100; pH 10). The slides were subjected to 
freshly prepared cold alkaline electrophoresis buffer (1 mM EDTA sodium salt and 
300 mM NaOH; pH ≥13) for DNA unwinding, then electrophorized for 30 minutes each 
at 4 °C in electrophoresis buffer. The electrophoresis buffer was neutralized with Tris 
buffer (400 mM, pH 7.4) and stained with 20 µg/ml ethidium bromide. Fifty cells from 
each concentration were scored ‘blindly’ at a final magnification of 400x using an 
image analysis system (Komet 4.0 attached to a fluorescence microscope equipped with 
a CCD camera). The Olive tail moment and % tail DNA were used as parameters to 
measure the DNA damage in each cell. Three repeat experiments were carried out over 
the dose ranges used. 
 
2.2.2.6 Cytokinesis-block micronucleus (CBMN) assay on HEp-2 cells 
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The in vitro CBMN assay was performed as described previously (Fenech, 1993). HEp-
2 cells were grown in 6-well cell culture plates suspended in 2 ml EMEM medium at a 
concentration of 1x105. After 24 hours of culture, either the TiO2 nanoparticles (10, 20 
and 50 µg/ml) or ZnO nanoparticles (10, 20, 50 and 100 µg/ml) or mitomycin C 
(positive control; 0.4 µM = 0.134 µg/ml) were added to the cultures. An untreated 
culture served as the negative control. Following 2 hours of incubation, the culture 
medium was removed and the cells were washed with PBS. After the treatment, 7.5 µl 
cytochalasin B (final concentration 0.01 mg/ml) was added to fresh culture medium and 
incubated overnight. HEp-2 cells were trypsinized and centrifuged at ~180 g for 8 
minutes. The cell pellet was treated with cold hypotonic solution (70 mM KC1) for 15 
minutes and centrifuged at ~180 g rpm for 8 minutes, fixed in methanol / acetic acid 
(3:1), and air-dried. Slides were stained with 5% Giemsa for 10 min for the detection of 
micronuclei in binucleated cells. Micronuclei were scored and frequencies were 
evaluated per 1000 binucleated cells. 
 
2.2.2.7 Detection of tyrosine phosphorylation in HEp-2 cells  
2.2.2.7.1 Culture of HEp-2 cells    
 
The cells were maintained in continuous culture in pre-warmed Eagle's minimal 
essential medium in Earle’s balanced salt solution (EMEM-EBSS) supplemented with 
1% non-essential amino acids (NEAA), 2 mM glutamine, 10% (v/v) fetal bovine serum 
(FBS), 100 U/ml penicillin and 100 mg/ml streptomycin (P/S) from Gibco, Paisley, UK. 
The medium was changed every 3-4 days and the cells were maintained in a humidified 
atmosphere of 5% CO2 at 37 ºC.  Cells were passaged upon confluence at a ratio of 1:3. 
Stocks of cells were routinely frozen and stored in liquid nitrogen. 
 
2.2.2.7.2 Treatment of HEp -2 cells and protein extraction 
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 A sub-confluent HEp-2 monolayer was treated with different concentrations (0, 10, 20, 
50 and 100 µg/ml) of ZnO or TiO2 nanoparticles and incubated for 4 hours. Untreated 
cells served as a negative control. After the treatment, the cells were trypsinized and 
suspended in 10 ml PBS and centrifuged at ~180 g for 9 minutes. The HEp-2 cell pellet 
was resuspended in 200 µl PBS and assessed (10 µl) for viability and membrane 
integrity using the Trypan blue dye exclusion test. Ninety microliters of cell suspension 
were added to 10 ml PBS for Western Blotting, while the rest (100 µl) was used for the 
Comet assay. After centrifugation (~180 g for 9 minutes), RIPA lysing buffer in 
addition to protease and phosphatase inhibitors was added to the pellet.   RIPA was used 
because its contents (table 2.4) are potent protein solubilizers without protein 
degradation. The resulting cell suspension was briefly sonicated (~5 seconds) at 30 W. 
Protein concentrations were determined in each sample using the Bio-Rad microplate 
DC assay (Lowry).  SDS detergent was used to break up cell membranes to release 
proteins for later analysis using Western blotting. The cell concentration in the lysing 
buffer was 104 cells /µl of lysis buffer. Samples were then collected in Eppendorf® 
tubes, labelled and kept at - 20ºC. A hole was made in the cap of each tube to prevent 
popping during boiling. The cell lysate was suspended in Laemli sample buffer and 35 
µg proteins from each sample was loaded on SDS gel and detected by the 
immunoblotting technique using a phosphotyrosine mouse monoclonal primary 
antibody (P-Tyr-100) and an anti-mouse IgG-HRP linked secondary antibody.      
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Table 2.4 Protein extraction and Western blotting buffers  
 
2.2.2.7.3 Protein concentration 
The protein concentration was measured using Bio-Rad DC Protein microplate assay 
which is colorimetric assay based on Lowry assay (Lowry et al., 1951).  The Bio-Rad 
DC Protein kit consists of reagent A which is an alkaline copper tartrate, reagent B 
Buffer Constituents 
Blotting buffer (10X) 0.25 M TRIS and1.92 M glycine.  On use add 20% 
methanol 
Laemmli sample 
buffer2x concentrate 
4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.125 M 
Tris HCl, pH 6.8, and 0.004% bromphenol blue  
Resolving gel buffer 1.5M tris HCl buffer pH 6.8 
RIPA buffer 
150 mM NaCl, 0.5% sodium deoxycholate, 1.0% IGEPAL, 
0.1% SDS and 50 mM Tris, pH 8.0 
 
SDS buffer(10X) 0.25 M Tris base, 1.92 M Glycine and 0.1% SDS pH 8.5 
Stacking gel buffer 0.5 M Tris HCl buffer pH 8.8 
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which is folin reagent and reagent S to activate reagent A.  The assay is based on the 
following reaction: 
 Alkaline copper tartrate + Proteins        loss of O2 ions from folin             reduced Folin 
products        development of blue colour with maximum absorbance at 750. The colour 
is basically due to amino acids tyrosine and tryptophan in different proteins. 
The microplate assay protocol was performed as follows: 
1. Reagent A' which is the active form of reagent A was prepared by adding 20 µl of 
reagent S to reagent A 
2. Eight protein standards from 0- 2 mg/ml in RIPA buffer were prepared. 
3. In 96 wells plate 5 µl of standards and samples were pipetted in triplicate 
4. 25 µl of reagent A' were then added into each well. 
5. Reagent B (200 µl) was then added to each well.  
6. Reagents were then mixed through gentle agitation and left to set for 15 minutes. 
7. The plate was taken to a microplate reader and the absorbances were read at 750 nm 
 
2.2.2.7.4 Western blotting  
 
2.2.2.7.4.1 Sodium dodecyl sulphate-polyacrylamide gel (SDS- PAGE) 
 Tris buffers (pH 6.8 & pH 8.8) were prepared for the resolving and stacking gels (table 
2.4). The catalysts APS and TEMED were added for poly-acrylamide gel 
polymerization.  
At the bottom a resolving gel with a pH of 8.8 was poured between 2 glass plates to a 
level of 1 cm below the teeth on the comb and overlaid with 0.1% (w/v) SDS solution. 
The overlay was poured off after the gel had set.  4% (w/v) stacking gel solution with a 
pH 6.8 was then poured on top of the solidified separating gel to pack proteins in 
together after loading.  While gels were setting, the protein samples were prepared by 
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mixing each sample with the 2X sample buffer (1:1) then heated in boiling water for 5 
min. The Laemli buffer was used because it contains 2-mercaptoethanol that reduces the 
disulfide bonds. It contains SDS detergent which denatures the proteins and gives each 
protein a negative charge, accordingly each protein separates on a size base and not on a 
charge base. In addition, bromophenol blue is used because of its colour that makes it 
easier see the samples and glycerol to increase samples viscosity.  Samples were then 
centrifuged for 10 sec after boiling, and loaded into separate lanes with the first left lane 
kept for the molecular weight reference.  The polyacrylamide gel was run using a 
discontinuous system (Laemmli, 1970).  A mini Protean-11 gel apparatus (Bio-Rad, 
Hertfordshire, UK) was used to run all gels.  The gel was run initially slowly through 
the stacking gel (50 Volts), to give sharper bands, then run at 100V (constant voltage) 
throughout the resolving gel. The protein ladder and the dye front was watched to 
determine when to stop the gel.  The gels were immersed in electrophoresis buffer (25 
mM Tris base, 192 mM glycine and 0.1% (w/v) SDS) within the running tank and 20µl 
of protein was loaded per well.  On each gel, one lane contained 10µl of a biotinylated 
protein ladder of molecular weight standards (cell signalling). The gel ran for ~ 2 hours 
at a constant voltage of 100V.  The SDS gel was used to separate proteins according to 
their size by electric current.  Low percentage gels separate larger proteins whereas 
higher percentage gels separate smaller proteins better. The problem is that all proteins 
have a charge associated with them, and in an electrical current this could cause 
problems. That was solved by the addition of SDS to the protein samples. SDS binds to 
proteins every few amino acids and neutralizes the charge differences that proteins 
have. This allows proteins to be separated by size and not by charge.  Every sample was 
loaded carefully and slowly to prevent the sample leaking out of the lane. 
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2.2.2.7.4.2 Transfer to membrane: After electrophoresis, proteins were transferred to 
blotting membrane using a Bio-Rad electrophoresis transfer unit by the method of 
(Towbin et al., 1979).  Transfer was carried out in blotting buffer (25 mM Tris base, 
192 mM glycine) in addition to 20% (v/v) methanol for one hour at a constant voltage 
of 100. 
2.2.2.7.4.3 Blocking: After transfer the nitrocellulose membranes were incubated with a 
generic protein to bind to any remaining sticky places on the membrane. The blocking 
solution contained 5% (w/v) BSA in Tris buffered saline containing Tween 20 “TBS-T” 
(150 mM NaCl, 20 mM Tris base and 0.1% (v/v) Tween 20, pH 7.4) for one hour at 
room temperature with gentle shaking. Membranes were washed 3 X for 10 minutes 
with TBS-T. 
2.2.2.7.4.4 Primary antibody: A primary antibody was then added to the solution 
which was able to bind to its specific protein. The blotting membranes were incubated 
over night at 4ºC with shaking with the primary antibody mouse immunoglobulin IgG1 
phosphor-Tyrosine Mouse mAb (P-Tyr-100) (Cell Signalling Technology) and GAPDH 
mouse monoclonal primary antibody was used as a loading control (ab9484).  A 
monoclonal antibody was used because it gives a better signal and lower background 
and has high specificity. The primary antibody was diluted 1:2000 in TBS-T containing 
5% (w/v) BSA. Membranes were then washed 3 X for 10 minutes with TBST. 
2.2.2.7.4.5 Secondary antibody: A secondary antibody-enzyme conjugates “Anti-
mouse IgG, HRP-linked antibody”, recognizing the primary antibody, was added to find 
locations where the primary antibody bound. The secondary antibody was diluted 
1:3000 with 5% (w/v) non fat milk in TBS-T solution together with HRP- conjugated 
anti- biotin antibody diluted (1:1000) to detect biotinylated protein markers.  The 
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membrane was incubated at room temperature with gentle agitation for one hour.  The 
membrane was washed 4 times for 15 minutes each. 
2.2.2.7.4.6 Detection: The membrane was stained with enhanced chemiluminescence 
(ECL) solutions 1 and 2.  The membrane was exposed to Kodak X ray film for 2 
minutes.  The film was immediately developed through quick and consecutive processes 
by immersing it in the developing solution, washing in water and lastly fixative 
solution.   
2.2.3 Methods: A comparison of the effects of nanoparticles in peripheral blood 
lymphocytes from respiratory disease patients and healthy individuals using 
genotoxic endpoints and ras p21 
 
2.2.3.1 Materials and Methods 
For materials used in each experiment refer to table 2.1 
 
2.2.3.2 Experimental design 
The experimental design was detailed in chapter 5 section 5.2.2.1.   
In general, the experiment was designed to find if there are differences in response 
between three different groups of respiratory diseases patients (lung cancer, chronic 
obstructive pulmonary disease (COPD), asthma) and a healthy control group 
lymphocytes exposed to different concentrations of TiO2 NPs using different end-points 
for genotoxic effects that include the Comet assay, CBMN assay and ras oncoprotein 
level determinations.  
 
2.2.3.3 Blood collection and lymphocyte isolation 
In general, 36 ml of blood were taken from each patient or healthy control in a 
heparanized tubes (9 ml in each of 4 tubes), all samples processed (fresh) within 2 hours 
of isolation.  Lymphocytes were then isolated as described in section 2.2.1.2.2 which 
was later used in the Comet assay and lymphocyte cell culture for ras P21 detection. 
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2.2.3.4 Nanoparticles and treatments preparation  
 
Prior to evaluation of the toxic potential of TiO2, different concentrations of TiO2 
suspensions (5, 10, 30 and 50 µg/ml) were prepared in 10 ml RPMI 1640 medium 
through probe-sonication at current 30 W. The different TiO2 suspensions particle sizes 
were determined using a high performance nano sizer (Malvern Instruments Ltd., 
Worcestershire, U.K.).  Different TiO2 concentrations were then prepared (10, 30 and 50 
µg/ml) for the Comet and ras p21 detection assays.   For the CBMN 5 and 10 µg/ml of 
TiO2 concentrations were prepared.   In addition 80 µM of hydrogen peroxide (H2O2) 
and 0.4 µM mitomycin C (MMC) were prepared as positive controls for the Comet and 
CBMN assays respectively.   
 
2.2.3.5 Cell viability and Comet assay 
 
The lymphocytes were treated for 30 minutes at 37ºC with the different concentrations 
of all chemicals used.  For TiO2, 10, 30 and 50 µg/ml were used, for H2O2, 80 µM was 
used and for MM C 0.4 µM.  Thereafter, cell viabilities were assessed by a trypan blue 
exclusion test as detailed in section 2.2.1.3.1.  Generally, the detection of DNA damage 
in the respiratory disease patients and healthy controls in the Comet assay pH ≥ 13 
system was carried out with different TiO2 concentrations (10, 30 and 50 µg/ml) and 
H2O2 (80 µM) as a positive control and a negative control of untreated lymphocytes.  
The Comet assay was carried out as detailed in section (2.2.1.3). 
 
2.2.3.6 Cytokinesis-block micronucleus assay (CBMN) 
Peripheral blood is the most frequent source of human lymphocytes.  Human 
lymphocytes have two major functions cellular immunity through T lymphocytes which 
are thymus- dependent cells and antibody production through B lymphocytes. Healthy 
individuals have 70% T- lymphocytes of the total lymphocyte cells. Normally, foreign 
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antigens provoke immune response with cellular division and proliferation.  Mitogens 
are substances mimicking foreign antigens that transform the majority of lymphocytes 
into a mitotically active state. Phytohaemagglutinin (PHA) is a mucoprotein and widely 
used as a mitogen.  Phytohaemagglutinin occurs naturally in red kidney bean 
(Phaseolus vulgaris). Hence, mitogen-stimulated lymphocytes by PHA, proliferate and 
divide with subsequent stimulation of further cell type divisions.  The whole process 
occurs as an immune response (Cantrell et al., 1993).  
 
Normally lymphocytes stimulated with PHA, start dividing during the first 24 hours 
post exposure that occurs without clear morphological transformation.  
The (CBMN) assay is used to assess chromosome damage and can detect aneuploidy or 
chromosome loss besides clastogenicity or chromosomal breakage.   
The advantages of CBMN assay can be summarized in the following: 
• It is relatively simple, inexpensive, and rapid, has a cell to cell approach, can 
detect chromosome mutations, apoptosis and necrosis and is applicable to 
variety of cell types.  In combination with fluorescene in situ hybridization 
(FISH) it can discriminate between clastogens and aneugens. In addition it could 
be used as a useful biomarker to access cancer risk. 
• Also can be used as an endpoint to assess the identification of chromosome 
mutations. It also can show cells that go nuclear division and that did not divide 
and can assess cell proliferation (% binucleated cells). 
The CBMN has some disadvantages that can be summarized in the following: 
• It requires cell division for expression of MN. 
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•  It does not detect all structural chromosome aberrations (only acentric 
fragments). 
•  The cytochalasin B itself could be cytotoxic and its cytoxicity differs between 
cell types. 
The scoring criteria for micronuclei selected according to Fenech et al, 2000: 
• Binucleated cells with main nuclei of approximately equal size that separate, 
touch, are linked by nucleoplasmic bridges or even overlap as long as there are 
clear boundaries between the 2 nuclei. 
• Binucleated cells in which the main nuclei are undergoing apoptosis are not 
scored because MN may be caused by the apoptotic process  
• The MN diameter should be less than 1/3 of the main nucleus  
• There should be a clear identification of the nuclear boundary between the main 
nucleus and the MN which should be separated from or slightly overlap with the 
main nucleus. 
• Staining of MN should be similar to the main nucleus  
2.2.3.6.1 Blood cultures 
 
Blood cultures were prepared from each (coded) sample in 25 cm3  cell culture flasks, 
each culture consisted of 500 µl of whole blood added to 4.5 ml fresh medium of RPM1 
1640 with Glutamax-I which contained 20% fetal bovine serum (Gibco) and 1% 
penicillin-streptomycin solution (P/S), then fresh medium allowed the cells to grow. 130 
µl of phyohaemagglutinin (PHA), a mitogen, was added to reach a final concentration 
of 2.5%, added because lymphocytes need to be stimulated to divide and proliferate. 
Cultures were then left in an incubator whilst the chemicals 50 µl  of TiO2 at different 
concentrations (5 and 10µg/ml) and 50 µl  of MMC were added as a positive control to 
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reach a final concentration of 0.4 µM (Meynard et al., 2007), a negative control of 
untreated lymphocytes was as well prepared.  At time 24 hours, Cytochalasin B at a 
final concentration of 6µg/ml was added to cell cultures at 44 hours which prevented the 
cells undergoing cytokinesis, so that binucleated cells were formed.  Incubation is 
continued until 72 hours.  Each sample was treated in duplicate flasks with TiO2 as well 
as positive and negative controls (Fenech, 2007).  
 
2.2.3.6.2 Hypotonic treatment and fixation 
 
The lymphocyte cells were harvested by centrifugation at 900 rpm (200g) for 9 minutes 
then treated with hypotonic treatment for ~5 minutes, centrifuged again for another 9 
minutes at 900 rpm (200g) then fixed in 3:1 v/v methanol: acetic acid and 3 drops of 
formaldehyde.  The fixation step was repeated until the pellet was clear. 
 
2.2.3.6.3 Slide preparation 
Two slides were prepared from each fixed cell sample in a fixative (concentration 
depending on the pellet).  A total of 4 slides per duplicate sample were prepared.  Each 
slide was dropped with 2 drops each x 20 µl of cell suspension then left to air dry.  The 
slides were stained with 10% Giemsa stain in phosphate buffer for 10 minutes, left to air 
dry over night, mounted and covered with a cover slip. 
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Figure 2.1 The various possible fates of cultured cytokinesis-blocked cells following 
exposure to cytotoxic/genotoxic agents 
From an article: Cytokinesis-block micronucleus cytome assay, by Michael Fenech 
Nature Protocols 2, 1084 - 1104 (2007) 
 
2.2.3.6.4 Slide scoring 
A total of 31 patients (13 lung cancer, 10 COPD and 8 Asthma) and 15 controls were 
used in the CBMN assay; 5 samples were excluded for technical reasons. 
 
The slides were coded and scored according to Fenech criteria (Fenech et al., 2000).  
The Micronuclei were counted using a 100X oil immersion objective on a light 
microscope and X12.5 eye piece.  One thousand cells with clear cytoplasm were scored 
to find out the number of the Mono, Bi and multinucleated cells which later used to 
calculate the nuclear division index (NDI) and the % BiNCs.  One thousand BiNCs that 
fit Fenech criteria were then scored simultaneously with the number of the MN, 
nucleoplasmic bridges NPBs, nuclear buds, mono-nucleated cells with MN and multi-
nucleated cells with MN. 
 
2.2.3.7 Ras oncoprotein detection technique 
 
2.2.3.7.1 Lymphocyte cell culture and chemical treatment 
The population for ras p21 study was detailed in table 5.2.  Twelve ml of blood from 
each patient or control was used to isolate 4 separate lymphocyte pellets.  The pellet of 
freshly isolated lymphocytes (lymphocytes isolation technique detailed in section 
2.2.1.2),was resuspended in 4.5 ml fresh medium of RPM1 1640 with Glutamax-I 
which contains 20% fetal bovine serum and 1% penicillin-streptomycin solution (P/S) 
and 130 µl of PHA to reach a final concentration of 2.5%.  Four separate lymphocyte 
cultures were prepared for each individual.  Cultures then incubated in a humidified 
incubator supplemented with 5% CO2 at 37ºC for 48 hours.  Thirty minutes before the 
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end the incubation period 50 µl of TiO2 different concentrations (10, 30 and 50µg/ml) 
were added to the cell cultures, untreated lymphocytes culture left as a negative control, 
cultures were then incubated for further 30 minutes.   At the end of the 30 minutes 
incubation, cultures were placed in 50 ml falcon tubes then centrifuged at 900 rpm 
(200g) for 9 minutes, the supernatant then discarded and the pellet then washed twice in 
PBS by centrifugation at 4ºC.  After the last centrifugation the pellet was then 
suspended in 100 µl of RIPA buffer, protease inhibitor cocktail was added as well and 
the cells left to lyse for 30 minutes on ice, thereafter centrifuged at 13000 rpm for 20 
minutes (X 400g) at 4ºC, supernatant was then moved to another labelled tubes, 5 µl 
from each sample was taken for DC Bio-Rad protein assay as described in section 
(2.2.7.3) and the rest of the cell lysates stored at -80ºC until used in ras p21 immuno-
blotting assay. 
 
2.2.3.7.2 Western blotting for ras p21 detection 
The Western blotting technique in section (2.2.7.4) was used for ras P21 detection, the 
only exceptions are the primary antibody was pan ras p21 mouse monoclonal antibody 
(ab86696) from Abcam, and SW480 cell lysate (Abcam) was used as a positive control 
(Bocca et al., 2010; Min et al., 2010) 
 
2.2.4 Statistical analysis 
 
In all experiments the results obtained from treated cells (lymphocytes, sperm and Hep- 
2 cells) with either ZnO, TiO2, H2O2 or MMC were compared to the negative control of 
untreated cells to find the p value and different statistical methods were used in this 
study depending on the result of the variance normality of distribution and /or 
homogeneity which were checked by Kolmogorov-smirnoff method.  
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In case of Comet assay,  slides were scored at 540 nm filter wave length using (Leica 
DMLB) fluorescence microscope connected to a Hitachi KPMI/EK charge coupled 
device (CCD) monochrome camera connected to a computer with a Komet 4.0 
programme (Kinetic Imaging, Liverpool, UK).  This was used to measure Comet 
parameters. The images from each cell were received by a camera then went through 
projection lens and appeared in a computer monitor screen at a magnification of 200X 
resulting from 20X objective lens and 10 X eye piece gave a magnification to score the 
slides.   
 
The number of cells per sample scored varies.  In  the in vivo experiments which have a 
lower sensitivity due to internal variations, up to 150 cells in 3 repeats have been scored 
blindly in coded slides ( 50 cells obtained from duplicate slides per dose or culture) as 
recommended (Ambrosini et al., 2006; Tice et al., 2000).  In studies where clinical 
samples were used each group was accessed as one unit due to limited access to clinical 
samples 2 independent experiments were carried out and 100 cells were scored from 
duplicate slides. 
 
The Olive tail moment which “is the value of the tail density multiplied by the 
migration distance (tail length)” (Olive et al., 1991) was automatically generated by the 
computer and used for lymphocyte assays. The Olive tail moment is considered as a 
preferred parameter in describing the observed DNA damage as it is more uniform.  
However, for sperm due to baseline damage of 20% SSB, head DNA was used.   
 
For clinical samples the Olive tail moment (OTM) and % tail DNA parameters were 
used as the use of two different parameters have been recently recommended 
(Kumaravel et al., 2009).  Kolgomrov-Smirnov used to test the OTM and % tail DNA 
data for normality of distribution, the data have been found to have normal distribution, 
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accordingly the parametric ANOVA test was applied. Groups were compared in 2 
different ways, in the first each group was compared to its counterpart untreated control 
and in the second each patient group or confounder was compared to its parallel healthy 
control sample. 
 
The data obtained was tested for normality of distribution using the Kolmorov- Smirnov 
test. Once the data show normal distribution ANOVA test was used, and when the data 
did not show normal distribution (nonparametric) Mann- Whitney U test was used on 
median values. However, for a clearer comparative presentation, histograms have been 
produced of 3 repeat experiments showing means and standard errors of the means. 
 
For MTT and NRU assays, 4 wells of a micro-plate were used and each was seeded 
with 1.5x103   HEp-2 cells and the means of 3 repeat experiments were analysed using 
Microsoft Excel 2007 and the software for Windows SPSS 15.0.  
  
 For CBMN assays because the data was nominal the number of MN in 1000 
binucleated cells was compared between the untreated and treated for each sample using 
the graph pad 2x2 contingency (Fisher exact test) for the p value.  For the nuclear 
division index (NDI) which can be used as an indicator of the cytostatic effect of the 
chemicals used, it was calculated according to the formula: NDI= (M1+ 2M2 + 3M3) / 
N; where M1, M2 and M3 presented mononucleated, binucleated and multinucleated 
cell respectively while N represented the total viable cells scored  or with the Chi square 
(χ2). 
 
 The null hypothesis theory which assumed no significant differences or no treatment 
effect at a fixed level of 0.05 was used to determine the level of significance.  
Accordingly, the p value was determined for the extreme values as < 0.05 and 
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represented as (*) when the null hypothesis was rejected at the level of 5% and 
represented as (**) if the null hypothesis rejected at the level of 1% and the p value was 
said to be significant at 0.01 and (***) were used if p was < 0.001. 
 
In all statistical work that was carried out, Microsoft EXCEL 2007 and SPSS 15.0 were 
used. For a clearer comparative presentation, tables and histograms have been produced 
showing means of the means and means of the standard errors of the means. 
 
 
 
Chapter 3 
 
 
The effect of zinc oxide and titanium dioxide nanoparticles in the Comet assay 
with UVA irradiation of human sperm and lymphocytes 
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3.1 Introduction 
The use of nanotechnology has seen a surge in recent years and the increasing 
applications of nanomaterials in diverse fields such as biotechnology, life sciences, 
medicine, defence and engineering have raised awareness of potential genotoxicity. 
These particles, by virtue of their size could enter the body either orally, by inhalation, 
absorption or could be injected into the body during medical procedures. Hence, caution 
should be exercised during the use and disposal of such manufactured nanomaterials to 
prevent unintended toxic effects on organisms and undesirable environmental impacts. 
The unique physico-chemical properties of these particles could produce unpredictable 
effects and the high surface to volume ratio could result in greater reactivity.  
Inhalation studies with rats exposed to ultra-fine TiO2 aggregate and carbon black 
showed that both compounds induced lung tumours in rats at considerably lower 
gravimetric lung burdens than larger sized TiO2 particles (Oberdorster, 1996).  
Significant species differences have been reported in the pulmonary responses to 
inhaled TiO2 particles. For example, rats developed a more severe and persistent 
pulmonary inflammatory response than mice or hamsters and were also unique in the 
development of progressive fibro-proliferative lesions and alveolar epithelial metaplasia 
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in response to exposure to a high concentration of TiO2 particles.  Published studies in 
CHO cells showed ZnO to be clastogenic, but may not represent a photo-genotoxic 
effect when compared to 8-MOP (Dufour et al., 2006).  TiO2 also did not exhibit 
photochemical genotoxicity in the same system (Theogaraj et al., 2007).  Nagakawa et 
al., (1998) demonstrated photo-genotoxic effects with TiO2 particles in mouse 
lymphoma (L5178Y) cells in the Comet assay and clastogenicity in Chinese hamster 
lung cells, but positives were generally only at toxic doses.  
Up to now, hardly any studies have focused on the effect of nanoparticles on the germ 
cells. One study has reported that when gold nano particles are mixed with human 
spermatozoa, penetration of gold nanoparticle into the sperm heads and tails was 
observed and 25% of them lost their motility. This led the authors to conclude that gold 
nanoparticles had spermatotoxic effects (Wiwanitkit et al., 2009).  The effects of 
different types of nanoparticles on mouse spermatogonial germline stem cells also 
demonstrated a concentration-dependent toxicity for silver, molybdenum and 
aluminium nanoparticles tested, whereas the corresponding soluble salts had no 
significant effect (Braydich-Stolle et al., 2005).  In spite of the fact that ZnO and TiO2 
are widely used ingredients in dermatological preparations and sunscreens and many 
other products, only two of the investigations have focused on the effects of these 
nanoparticles on human germ cells. DNA damage to somatic cells can give rise to 
cancer but damage to germ cells can not only give rise to cancer, but also cause 
congenital defects in future generations. Accordingly, it was decided to investigate the 
effect of commonly used ZnO and TiO2 (anatase form) nanoparticles in human sperm 
and lymphocytes in vitro using the Comet assay, a simple but sensitive technique for 
evaluating intercellular differences in DNA damage (Singh et al., 1988; Tice et al., 
2000).  Sperm and lymphocytes represent primary human cells, with some metabolic 
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activities intact, of a haploid and diploid nature respectively. It is very useful to obtain 
information on cells of direct relevance to man. For over 40 years human lymphocytes 
have been used as surrogates for prediction of toxic effects in man (Albertini et al., 
2000). 
 
 
 
 
 
 
 
3.2 Materials and methods 
3.2.1 Preparation of ZnO and TiO2 nanoparticle stock suspensions  
Refer to methods (2.2.1.1), ZnO/TiO2 (anatase) nano-powders were suspended in 
DMSO then the optical density (OD) was measured. The suspensions were then filtered 
through a 0.2 µm syringe filter and the OD of the filtrate measured. Using the OD 
before and after filtration, the concentrations of the filtrate was determined. Serial 
dilutions of the filtrate were made to prepare the stock suspensions to be used for the 
experiments. Four concentrations were used for each of the compounds tested. For ZnO, 
the concentrations used were 11.5, 46.2, 69.4 and 92.3 µg/ml and for TiO2 the doses 
used were 3.73, 14.92, 29.85 and 59.7 µg/ml.  
 
3.2.2 Ethics: The collection of lymphocytes and sperm had been approved by the 
University of Bradford Subcommittee for ethics in research involving human subjects 
(Reference 0405/8). 
 
3.2.3 Cell isolation:  The isolation of lymphocytes was described in chapter 2 section 
2.2.1.2.1 and 2.2.1.1.7.  For the semen sample collection refers to section 2.2.1.3.2. 
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3.2.4 UV Irradiation: Three sets of 6 well cell culture plates were used for each 
experiment (details on chapter 2 sections, 2.2.1.3.1.3 and 2.2.1.3.2.2). 
3.2.4.1 D method: Refer to methods 2.2.1.3.1.3.1 and 2.2.1.3.2.2.2. 
3.2.4.2 PI method: Refer to method 2.2.1.3.1.3.2 and 2.2.1.3.2.2.3. 
3.2.4.3. SI method: Refer to method 2.2.1.3.1.3.3 and 2.2.1.3.2.2.4. 
 
 
 
 
 
 
 
3.2.5 The Comet assay 
The Comet assay carried out as described in chapter 2 sections 2.2.1.3.1 and 2.2.1.3.2.  
The main experiments were repeated three times making a total of 150 cells per 
experimental observation. 
 
3.2.6 Statistical analysis 
The data obtained were tested for normality of distribution using the Kolmorov- 
Smirnov test and found to violate the normal distribution pattern. The non-parametric 
Mann-Whitney U test was used to compare treated samples with the negative control 
values to obtain the p values. However, for a clearer comparative presentation, 
histograms have been produced of the combined results from triplicate experiments, 
showing the means and standard errors. 
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3.3 Results 
3.3.1 Effect of H2O2 in human lymphocytes and sperm 
The Comet assay was carried out as described in chapter 2 sections 2.2.1.3.1.2 and 
2.2.1.3.2.1. 
The dose response curve of human lymphocytes and sperm in the Comet assay, after 
treatment with H2O2 and incubation for 30 minutes. A total of 150 cells were scored for 
each dose in three independent experiments. The Kolmogorov-Simrnov test (KS-test) 
was used to test the normality of the sample distribution. The average median of the 
Olive tail moment (lymphocytes) or % head DNA (sperm) of the control (cells treated 
with PBS) was compared versus the treatment doses with Mann-Whitney. The bars 
indicate the standard errors for three independent experiment (ns, not significant, **p < 
0.01, ***p < 0.001). 
3.3.1 DNA damage on sperm cells treated with H2O2 
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Figure 3.1 The dose response curve of the effect of different H2O2 concentrations on 
human sperm in the Comet assay, in addition to a negative control of untreated sperm 
cells.  The means of the % head DNA of untreated sperm (control) compared to the 
means of treated sperm cells with one way ANOVA using SPSS 15.  Line indicate 
mean % head DNA of 3 experiments ns indicates and ***p < 0.001.   Bars indicate 
standard errors.    
 
3.2 DNA damage and repair in lymphocytes treated with H2O2 
 
 
 
Figure 3.2A The dose response curve of the effect of different H2O2 concentrations, in 
addition to a negative control of untreated lymphocytes, in human lymphocytes in the 
Comet assay.  The means of the OTM of untreated lymphocytes (control) compared 
with the OTM means of of treated lymphocytes analysed by one way ANOVA using 
SPSS 15.  Line indicate mean OTM of 3 experiments **p > 0.01 and ***p < 0.001.   
Bars indicate standard errors.    
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Figure 3.2B The dose response of DNA damage and repair in lymphocytes obtained 
from healthy donors and treated with different H2O2 concentrations. Results of 3 repeats 
at each H2O2 concentration for damage were compared with those for repair by one way 
ANOVA in SPSS 15 (*p < 0.05, and ***p < 0.001) 
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Figure 3.3 DNA damage in A) lymphocytes and B) sperm.  Viewing magnification 
x200 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2 Effect of nanoparticles on human lymphocytes and sperm treated under    
different illumination conditions   
 
3.3.2.1 Particles characterization with SEM 
 
Zinc oxide (ZnO) and TiO2 were characterized with SEM as described in chapter 2 
section 2.2.1.1 and found to be ZnO 40 and TiO2 70 nm. 
B) 
  
 
Figure 3.4: Scanning electron micrograph of A) ZnO NPs (40 nm) and 
nm)  
 
3.3.2.2 ZnO nanopart
 
In general, the sperm percentage head DNA showed a progressive reduction with 
increasing concentrations of ZnO nanoparticles after treatment in the dark, and for PI as 
well as SI samples. However, the percentage reduction was greater for PI and SI 
samples compared with samples treated in the dark (table 3.1 and figure 3.5A).
 
B) 
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For lymphocytes, the SI and PI samples showed a higher level of damage compared 
with the samples treated in the dark (table 3.1 and figure 3.5B). In both cell types, there 
was damage that was not as great as that in the positive control. By comparison with the 
negative control, all values were highly statistically significant for sperm except at the 
lowest concentration in the dark, which was not significant, and for SI samples at the 
lowest concentration, which was significant only at the 5% level (table 3.1 and figures 
3.5 A & B).   
 
With regard to photo-genotoxicity, responses for sperm treated in PI and SI incubation 
conditions were not statistically significant compared to responses of sperm treated in 
the dark, except at the lowest concentration for SI samples. However, for lymphocytes, 
responses were statistically significant at the highest concentration for both PI and SI 
samples (table 3.1 and figures 3.5 A & B). 
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Table 3.I: Effect of ZnO nanoparticles on % head DNA of sperm and Olive tail moments for lymphocytes 
 
 
ZnO concentration 
(µg/ml) 
 
Nc 
 
11.5 
 
46.2 69.4 92.3 Pc 
Median Mean Median  Mean Median  Mean Median  Mean  Median Mean Median  Mean 
 Sp D 76.38 75.99 
±1.15 
76.71ns 74.25 
±2.20 
71.69*** 70.53 
±1.62 
70.98*** 68.41 
±1.33 
66.2*** 66.33 
±1.59 
57.48*** 58.78 
±1.46 
 Sp PI 76.39 75.45  
±1.26 
72.71*** 71.54 
±1.37 
71.28*** 72.81 
±1.49 
67.07*** 64.65 
±1.59 
63.45*** 63.52 
±1.72 
59.59*** 63.8 
±1.82 
 Sp SI 78.23 78.79 
±1.75 
69.46*** 
(***) 
69.97 
±1.68 
68.75ns 68.68 
±1.48 
66.03ns 67.73 
±1.81 
64.51** 63.41 
±1.88 
57.81*** 59.55 
±1.88 
 Ly D 2.14 2.65 
±0.30 
2.87*** 4.17 
±0.53 
3.54*** 4.66 
±0.60 
5.33*** 6.25 
±0.59 
5.24*** 6.46 
±0.71 
9.76*** 9.81 
±0.71 
 Ly PI 2.03 2.89 
±0.42 
3.59*** 5.04 
±0.63 
4.37*** 6.33 
±0.79 
4.39*** 5.62 
±0.66 
6.20*** 8.25 
±0.71 
10.45*** 
(***) 
11.04 
±0.74 
 Ly SI 1.95 2.99 
±0.44 
2.02* 3.79 
±0.62 
3.99*** 5.85 
±0.72 
5.22*** 6.51 
±0.55 
6.25*** 8.36 
±0.91 
7.29*** 
(***) 
9.74 
±1.17 
 
 
Nc= negative control of untreated cells 
Pc= positive control of H2O2 (80 µM/ 2.72 µg/ml)  
 
Sp D = sperm: Treatment in dark 
Sp PI = sperm: Treatment after pre-irradiation with UVA 
Sp SI = sperm: Treatment with simultaneous UVA irradiation 
 
Ly D = Lymphocytes: Treatment in dark 
Ly PI = Lymphocytes: Treatment after pre-irradiation with UV 
Ly SI = Lymphocytes: Treatment with simultaneous UV irradiation 
When comparing D, PI and SI for different ZnO concentrations with negative control: ns = not significant; * p < 0.05; ** p < 0.01; *** p < 0 .001. In 
parentheses, when comparing PI and SI with D. (***) p < 0.001. 
 
 
86 
 
 
 
Figure 3.5 Effect of UVA irradiation on human sperm and lymphocytes treated with 
ZnO nanoparticles 
 
 
Figure 3.5A Effect of ZnO nanoparticles as well as negative control of untreated sperm 
cells (Nc) and positive control (Pc) of 80 µM (2.72 µg/ml) H2O2 on human sperm 
treated in the dark (D), after pre-irradiation with UV (PI) and with simultaneous 
irradiation with UV (SI). Significance values are shown in Table 3.1.  The values 
represent the means of three separate experiments combined.  Bars indicate standard 
errors. 
 
 
 
Figure 3.5B Effect of ZnO nanoparticles as well as negative control of untreated 
lymphocyte cells (Nc) and positive control (Pc) of 80 µM (2.72 µg/ml) H2O2 on human 
lymphocytes treated in the dark (D), after pre- irradiation with UV (PI) and with 
simultaneous irradiation with UV (SI).  Significance values are shown in Table 3.1.  
The values represent the means of three separate experiments combined.  Bars indicate 
standard errors. 
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3.3.2.3 TiO2 nanoparticles 
 
With TiO2, the % head DNA showed damage which tended to plateau at the highest 
concentration of 59.7µg/ml for sperm for all treatments (figure 3.6A and table 3.2). 
 
However, in lymphocytes there was no tendency towards plateau formation with the 
highest concentration. The maximum damage was observed in SI samples throughout 
the concentration range followed by the PI samples. Those samples treated in the dark 
had lower values for Olive tail moment (figure 3.6B and table 3.2).  For both sperm and 
lymphocytes, all values by comparison with the negative control were highly significant 
(figure 3.6A&B and table 3.2).   
 
With regard to photo-genotoxicity, there were no statistically significant responses for 
the sperm when the results for PI and SI samples were compared to responses in the 
dark, except at the lowest dose for PI samples. However, for lymphocytes, responses 
were statistically significant at the highest concentration after treatment for both PI and 
SI samples. For SI samples there was a concentration – related increase over the whole 
dose range and the highest three doses were statistically significantly different by 
comparison with treatment in the dark (figure 3.6A &B and table 3.2 
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Table 3.2: Effect of TiO2 nanoparticles on percentage head DNA of sperm and Olive tail moments for lymphocytes 
 
TiO2 concentration µg/ml 
 
Nc 3.73 14.92 29.85 59.7 Pc 
Median Mean Median Mean Median Mean Median Mean Median Mean Median Mean 
Sp D 87.49 85.98 
±1.32 
77.59*** 75.55 
±1.82 
69.66*** 71.64 
±1.35 
65.00*** 66.83 
±1.40 
67.92*** 68.57 
±1.32 
61.70*** 60.03 
±2.50 
Sp PI 75.39 75.69 
±1.55 
59.83*** 
(***) 
61.50 
±2.54 
68.29*** 71.29 
±2.31 
68.99** 67.88 
±1.66 
67.36*** 68.98 
±1.94 
61.43*** 62.58 
±1.73 
Sp SI 78.85 78.79 
±1.75 
 
74.12*** 73.90 
±1.75 
71.39*** 72.19 
±1.38 
69.23*** 67.59 
±2.31 
68.45*** 69.46 
±1.32 
57.95*** 59.62 
±2.51 
Ly D 0.84 1.9 
±0.29 
2.45*** 3.17 
±0.31 
2.5*** 3.43 
±0.43 
2.85*** 3.67 
±0.44 
6.05*** 6.16 
±0.51 
5.62*** 6.99 
±0.65 
Ly PI 1.24 2.52 
±0.4 
2.44*** 3.08 
±0.39 
3.5*** 4.4 
0±0.52 
6.49*** 6.44 
±0.48 
6.17*** 
(***) 
7.30 
±0.81 
6.60*** 8.81 
±0.75 
Ly SI 1.83 2.98  
±0.35 
2.74** 4.31 
±0.35 
4.74*** 
(***) 
7.33 
±0.47 
6.22*** 
(***) 
8.97 
±0.46 
10.44*** 
(***) 
10.66 
±0.66 
9.95*** 10.88 
±0.70 
 
Nc= negative control of untreated cells 
Pc= positive control of H2O2 (80 µM/ 2.72 µg/ml)  
 
Sp D = sperm: Treatment in dark 
Sp PI = sperm: Treatment after pre-irradiation with UVA 
Sp SI = sperm: Treatment with simultaneous UVA irradiation 
 
Ly D = Lymphocytes: Treatment in dark 
Ly PI = Lymphocytes: Treatment after pre-irradiation with UV 
Ly SI = Lymphocytes: Treatment with simultaneous UV irradiation 
When comparing D, PI and SI with negative control: ** p < 0.01; ***p < 0 .001. In parentheses, when comparing PI and SI with D. (***) p < 0.001 
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Figure 3.6 Effect of UVA irradiation on human sperm and lymphocytes treated with 
TiO2 nanoparticles 
 
 
 
 
 
Figure 3.6A Effect of TiO2 nanoparticles as well as negative control of untreated sperm 
cells (Nc) and positive control (Pc) of 80 µM (2.72 µg/ml) H2O2on human sperm treated 
in the dark (D), after pre-irradiation with UV (PI) and with simultaneous irradiation 
with UV (SI).  Significance values are shown in Table 3.2.  The values represent the 
means of three separate experiments combined.  Bars indicate standard errors. 
 
 
 
Figure 3.6B Effect of TiO2 nanoparticles as well as negative control of untreated 
lymphocyte cells (Nc) and positive control (Pc) of 80 µM (2.72 µg/ml) H2O2 on human 
lymphocytes treated in the dark (D), after pre- irradiation with UV (PI) and with 
simultaneous irradiation with UV (SI).  Significance values are shown in Table 3.2.  
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The values represent the means of three separate experiments combined.  Bars indicate 
standard errors. 
3.4 Discussion 
Nanotechnology has numerous useful applications in a variety of fields which has 
attracted publicity, however, many of these nanoparticles are non-biodegradable and 
their long-term behaviour is not well understood (Braydich-Stolle et al., 2005). 
The aquatic toxicity screening studies in a 72h acute test involving the green algae 
Pseudokirchneriella subcapitata have concluded that  ultra-fine TiO2  (median particle 
size 140 nm) has a low hazard potential (Warheit et al., 2007a).  However, 
investigations on toxicity of TiO2, SiO2 and ZnO water suspensions towards bacteria 
(Bacillus subtilis, Escherichia coli) and the eukaryotic Daphnia magna have revealed 
that these were hazardous to all test organisms, with toxicity increasing with particle 
concentration. Toxicity of the three compounds decreased from ZnO to TiO2 to SiO2 
(Adams et al., 2006a; Adams et al., 2006b).  Zhu et al. (2008) have studied 
developmental toxicity of metal oxide nanoparticles, and the results have demonstrated 
that nanoparticles of ZnO were very toxic to zebrafish embryos and larvae.  
Turkez and Geyikoglu (2007) have reported that TiO2  increased sister chromatid 
exchanges (SCE) and micronuclei (MN) frequencies in human whole blood cultures 
suggesting that TiO2 can enhance oxidative stress mediated DNA damage.  As particle 
size decreases, surface area increases leading to inflammatory response for, e.g., in lung 
tissue (Brown et al. 2001). Studies investigating the genotoxic capacity of coal fly ash 
have shown a role for particulate size and iron release leading to radical generation and 
oxidative DNA damage in human lymphocytes and human airways epithelial cells 
(Kleinjans et al., 1989; Prahalad et al., 1999). 
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The bactericidal action of photo-activated TiO2 particles have also been demonstrated 
on contaminated dental implants (Suketa et al. 2005) and metal pins used for skeletal 
traction (Tsuang et al. 2008). Studies involving intravenous or intra abdominal 
administration of nanoparticles have reported their accumulation in brain and testes 
indicating their ability in crossing the blood-brain and blood-testis barriers (Chen et al. 
2003; Borm and Kreyling 2004). 
 
Some nanoparticles have their activity enhanced by UV and other catalysts used as 
endogenous antioxidants (Nakagawa et al., 1997).  Hence, their potential to cause 
undesirable problems for man and the environment by virtue of their size and properties 
should not be under-estimated (Hoet et al., 2004).  For soluble chemicals, as early as 
1978, dichlorobromopropane resulted in lower sperm counts because of the destruction 
of undifferentiated spermatogonia (Potashnik et al., 1978).   
 
A decrease in human semen quality was reported in 1992 and oestrogen-like 
compounds were suspect (Carlsen et al., 1992). With increasing use of nanoparticles, 
one area of concern could be the effect of the nanoparticles on germ cells, as these could 
have serious implications on the health of future generations.  
 
The study with H2O2 on lymphocytes and sperm in the Comet assay showed that the 
system was capable of detecting DNA damage and repair induced by chemicals activity 
through oxygen radical generation mechanisms.  Thus it was considered suitable for use 
with ZnO and TiO2 nanoparticles which might also induce oxygen radical mechanisms.  
The present investigation suggests that both ZnO and TiO2 are capable of inducing 
genotoxic effects on human sperm and lymphocytes and that the effect of ZnO is 
enhanced by UVA both in case of lymphocytes and sperm, but effects are only 
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statistically significantly different from responses in the dark at the highest does after 
pre-irradiation and simultaneous irradiation.  However, TiO2 tended not to produce any 
photogenotoxic effects in sperm, but TiO2 does have some photogenotoxic effects with 
lymphocytes, especially after simultaneous irradiation with UVA, where responses were 
dose-related.  Photo-genotoxic effects have been produced in the absence of overt 
toxicity in contrast to the findings of Nakagawa et al. (1997), and Kamat et al. (1998), 
where toxicity was reported. The mixed results of TiO2 nanoparticle toxicity have been 
attributed to the unique clustering property of TiO2 nanoparticles under different 
conditions of pH and ionic strength (Baveye and Laba, 2008). 
 
The probable cause could be the oxygen radicals generated from these oxides, which 
could act synergistically with UVA to exacerbate the responses.  For ZnO the 
mechanism could be the dissolution of Zn2+ (Brunner et al., 2006; Schrand et al., 2010). 
Although the exact mechanism is unknown, studies with vitamin C could confirm the 
mechanism of free radical generation. 
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Chapter 4 
 
 
Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells 
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4.1 Introduction 
Nanoparticles have become very attractive for commercial and medical products in the 
last decade because of their various properties. Nanoparticles have been widely used for 
manufacturing many consumer products such as electronics, computers, food colorants 
or clothes, arriving on the market at a rate of 3-4 per day (PEN, 2008). In medical fields 
such as oncology, cardiovascular medicine, molecular diagnostics, drug discovery and 
drug delivery nanoparticles are also increasingly used (Kubik et al., 2005; LaVan et al., 
2003; Leary et al., 2006). One of the future intended usages of titanium dioxide (TiO2) 
is for artificial orthopaedic implants (Schuler et al., 2006). Most recently, titanium 
dioxide nanoparticles chemically linked to antibodies via bivalent dihydroxybenzene, 
so-called phototoxic "nanobio hybrids", were used to selectively kill glioblastoma 
multiform brain cancer cells (Rozhkova et al., 2009). By conventional definition one 
dimension of nanoparticles has to be < 100 nm, however, due to their biological 
uniqueness not being constrained by this definition the pharmaceutical industry uses 
sizes of 1-1000 nm to describe nanomaterials (Sun et al., 2004; Teeguarden et al., 
2007). Nanoparticle properties are rather different from bulk materials and these 
differences include their small size in the nanometre range, a large surface area to 
volume ratio (Oberdorster et al., 2005) and unique physico-chemical properties. 
Consequently, nanoparticles can easily pass through cell membranes and may show 
unpredictable toxic effects. The major toxicological concern arising from this is that 
many nanoparticles which cross cell membranes become lodged in mitochondria (Foley 
et al., 2002) with some of the engineered nanomaterials also being redox active (Colvin, 
2003). Hence, the increasing applications of nanoparticles in various fields may lead to 
an increase in human exposure which in turn may increase direct toxicological effects. 
Despite apparent advantages of certain nanoparticles and their applications, many 
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undesirable side effects of nano-sized particles have been documented in previous 
studies over the last decade (Goldston, 2007; Igarashi, 2008). 
Nanoparticles such as zinc oxide (ZnO) and TiO2 are increasingly used in a variety of 
industrial and medical applications including high-tech materials, plastics, paints and 
production of paper, and also very frequently in cosmetics and sun screens (Wang et al., 
2007a). Zinc oxide and TiO2 nanoparticles with sizes between 50–500 nm are employed 
to increase the sun protection factor (SPF) of e.g. sunscreens due to their scattering 
properties, which enables them to act as nano-mirrors reflecting UV light and as UV 
filters against sun radiation. In addition to UV reflection properties, their small size is 
also used as an advantage to improve homogeneity of distribution in cosmetics. 
However, TiO2, in spite of its reflection and scattering properties to UVB and UVA, 
also absorbs about 70% of the total irradiated UV light (Dunford et al., 1997). 
The cytotoxic effects of TiO2 nanoparticles on human A549 lung epithelial cells were 
accompanied by the active up-take of TiO2 nanoparticles by endocytosis (Stearns et al., 
2001). In animals, in vivo studies have also shown that exposure and inhalation of TiO2 
particles can induce cytotoxicity in lung cells with subsequent inflammatory responses 
in lung tissue being directly related to the particle size (Dick et al., 2003; Monteiller et 
al., 2007; Rehn et al., 2003; Renwick et al., 2004; Warheit et al., 2007b). Garabrant and 
colleagues noted that 17% of the workers exposed to TiO2 were affected by pleural 
diseases, which were proportionate to the duration of work in TiO2 manufacturing 
(Garabrant et al., 1987). In vitro studies on human sperm and lymphocytes also showed 
that both nano-sized ZnO and TiO2 (10-100 µg/ml) were genotoxic to both cell types 
within the Comet assay in the absence of toxicity (Gopalan et al., 2009), the same was 
true for bacteria and vertebrates (Brayner et al., 2006; Heinlaan et al., 2008). In 
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addition, in vitro studies of ZnO in Chinese hamster ovary (CHO) cells and in human 
epidermal cell lines have revealed clastogenic properties (Dufour et al., 2006; Sharma et 
al., 2009). Studies on lymphocytes treated with TiO2 or ZnO nanoparticles showed 
significantly increased DNA breakage and micronucleus formation (Gopalan et al., 
2009; Kang et al., 2008). Effects of TiO2 nanoparticles on non-human mammalian cells 
were also reported, e.g. exposure of rat liver cells to TiO2 nanoparticles resulted in 
cytotoxicity (Hussain et al., 2005). Titanium dioxide also induced apoptosis and 
micronuclei in Syrian hamster embryo fibroblasts (Rahman et al., 2002). Various 
nanoparticles have shown some cytotoxicity and/or genotoxicity (Dhawan et al., 2006; 
Lewinski et al., 2008; Singh et al., 2007; Wang et al., 2007a, b), and different 
mechanisms of damage induction have been suggested including radical oxygen species 
(ROS) and lipid peroxidation, as well as alteration of signal transduction (Shrivastava et 
al., 2007), but the exact mechanism(s) has (have) yet to be found. 
 
Signal transduction pathways are important mechanisms through which the cell 
coordinates particular functions. Trans-membrane receptors receive and then deliver 
signals from the extracellular lumen via different mechanisms into the nucleus (Wang et 
al., 2003). Tyrosine phosphorylation is the major signalling pathway through which 
receptor tyrosine kinases catalyze the transfer of a phosphate from ATP to the hydroxyl 
group on tyrosine residues of protein substrates in turn mediating cell growth, 
differentiation, host defence, and metabolic regulations (Hubbard et al., 1998). The 
importance of tyrosine phosphorylation events in the presence of toxic nanoparticles 
was previously reported in a study characterizing the anti-bacterial effects of novel 
silver nanoparticles, which were able to penetrate the bacteria and subsequently 
modulate the phosphotyrosine profile (Shrivastava et al., 2007). 
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In this study, the cytotoxicity and genotoxicity of ZnO and TiO2 nanoparticles was 
investigated using the human epithelial HEp-2 cell line.  In addition the tyrosine 
phosphorylation events caused by ZnO and TiO2 occurring simultaneously to 
cytotoxicity and or genotoxicity was also investigated. 
 
4.2 Materials and Methods 
4.2.1 Cell culture of the HEp-2 cell line  
HEp-2 cells (HeLa derivative) were cultured in EMEM-EBBS medium.  For details 
refer to section 2.2.2.1. 
 
4.2.2 Chemicals 
All chemicals used have been mentioned in chapter 2 section 2.2.2.2 
 
4.2.3 Particle preparation and characterization 
Zinc oxide and titanium dioxide nanoparticles were suspended in 10 ml EMEM-EBBS 
medium at concentrations of 10, 20, 50, and 100 µg/ml. Suspensions were probe-
sonicated. The resulting ZnO and TiO2 suspensions were measured as a function of 
incubation time. Prior to evaluation of the toxic potential, the mean size (hydrodynamic 
diameter) of the nanoparticles was determined using a high performance particle sizer 
(Malvern Instruments Ltd., Worcestershire, U.K.) (details in section 2.2.2.3). 
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4.2.4 Cytotoxicity assays 
4.2.4.1 Mitochondrial activity assay 
The MTT assay to evaluate the mitochondrial activity was done according to the 
originally described method (Mosmann, 1983) (details in section 2.2.2.4.1). 
 
4.2.4.2 Neutral red uptake (NRU) assay  
The NRU assay was done to determine the accumulation of the neutral red dye in the 
lysosomes of viable, uninjured cells (Borenfreund and Puerner, 1985) details in section 
2.2.2.4.2. 
 
4.2.5 Cell viability 
Prior to the Comet assay, cells were incubated with ZnO or TiO2 nanoparticles for 4 h at 
different concentrations (10, 20, 50, 100 µg/ml) and assayed for viability using the 
Trypan blue dye exclusion test. The cut-off point was 75% as suggested by Henderson 
and colleagues (Henderson et al., 1998)  details in section 2.2.2.5.1. 
 
4.2.6 Genotoxicity assays 
4.2.6.1 Comet assay 
The sub-confluent monolayer was exposed to four different concentrations of ZnO and 
TiO2, and 80 µM/ml of hydrogen peroxide (H2O2) as a positive control (Pc). There was 
also a negative control using untreated cells (Nc). After an incubation of 4 hours for 
NPS and 30 minutes for H2O2, cells were washed with cold PBS and harvested with 
trypsin-EDTA and followed by a centrifugation. The pellet was finally resuspended in 
PBS. The Comet slides were prepared by the method as previously described (Tice et 
al., 2000) (details in section 2.2.2.5). 
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4.2.6.2 In vitro cytokinesis-block micronucleus (CBMN) assay 
The CBMN assay was performed as described previously (Fenech, 1993). HEp-2 cells 
were grown in 6-well cell culture plates suspended in 2 ml EMEM medium at a 
concentration of 1x105. After 24 hours of culture, either the TiO2 nanoparticles (10, 20 
and 50 µg/ml) or ZnO nanoparticles (10, 20, 50 and 100 µg/ml) or mitomycin C 
(positive control; 0.4 µM = 0.134 µg/ml) were added to the cultures. An untreated 
culture served as the negative control for details refer to section 2.2.2.6. 
 
4.2.7 Detection of tyrosine phosphorylation in HEp-2 cells 
 
A sub-confluent HEp-2 monolayer was treated with different concentrations (0, 10, 20, 
50 and 100 µg/ml) of ZnO or TiO2 nanoparticles and incubated for 4 hours. Untreated 
cells served as a negative control. Viability and membrane integrity was determined 
using the Trypan blue dye exclusion test. Protein was quantified  using the Bio-Rad 
assay (Lowry et al, 1951). The cell lysate was suspended in Laemli sample buffer and 
equal proteins (35 µg) protein from each sample was loaded on SDS gel and detected by 
the immunoblotting technique using a phosphotyrosine mouse monoclonal primary 
antibody (P-Tyr-100) and an anti-mouse IgG-HRP linked secondary antibody details in 
section 2.2.2.7. 
4.2.8 Statistical analysis 
The means from MTT and NRU data were compared to the means of the negative 
control data using the one-way ANOVA test. A Mann-Whitney U-test was used for the 
Comet assay. For the CBMN assay, the Chi square test and Fisher exact test were used 
to compare the number of MN in the treated samples to the negative control of untreated 
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HEp-2 samples. The threshold of significance was p < 0.05. Values at or below this 
were considered significant. 
4.3 Results 
4.3.1 Particle characterization 
Dynamic light scattering (DLS) measurements of ZnO and TiO2 nanoparticle 
suspensions (figure 4.1), were obtained with a high performance particle sizer. Using 
DLS, particle sizes were observed to be widely distributed. The increase in size 
(aggregation) occurred with increasing concentrations but remained constant over a 48-
hour period except at higher concentrations of TiO2 (Table 4.1). Although the particle 
size considerably increased as a function of concentration it was minimally increased as 
a function of time. 
 
Table 4.1:  Physical characterization of ZnO and TiO2 nanoparticles using a Zeta sizer.  
Shown are the sizes of nanoparticles in nanometers measured for different ZnO and TiO2 
concentrations in cell culture media for different incubation times. The values generated 
by the Zeta sizer originate from an average of three measurements each with three runs. 
 
Incubation periods in 
hours 
Particle size [nm] at concentrations of 
10 µg/ml 20 µg/ml 50 µg/ml 100 µg/ml 
Zn
O
 
0 h 17.0 307.1 419.9 406.2 
2 h 17.9 151.6 369.9 399.6 
4 h 24.7 281.3 373.0 389.2 
2 h 19.0 257.4 319.6 355.7 
48 h 30.8 308.6 370.0 397.9 
Ti
O
2 
0 h 143.0 383.6 440.7 507.5 
2 h 313.9 399.1 403.2 577.5 
4 h 339.2 426.4 475.7 567.9 
2 h 400.0 403.2 399.1 662.7 
48 h 383.6 383.6 507.5 721.8 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 4.1A The mean hydrodynamic diameter of ZnO NPs
EBBS at a concentration of 
as determined by DLS 
 
 
 
 
 
Figure 4.1B The mean hydrodynamic diameter of TiO
EBBS at a concentration of 
determined by DLS (dynamic lig
 
 
A) 
B) 
 suspended
100 µg/ml for 48 hours. The mean hydrodynamic diameter 
(dynamic light scattering) is 397.9 nm.  
2 NPs suspended
10 µg/ml for 4 hours. The mean hydrodynamic diameter as 
ht scattering) is 339.2 nm.  
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4.3.2 Cytotoxicity  
4.3.2.1 The MTT assay and the NRU assay 
The results demonstrated a concentration- and time-dependent cytotoxicity as measured 
by optical density (OD) at 570 nm after exposure to ZnO or TiO2 nanoparticles which 
was evident for ZnO but not for TiO2 due to precipitation after 24 h (Figure 4.2). The 
percentage (%) cell survival in the MTT assay compared to the untreated control was 
decreased dramatically in 24 and 48 hours in ZnO treated cells reaching ~16% at the 
highest ZnO concentration (100 µg/ml). However, the highest concentrations of TiO2 
(50 and 100 µg/ml) were precipitated within 24 hours as the results for the OD showed 
higher readings compared with the negative control (> 140%). 
 
The NRU assay showed similar results as the MTT assay and demonstrated a 
concentration and time dependent cytotoxicity after exposure to ZnO or TiO2 
nanoparticles for more than 4 hours (Figure 4.2 and tables 4.2 & 4.3). 
 
Optical density (OD) means ± SD of triplicates MTT assays on HEp-2 cells treated with 
different ZnO and TiO2 concentrations and for different times as well as untreated 
controls.  
. 
 
 
 
  
 
 
Figure 4.2 Cytotoxicity of ZnO A) and TiO
hours) and  for TiO2 (2, 4, and 24 hours), was measured using the MTT and the NRU assays. The % cell survival compared to the negative 
control of untreated HEp-2 cells was evaluated for different concentrations of ZnO and TiO
of three separate experiments.  * p < 0.05, **
A) 
B) 
2 B) nanoparticles on human HEp-2 cells treated for different times for Zn
2 nanoparticles. The values represent the mean 
 p < 0.01 and *** p < 0.001.  Bars indicate standard errors 
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 Table 4.2: Optical densities from MTT assays of HEp-2 cells treated with different 
concentrations of ZnO and TiO2.  Optical density (OD) means ± SD of triplicates MTT 
assays on HEp-2 cells treated with different ZnO and TiO2 concentrations and for 
different times as well as untreated controls (Nc). * p < 0.05, ** p < 0.01, *** p < 0.001 
 
 
Treatment in 
hours 
Concentration in µg/ml 
Nc 10 20 50 100 
Zn
O
 
2 1.16 ± 0.37 1.11 ± 0.04 0.92 ± 0.26 1.01 ± 0.28 0.92 ± 0.32 
4 1.26 ± 0.36 0.98 ± 0.49 1.05 ± 0.23 1.01 ± 0.47 0.92 ± 0.56 
24 0.97 ± 0.26 0.82 ± 0.16 0.66 ± 0.26 ** 0.24 ± 0.21 *** 0.16 ± 0.04 *** 
48 0.76  ± 0.46 0.37 ± 0.14 ** 0.15 ± 0.06 *** 0.11 ± 0.05 *** 0.13 ± 0.02 *** 
Ti
O
2 
2 0.81 ± 0.19 0.78 ± 0.14 0.80 ± 0.28 0.72 ± 0.16 0.63 ± 0.13 ** 
4 0.91 ± 0.24 0.82 ± 0.24 0.80 ± 0.14 0.79 ± 0.11 0.64 ± 0.09 *** 
24 0.64 ± 0.09 0.59 ± 0.08 0.53 ± 0.08 * 0.81 ± 0.04 0.82 ± 0.11 
 
 
Table 4.3: Optical densities from NRU assays of HEp-2 cells treated with different 
concentrations of ZnO and TiO2.  Optical density (OD) ± SD means of triplicates NRU 
assays on HEp-2 cells treated with different ZnO and TiO2 concentrations and different 
time as well as untreated controls (Nc).  ** p < 0.01, *** p < 0.001 
 
 
Treatment in 
hours 
Concentration in µg/ml 
Nc 10 20 50 100 
Zn
O
 
2 0.18 ± 0.08 0.17±0.06 0.19 ± 0.08 0.15 ± 0.04 0.15 ± 0.03 
4 0.70 ± 0.07 0.66±0.08 0.64 ± 0.10 0.66 ± 0.15 0.62 ± 0.06 
24 0.20 ± 0.11 0.20±0.09 0.09 ± 0.04 *** 0.07 ± 0.01 *** 0.07 ± 0.01 *** 
48 0.11± 0.02 0.10±0.02 0.07 ± 0.01 *** 0.07 ± 0.01 *** 0.08 ± 0.02 *** 
Ti
O
2 
2 0.50 ± 0.09 0.49 ± 0.08 0.49 ± 0.08 0.48 ± 0.04 0.32 ± 0.11 *** 
4 0.72 ± 0.11 0.68 ± 0.09 0.68 ± 0.11 0.65 ± 0.09 0.41 ± 0.13 *** 
24 0.45 ± 0.08 0.42 ± 0.06 0.36 ± 0.07 ** 0.65 ± 0.09 0.68 ± 0.11 
 
 
 
 
 
 
105 
 
 
4.3.3 Cell viability and membrane integrity 
 
The cell viability in the Comet assay and immunoblotting assay using the Trypan blue 
dye exclusion assay was between 70-85% (mostly ~ 85%) for all ZnO and TiO2 
samples, with the exception of the highest dose of TiO2 (100 µg/ml), which showed 
65% viability. All doses examined, therefore had high membrane integrity. 
 
4.3.4 Genotoxicity 
4.3.4.1 DNA damage 
The parameters of Olive tail moment (OTM) and % tail DNA indicated significant 
(p < 0.05) dose-related DNA damage in HEp-2 cells. Exposure for 4 h to different 
concentrations of ZnO or TiO2 nanoparticles showed a 3-fold increase for ZnO and a 2-
fold increase for TiO2 in DNA damage compared to the negative control of untreated 
HEp-2 cells. However, for the lowest ZnO dose the induced damage, measured in % tail 
DNA, did not reach significance levels, but did for the OTM (refer to table 4.4 and 
figure 4.3). 
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Figure 4.3: The effect of TiO2 or ZnO nanoparticle exposure on DNA damage in HEp-2 cells as 
measured by the Comet assay parameters, mean Olive tail moment and % tail DNA. Cells were 
exposed to TiO2 or ZnO at concentrations of 10, 20, 50, or 100 µg/ml or a negative control of 
untreated Hep-2 cells (Nc) for 4 hours. The positive control (Pc) was treated with 80 µM (2.72 
µg/ml) H2O2 for 30 minutes. Significance values are shown in Table 4.4. The values represent 
the means of three separate experiments.  Bars indicate standard errors. 
 
 
 
 
 
Table 4.4: Effect of ZnO and TiO2 nanoparticles on HEp-2 cells in the Comet assay.  The DNA 
damage was evaluated using the Comet assay parameter, mean Olive tail moment and % tail DNA. 
The values resulted from three independent experiments.  Nc= negative control of untreated Hep-2 
cells, Pc= positive control of H2O2 80 µM, ns = non significant, * p < 0.05, ** p < 0.01 and 
*** p < 0.001 
 
 
Treatment 
concentration µg/ml Comet parameter DNA damage 
OTM % tail DNA 
Zn
o
 
Nc 1.76 ± 0.26 8.51 ± 1.11 
10 2.25 ± 0.39 ** 10.21 ± 1.11 ns 
30 3.88 ± 0.48 *** 14.79 ± 1.59 *** 
50 5.18 ± 0.69 *** 22.20 ± 2.20 *** 
100 6.68 ± 0.75 *** 25.92 ± 2.38 *** 
Pc 9.68 ± 0.98*** 34.63 ± 2.89 *** 
Ti
O
2 
Nc 1.14 ± 1.40 4.34 ± 0.82 
10 1.39 ± 1.93 *** 5.38 ± 0.97 * 
30 1.98 ± 2.93 *** 6.57 ± 1.22 *** 
50 2.21 ± 2.88 *** 7.77 ± 1.52 *** 
100 4.06 ± 5.64 *** 9.65 ± 1.71 *** 
Pc 7.02 ± 5.76 *** 15.78 ± 2.61 *** 
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4.3.4.2 In vitro CBMN assay 
It was observed the formation of MN after treatment with different ZnO (0, 10, 20, 50, 
and 100 µg/ml) and TiO2 concentrations (0, 10, 20, and 50 µg/ml) for 2 hs (Table 4.5). 
The Chi-squared analysis of the MN frequencies from HEp-2 cells exposed to different 
ZnO and TiO2 concentrations revealed a significant increase in induced MN treated with 
high concentrations of ZnO (50 and 100 µg/ml) or TiO2 (50 µg/ml) compared to the 
untreated cell control (p < 0.05). However, lower concentrations (< 50 µg/ml) of either 
ZnO or TiO2 did not induce significant alterations in MN induction. The MN frequency 
increased with ZnO concentration in a specific dose dependent manner (p < 0.05, Chi-
squared test) from an average frequency of 11 MN per 1000 binucleated cells in the 
control to 28 MN per 1,000 binucleated cells at 100 µg/ml. For TiO2, the MN 
frequencies increased in a similar way reaching 31 MN per 1000 binucleated cells at a 
concentration of 50 µg/ml. 
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Table 4.5: The effects of ZnO and TiO2 on HEp-2 cells in the cytokinesis-blocked 
micronucleus (CBMN) assay. The genetic damage was evaluated for various 
concentrations setting up two independent cultures per dose. The induction of 
micronuclei was assessed in a total of 1000 binucleated cells with two nuclei of 
approximately equal size, while the nuclear division index (NDI) was calculated from a 
total of 1000 cells (mononucleated, binucleated and multinucleated cells) using the 
Contingency table. The number of micronuclei was analyzed statistically with the Chi 
square test. 
 
Treatment concentration in µg/ml NDI MN per 1000 BNC 
Control 0 2.03 11 
Zn
O
 
10 1.68 17 
20 1.81 17 
50 1.62 23 * 
100 1.82 28 ** 
Ti
O
2 
10 1.70 13 
20 1.60 19 
50 1.57 31 ** 
100 - Precipitated 
MMC 0.134 1.76 49 *** 
 
*
 p < 0.05, ** p < 0.01; BNC - binucleated cells; NDI, nuclear division index calculated 
as described previously; MMC - mitomycin C 
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4.3.5 Tyrosine phosphorylation 
HEp-2 cells were challenged with different concentrations of ZnO (10, 20, 50, and 100 
µg/ml) and TiO2 (10, 20, and 50 µg/ml) for 4 h, and phosphotyrosine expression was 
analyzed by Western blotting analysis. The level of tyrosine phosphorylation was up-
regulated by ZnO nanoparticles, which induced an increase in phosphorylation of 
tyrosine residues on 20, 21-22, 25, 30, and ~80 kDa proteins (Figures 4.4 and 4.5). Less 
effect was seen with TiO2 inducing a fainter effect at 20, 21-22, 25, and 30 kDa at the 
highest concentrations; however, no effect was observed at ~80 kDa. 
 
Figure 4.4 Effects of A) and C) ZnO and B) TiO2 on HEp-2 receptor signalling are shown. An 
increase in phosphorylation of tyrosine residues can be seen in a Western blot of equal amounts of 
total proteins from HEp-2 cells treated for 4 hours with different ZnO concentrations 10, 20, 50 
and 100 µg/ml (lanes 2 to 5). In lane 1, the result for untreated HEp-2 cells is shown. This figure 
also illustrates, that two specific bands of increased phosphorylation at 20 kDa and 21-22 kDa 
were observed in cells treated with A) ZnO (10-100 µg/ml) and B) TiO2 (50 µg/ml only). C) For 
HEp-2 cells treated with 100 µg/ml ZnO additionally showed an increase in phosphorylation of a 
protein with a size of 80 kDa. 
 
Lane 1 Lane 2 Lane 3 Lane 4 Lane 5
22 kDa
20 kDa
22 kDa
20 kDa
80 kDa
Neg.control 10 µg/ml 20 µg/ml 50 µg/ml 100 µg/ml
ZnO
TiO2
ZnO
21 kDa
21 kDa
A)
B)
C)
110 
 
 
 
 
Figure 4.5 Effects of ZnO and TiO2 on HEp-2 phosphotyrosine receptor signalling are shown. 
An increase in phosphorylation of tyrosine residues can be seen in a Western blot of equal 
amounts of total proteins from HEp-2 cells treated for 4 h with different concentrations 10, 20, 
and 50 µg/ml as well as 100 µg/ml (only for ZnO). Untreated HEp-2 cells served as a negative 
control (Con). Panel A illustrates for ZnO that all bands at all concentrations are phosphorylated 
at 20 and 21-22 kDa, but also at 25 and 30 kDa and to some extent at ~80 kDa. For TiO2, there 
is less of an effect at the three concentrations examined at 20 and 21-22 kDa. The values 
represent the mean of three separate experiments. Panel B shows as an example the effect of 
GAPDH as an internal control seen alongside ZnO at 50 and 100 µg/ml to confirm equal protein 
loading. 
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4.4 Discussion 
Many toxicology studies over the past years have raised concerns regarding the safety 
of nanoparticles as they readily generate oxidative stress through reactive oxygen 
species (ROS). A strong link between nanoparticles and oxidative stress via ROS has 
been documented (Stone et al., 2007; Xia et al., 2006). Many investigators have shown 
that ROS play a major role in nanoparticle-induced DNA damage (Donaldson and 
Stone, 2003). However, detailed molecular mechanisms involved in the cellular 
responses to genotoxic effects are not yet fully understood. Oxygen radicals can cause 
single and double strand breaks. Damaging the DNA sugar-phosphate backbone or the 
bases may then lead to acute DNA damage, which triggers cell cycle arrest and leads to 
prolonged repair time or cell death (Friedberg and Meira, 2004). Accumulation of 
mutations which are caused by excessive or incomplete DNA repair is a known cause of 
oncogenesis (Rusyn et al., 2004). Morz and colleagues found that nanoparticles 
produced an effect similar to irradiation by inducing carcinogenesis pathways through 
ROS-induced DNA damage, as well as activating p53 and proteins related to DNA 
repair (Mroz et al., 2008). The DNA damage may be either primary as a direct effect of 
the nanoparticles or a secondary effect due to generated ROS (Schins and Knaapen, 
2007). Accordingly, ROS may be one of the possible modes suggested for ZnO and 
TiO2 induced DNA damage. Oxidative stress is now considered a major cellular 
signalling regulator and it was suggested that genotoxicity mediated by ROS could be 
further linked to other pathways (Schins and Knaapen, 2007); therefore, we investigated 
the tyrosine phosphorylation pathway additionally to the induction of DNA damage. 
 
In view of the importance of tyrosine kinase activity in the control of cell function and 
the importance of redox mechanisms in regulating the phosphorylation by tyrosine 
kinases, it was of interest to determine whether the functional changes induced by 
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altering the redox status of HEp-2 cells were associated with changes in the pattern of 
tyrosine phosphorylation. The immunoblotting analyses of HEp-2 cells cultured and 
treated with ZnO for 4 hours, then using
 
a
 
monoclonal anti-phosphotyrosine antibody, 
revealed heavily phosphorylated tyrosine residues on a protein with a molecular mass of 
20 kDa (Figure 4.4 & 4.5). Also bands at 25 and 30 kDa showed phosphorylation of 
tyrosine residues. A diffuse band of immuno-reactive material could also frequently be 
observed migrating in advance of this protein with a molecular mass of 21-22 kDa.  
This could be highly significant as a correlation was previously found between cell 
transformation and the tyrosine phosphorylation of 22-kDa protein (Glenney, 1989). In 
addition, previous studies showed, that dysregulation of protein tyrosine 
phosphorylation is crucial for cell signalling maintenance with subsequent cell 
proliferation and the early stages of neoplasia (Blume-Jensen and Hunter, 2001; Hahn 
and Weinberg, 2002). Stimulation of HEp-2 cells with ZnO was also associated with a 
dramatic enhancement in the intensity of phosphotyrosyl proteins. The increase in a 20 
kDa protein tyrosine phosphorylation induced by ZnO
 
was observed over the whole 
range of concentrations (10-100 µg/ml). Zinc oxide nanoparticles at a dose of 100 µg/ml 
additionally had a stimulatory effect on tyrosine phosphorylation of an 80 kDa protein 
(Figure 4.3 & 4.4). The same dose gave a significant 3-fold increase in the Olive tail 
moment and % tail DNA in the Comet assay when compared to the untreated control 
(Table 4.4). On the other hand, TiO2 produced fainter bands at 20 kDa and only for the 
50 µg/ml treatment dose phosphorylation at 21-22, 25, and 30 kDa (Figure 4.4 & 4.5).  
No effect was seen at ~80 kDa for TiO2. As a result, tyrosine phosphorylation may have 
contributed to the genotoxicity of ZnO but less to TiO2 genotoxicity. 
 
The consequences of genotoxic injury to HEp-2 cells were examined by ZnO and TiO2 
to elaborate the signalling events that modulate cell survival after genotoxic exposure. 
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Previous studies on HeLa cells showed activation of Cdk1 as a result of etoposide 
treatment lead to cell cycle checkpoint override with subsequent cell death (Jiang et al., 
2005). In in-vitro studies on human U937 monocytes nano-cobalt increased the 
transcription of matrix metalloproteinases (MMP-2 and MMP-9) and protein tyrosine 
kinase (PTK) signalling pathways were involved through oxidative stress (Wan et al., 
2008). Additionally, sodium vanadate was also found to induce protein tyrosine 
phosphatase (PTP) inhibition. This resulted in a bypass of growth arrest that occurred as 
the result of genotoxic exposure which indicates a role for tyrosine phosphorylation in 
the regulation of cell survival (Bae et al., 2009). PTP inhibition was also previously 
reported in primary mammary epithelial cells which enhanced cell survival by 
decreasing apoptosis (Furlong et al., 2005). 
 
In this study, cytotoxic and genotoxic effects of ZnO and TiO2 were tested in HEp-2 
cells. Cytotoxicity was measured using the MTT and NRU assays; genotoxicity was 
assessed by the Comet and CBMN assays to measure the DNA damaging and genotoxic 
potential. The data showed a cytotoxic effect of ZnO in mitochondrial activity (MTT 
assay) and the ability of lysosomes to retain neutral red stain (NRU assay) in HEp-2 
cells after treatment for 24 and 48 hours with different ZnO concentrations with the 
exception of the lowest dose (10 µg/ml) which showed no cytotoxicity even after 48 
hours treatment (Figure 4.2, Table 4.2 and 4.3). The treatment times used for cell 
cultures extended well beyond the 4 h treatment times used for the Comet assay. On the 
other hand, 100 µg/ml of TiO2 proved to be significantly toxic after 2 hours on HEp-2 
cells (Figure 4.2). For both doses, 50 and 100 µg/ml, TiO2 precipitated in the wells after 
24 hours. Hence, treated cells showed an OD which was > 140% when compared to the 
untreated control in the MTT and NRU assays. The TiO2 concentration of 20 µg/ml was 
cytotoxic to the cells in both assays to different extents in 24 hours treatment assays.  
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Aggregation of nanoparticles observed in our study has been reported previously for 
TiO2 (Lovern and Klaper, 2006) as well as for ZnO (Adams et al., 2006b) and is 
considered as an inherent property of uncoated oxide nanoparticles which occur in 
aqueous conditions from distilled water to complex biological media. Although, 
previous studies have shown that particle solubility of metal oxide nanoparticles like 
ZnO which release free hydrated zinc ions (Zn2+) strongly influenced cytotoxicity 
compared to extremely less soluble metal oxides like TiO2 (Brunner et al., 2006; 
Franklin et al., 2007; Xia et al., 2008), in this study, as the particle size increased with 
the concentration, the aggregation did not change over a time period of up to 48 hours 
for ZnO and 24 hours for TiO2. Despite increasing in ZnO and TiO2 sizes, particles 
stayed well below the pharmaceutical size definition (< 1000 nm) for nanoparticles (Sun 
et al., 2004; Teeguarden et al., 2007).  Therefore, it was assumed that the rate and 
quantities of dissolution was either negligible or of little significance for the 
experiments.  
 
The Comet assay results demonstrated the DNA damaging potential of different 
concentrations of ZnO or TiO2 with significant increases in the tail moment and % tail 
DNA in the Comet assays (3-fold for ZnO) at the highest concentration and (2-fold for 
TiO2) at the highest concentration compared to untreated control (Figure 4.3). The DNA 
damaging and mutagenic potential of ZnO or TiO2 at various concentrations was also 
seen for the CBMN assays. The genotoxic potential of ZnO or TiO2 is supported by a 
previous studies conducted by Gopalan and colleagues (Gopalan et al., 2009), which 
showed a concentration-related increase in Olive tail moment in lymphocytes and 
sperm. Also, an increase in chromosome aberrations in CHO cells treated with ZnO has 
been previously reported (Dufour et al., 2006). PTP inhibition (Bae et al., 2009) or 
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increased transcription of matrix metalloproteinases (MMP-2 and MMP-9) and PTK 
signalling pathways (Wan et al., 2008) could explain our findings of increased tyrosine 
phosphorylation as the result of genotoxic insult of ZnO and the highest concentration 
of TiO2. 
 
4.5 Conclusions 
The present investigation conclusively provides further evidence for the genotoxic 
effect of ZnO and TiO2 nanoparticles in both the Comet assay and the micronucleus 
assay with induction of chromosomal damage at high, but non-cytotoxic (according to 
Trypan blue exclusion) concentrations of ZnO (50 and 100 µg/ml) and TiO2 (50 µg/ml). 
It also provides evidence of significantly increased chromosomal mutations at the 
highest concentrations which showed no cytotoxic effects in the NRU and MTT assays. 
Furthermore, ZnO increased tyrosine phosphorylation of five proteins at 20, 21-22, 25, 
30, and ~80 kDa with less effect of TiO2 which showed increased phosphorylation 
compared to the negative control at 20, 21-22, 25, and 30 kDa for the highest dose but 
not at ~80 kDa. Thus, tyrosine phosphorylation is modified by both ZnO and TiO2 while 
causing genotoxic damage seen for two different end points in the Comet and CBMN 
assays in the absence of cytotoxicity. 
 
4.6 Executive summary 
• Cytotoxicity of ZnO  
The mitochondria and lysosome activity tests (MTT assay and NRU) indicated 
cytotoxicity of ZnO to HEp-2 cells treated beyond 4 h reaching cell survival of < 16% 
after 48 hours.  
• Cytotoxicity of TiO2 
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The highest
 
TiO2 concentration (100 µg/ml) was cytotoxic to HEp-2 cells in less than 2 
hours. 
• Genotoxicity of ZnO  
Genotoxicity of ZnO in HEp-2 cells was seen within the Comet assay showing a 3-fold 
increase in DNA damage. For the CBMN assay, an increase in the formation of 
micronuclei was found after treatment with different concentrations ZnO. 
• Genotoxicity of TiO2  
The genotoxic potential of TiO2 in HEp-2 cells was confirmed in both cytogenetic 
assays, for the Comet assay showing a 2-fold increase in DNA damage after treatment 
and for the CBMN assay revealing a dose-dependent increase in MN formation. 
• Tyrosine phosphorylation of HEp-2 cells treated with ZnO 
The level of tyrosine phosphorylation was up-regulated after exposure to ZnO 
nanoparticles, significantly increasing phosphorylation events of tyrosine residues on 20 
kDa, 21-22 kDa, 25 kDa, 30 kDa, and 80 kDa proteins. 
• Tyrosine phosphorylation of HEp-2 cells treated with TiO2 
TiO2 showed less effect on tyrosine phosphorylation at the higher doses. There was 
some effect on 21-22, 25, and 30 kDa proteins but not at ~80 kDa.  
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Chapter 5 
 
 
A comparison of the effects of titanium dioxide (TiO2) nanoparticles in peripheral 
blood lymphocytes from respiratory disease patients and healthy individuals using 
genotoxicity endpoints and ras p21 
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5.1 Introduction 
 
Nanotechnology has great potential in medical and biomedical applications and is 
increasingly used in a variety of applications such as prostheses, implants, medical 
imaging as well as in drug-delivery devices, which have been used for drug targeting of 
specific sites such as cancer sites and for gene delivery (Colilla et al., 2008; Kim et al., 
2008; Wan et al., 2007; Wang et al., 2008). In addition, NPs have been used for treating 
many human diseases such as tumours due to their unique physicochemical properties 
which have helped in the production of many nanomedicines, some currently in use and 
many under development, which bring human cells into direct contact with the NPs 
(Arvizo et al., 2010; Beck-Broichsitter et al., 2010; Ossipov, 2010). 
 
Titanium dioxide, TiO2,  has  well known photo-catalytic properties, hence it was used 
as a photosensitizer in photodynamic therapy for bronchial and oesophageal cancer 
treatment (Ackroyd et al., 2001).  Substantial numbers of reports have shown that, 
ultraviolet (UV) light can cause skin damage, aging and cancer. Hence due to the TiO2  
property of
 
effectively blocking long waves of ultraviolet sun light from 400–700 nm 
wavelengths (Maier and Korting, 2005),  it is widely used in sun creams and cosmetics 
as a sun blocking factor (SBF) to shield and protect human skin from the dangers of UV 
light (Antoniou et al., 2008). TiO2 is also routinely applied to waste water and released 
to the environment as a disinfectant (Cho et al., 2004) . In addition, TiO2 crystalline 
forms (anatase and rutile) absorb UV light in aqueous media hence, catalyzing the 
generation of different reactive oxygen species, such as free hydroxyl radicals, 
hydrogen peroxide and superoxide anion radicals (Hirakawa et al., 2004; Kawahara et 
al., 2003).  
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The industrial use of titanium dioxide is rapidly increasing in a variety of everyday life 
applications such as papers, plastics and sun creams.  In addition, TiO2 is frequently 
used in paints because of its whiteness and brightness and as the consequence of such 
wide use; the environmental and occupational exposure to TiO2 is consequently 
increasing, with the information regarding the hazardous effects to human health 
exposed to TiO2 dust lagging behind. Several studies have shown that nanoparticles may 
be more toxic than larger particles of the same substance because of the NPs large 
surface area, which could enhance NPs chemical reactivity and subsequently make it 
easier to penetrate the cell (Lam et al., 2004). 
 
 The effect of titanium dioxide (TiO2) of a size  greater than 100 nm on humans and 
animals was previously classified as being biologically inert (Hart and Hesterberg, 
1998; Lindenschmidt et al., 1990), as a result it has been increasingly used as an 
additive in many consumers products such as food colourant (Lomer et al., 2002), white 
pigment , and in sunscreens and cosmetic creams (Gelis et al., 2003).
 
 However, other  
studies have shown that the NPs size was not the effective factor of their cytotoxicity 
(Yamamoto et al., 2004).   
 
Although the previous studies have shown that the pathological effects of TiO2 dust to 
the lungs
 
 is not as great as asbestos and silica particles, still some consideration has 
been given to it is health effect as nuisance dust (Becker et al., 2002; Chen et al., 2009; 
Driscoll et al., 1997; Schins, 2002).  Garabrant and colleagues (1987) have found that 
17% of the workers exposed to TiO2 metal production developed pleural thickening and 
plaques on their X-rays and the extent of the thickening and plaques was related to the 
duration of work in TiO2 manufacturing environment. In addition, TiO2 dust exposure 
has also been reported to deposit in the lung tissues and induce lung fibrosis (Bermudez 
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et al., 2004; Lee et al., 1985).  Studies on in alveolar type II cells have shown that TiO2 
as well as other
 
poorly soluble particles such as carbon black and quartz increased hprt 
gene mutation (Driscoll et al., 1997; Schins, 2002) 
 
In vivo studies in animals have shown that rat lungs instilled with low doses of 
commonly used TiO2 did develop pulmonary inflammation or cytotoxicity (Rehn et al., 
2003; Warheit et al., 2005).  Numerous studies have shown that TiO2 exposure 
significantly increases the production of hydroxyl radicals (Lee et al., 1985; Rossi et al., 
2010) but the cytotoxicity of particular TiO2 was low compared to other nanoparticles 
(Peters et al., 2004; Yamamoto et al., 2004).   
 
The ability of TiO2 to cause inflammation or to produce inflammatory cells was also 
tested, as for example,  in vivo and in vitro administration of TiO2 have shown an 
increase in the activity of growth factors or the release of tumour necrosis factor 
secreted from macrophages (Renwick et al., 2001; Schins, 2002).  Studies of TiO2 on 
Chinese hamster ovary (CHO-K1) cells, was shown to enhance MN production which 
was dose-dependent (Lu et al., 1998). On the other hand, in vitro assays on the same 
cells (CHO), has found that TiO2 did not induce MN possibly due to poor solubility of 
TiO2 (Miller et al., 1995) . 
 
In vivo studies on mice have reported that TiO2 NPs induced 8-hydroxy-2'-
deoxyguanosine, gamma-H2AX foci, micronuclei, and DNA deletions. Titanium 
dioxide/hexachloroethane smoke condensate has been reported to induce mutations in 
strains TA98 and TA100 of Salmonella assays, inhibited erythropoietic activity  but did 
not induce micronuclei in mice (Karlsson et al., 1991).  However, in a separate report 
mice exposed to TiO2 three times a day have induced significant elevation in MN 
frequency (Shelby and Witt, 1995). 
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Titanium dioxide without photoactivation has been shown  not to induce DNA damage 
in human cells (Dunford et al., 1997)  or genotoxicity in rats (Rehn et al., 2003)  In 
contrast to the above mentioned findings, other studies have reported that TiO2 NPs  
tested without photoactivation, caused a significant dose-dependent increase in 
micronuclei production and apoptosis in Syrian hamster embryo fibroblasts (Rahman et 
al., 2002) and chronic pulmonary inflammation in rats (Oberdorster et al., 1992).   
 
Given the scale of nanotechnology production, therefore, it is inevitable that the waste 
of nanotechnology products will accumulate and contaminate the environment. It is 
necessary to understand how engineered TiO2 NPs interact with human cells following 
exposure of the more vulnerable respiratory disease patients compared to the healthy 
individuals.  Lymphocytes from pulmonary disease patients and controls were used as a 
surrogate for respiratory cells to test whether TiO2 is genotoxic in the Comet and 
CBMN assays and to determine whether the respiratory disease patients had a specific 
mechanism, which could contribute to TiO2 potential toxicity.  The respiratory pathway 
is the main route of entry of environmental pollutant particles to the body through 
inhalation. Accordingly, this study was to determine if there are any differences in 
sensitivity to nano-chemical insult (TiO2) between the patient and control groups.  
 
Nanotechnology has raced ahead of nanotoxicology and little is known of the effects of 
nanoparticles in human systems, let alone in diseased individuals. This study was 
carried out to investigate the health effect of TiO2 on patients with respiratory diseases 
(lung cancer, COPD and asthma) compared to healthy individuals because their 
respiratory system is compromised by their primary lung disease.  In addition, previous 
studies have shown that oxidative stress, induced by exposure to hydrogen peroxide, 
can produce differences in response between respiratory disease patients with lung 
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cancer, COPD and asthma and a healthy control group, and between different patient 
groups (Falque-Gonzales, 2008). Confounding factors such as age and gender and 
smoking have been taken into account. Responses have been measured using different 
end-points for genotoxic effects. These include the Comet assay, the micronucleus assay 
and ras oncoprotein level determinations. Therefore, our objective was to compare the 
effects of nanoparticles in peripheral blood lymphocytes from patients with respiratory 
diseases and healthy individuals using genotoxic endpoints. Thus, in this report the 
genotoxic effects of anatase TiO2 were examined in the absence of UV irradiation 
(Comet assays and CBMN) and on the ras p21 signalling pathway on lymphocyte cells 
from respiratory disease patients as well as from healthy control individuals. 
 
5.2. Materials and Methods  
 For materials used in each experiment see table 2.1 
 
5.2.1.1 Blood samples 
 
This study was approved by Leeds (Central) Research Ethics Committee (REC 
reference number: 09/H1313/37) and the Research Support & Governance Office, 
Bradford Teaching Hospitals NHS Foundation (ReDA number: 1202).  Ethical 
permission was also provided by University of Bradford Research Ethics sub 
Committee on Research in Human Subjects reference no: 0405-8. 
 
5.2.1.1 Patients samples 
The patients for this study were from the Outpatient Respiratory Disease Clinic of Dr. 
Badie K. Jacobs (St Luke’s Hospital, Bradford, UK).  The criteria for cases included 
lung cancer without prior chemotherapy or radiotherapy, COPD or asthma. Exclusion 
criteria included anaemia, other diseases beside their respiratory condition or previous 
occupational exposure to other NPs (e.g. silica or asbestos).  All individuals were given 
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an information sheet, completed an interviewer questionnaire and signed a consent form 
prior to 36 ml of blood being taken from each patient in heparanized tubes (9 ml in each 
of 4 tubes). The population for this study consisted of 51 subjects in total, 36 respiratory 
disease patients and 15 healthy controls.  The sub group of the respiratory disease 
persons was as follows: 16 patients with lung cancer, 11 with COPD and 9 with asthma.  
According to gender, the population included 19 males and 17 females with respiratory 
diseases and 10 males and 5 females as healthy controls. The patients were aged 6 
below 50, 14 aged 50-65 and 16 above 65 years of age, the controls aged 9 < 50 and 6 
aged 50-65.  As for smoking habits, 28 smoking patients who smoked an average of 18 
cigarettes per day over an average of 25 years and 8 non present smokers while all 
controls were non smokers.  Regarding ethnicity, the subjects for this study have been 
detailed in table 5.1.  This study has been carried out as a coded study, as the 
investigator had no prior knowledge of the diagnosis of each sample used.   
5.2.1.2 Healthy controls 
The individuals for this study were recruited from healthy controls at Bradford 
University. All individuals were given an information sheet, completed an interviewer 
questionnaire and signed a consent form prior to 36 ml of blood being taken from each 
patient in heparanized tubes. Exclusion criteria included anaemia, chest disease or any 
other disease. Healthy control individuals used in this study have also been detailed in 
table 5.1. 
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Table 5.1: Demography of the respiratory disease patient and healthy control populations: 
includes, respiratory disease patients (lung cancer, COPD and Asthma) coded as P and healthy control 
volunteers coded as V.  Numbers indicate the sequence in which samples were received. The total of 36 
patients and 15 healthy controls samples were used in the Comet and CBMN assays with the exception of 
X
 (denotes not used in CBMN assay). 
 
Serial 
No. 
Study 
code 
Age Gender Ethnicity Smoking 
history 
Cigarettes 
per day 
Years 
smoked 
Diagnosis 
1 P 1 69 M Caucasian Past  30 50 lung cancer X 
2 P 13 60 M Caucasian yes  20 15 lung cancer X 
3 P 14 72 M Caucasian yes 20-30 39 lung cancer 
4 P 15 77 M Caucasian yes  15 30 lung cancer 
5 P 18 58 M Caucasian No - - lung cancer 
6 P 20 51 F Caucasian yes 20 30 lung cancer 
7 P 22 69 F Caucasian yes 20 50 lung cancer 
8 P 24 81 M Caucasian yes 15 40 lung cancer 
9 P 25 70 M Caucasian yes 20 50 lung cancer 
10 P 27 64 M Caucasian yes  15-20 50 lung cancer 
11 P 28 70 F Caucasian yes  20 50 lung cancer 
12 P 30 81 M Asian yes  20 34 lung cancer 
13 P 31 63 F Caucasian yes 20 30 lung cancer 
14 P 32 78 M Caucasian yes  20-30 60 lung cancer 
15 P 33 73 F Caucasian yes  15 15 lung cancer X 
16 P 35 64 F Caucasian yes 20 50 lung cancer 
17 P 2 62 M Caucasian Past 15-20 20 COPD 
18 P 3 74 F Caucasian yes 15 50 COPD 
19 P 4  F Caucasian yes 20 30 COPD 
20 P 7 76 F Caucasian Passive - - COPD 
21 P 10 72 M Caucasian No - - COPD 
22 P 11  73 M Caucasian pipe 2 oz/wk  COPD X 
23 P 12 64 M Caucasian yes 10 20 COPD 
24 P 16 69 F Caucasian yes 10 40 COPD 
25 P 21 63 M Caucasian yes 20 40 COPD 
26 P 23 62 F Caucasian Past 10-20 40 COPD 
27 P 29 69 F Caucasian yes  20 40 COPD 
28 P 34 53 M Caucasian yes 20 35 Asthma 
29 P 5 44 F Asian yes   Asthma 
30 P 6 28 F Asian No - - Asthma 
31 P 8 47 F Kenyan yes 12 20 Asthma 
32 P 9 58 M Asian No - - Asthma 
33 P 17 56 F Asian No   Asthma 
34 P 19 63 F Caucasian  Past  30 10 Asthma X 
35 P26 41 F Asian No - -              Asthma 
36 36 29 F Caucasian yes  6 7  Asthma 
37 V1 34 M Asian No - - Healthy control 
38 V2 29 M Caucasian No - - Healthy control 
39 V3 29 M Asian No - - Healthy control 
40 V4 29 M Caucasian past - - Healthy control 
41 V5 51 M Caucasian No - - Healthy control 
42 V6 54 F Caucasian No - - Healthy control 
43 V7 63 M Asian No - - Healthy control 
44 V8 31 F Caucasian No - - Healthy control 
45 V9 57 F Caucasian No - - Healthy control 
46 V10 54 M Asian No - - Healthy control 
47 V11 45 F Asian No - - Healthy control 
48 V12 52 F Caucasian No - - Healthy control 
49 V13 67 M Caucasian No - - Healthy control 
50 V14 55 M Caucasian No - - Healthy control 
51 V15 37 M Caucasian No - - Healthy control 
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Table 5.2: Demography of the population used for ras p21 studies: includes, respiratory disease 
patients (lung cancer, COPD and Asthma) coded as P and healthy control volunteers coded as 
V.   
 
Study 
code 
Age Gender Ethnicity Smoking 
history 
Cigarettes 
per day 
Years 
smoked 
Diagnosis 
V1 34 M Asian No - - Healthy control 
V5 51 M Caucasian No - - Healthy control 
V6 54 F Caucasian No - - Healthy control 
V9 57 F Caucasian No - - Healthy control 
V11 45 F Asian No - - Healthy control 
V13 67 M Caucasian No - - Healthy control 
P 1 69 M Caucasian Past  30 50 lung cancer 
P 13 60 M Caucasian yes  20 15 lung cancer 
P 14 72 M Caucasian Yes 20-30 39 lung cancer 
P 15 77 M Caucasian yes  15 30 lung cancer 
P 18 58 M Caucasian No - - lung cancer 
P 20 51 F Caucasian Yes 20 30 lung cancer 
P 22 69 F Caucasian Yes 20 50 lung cancer 
P28 70 F Caucasian yes  20 50 lung cancer 
P 2 62 M Caucasian Past 15-20 20 COPD 
P 3 74 F Caucasian Yes 15 50 COPD 
P 7 76 F Caucasian Passive - - COPD 
P 10 72 M Caucasian No - - COPD 
P 11 73 M Caucasian Pipe 2 oz/wk 
 
COPD 
P 12 64 M Caucasian Yes 10 20 COPD 
P 16 69 F Caucasian Yes 10 40 COPD 
P 21 63 M Caucasian Yes 20 40 COPD 
P 34 53 M Caucasian Yes 20 35 Asthma 
P 5 44 F Asian Yes 
  
Asthma 
P 6 28 F Asian No - - Asthma 
P 17 56 F Asian No 
  
Asthma 
P 34 53 M Caucasian Yes 20 35 Asthma 
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5.2 Methods 
 
5.2.2.1 Experimental design 
The experiment was designed to find the difference in response of lymphocytes exposed 
to different concentrations of TiO2 NPs, between respiratory disease patients with lung 
cancer, chronic obstructive pulmonary disease (COPD), asthma and a healthy control 
group, and between different patient groups. Confounding factors such as age and 
gender and smoking habit have been taken into account. Responses were measured 
using different end-points for genotoxic effects. These involved the Comet assay, the 
micronucleus assay and ras oncoprotein level determinations.  
 
5.2.2.2 Comet assay 
 
The Comet assay measures DNA strand breakage in any single cell (Tice et al, 2000). 
Briefly in the Comet assay, cells can be taken from humans (human blood) and treated 
with a chemical or series of chemicals to determine effects on the genome. Cells are 
distributed on slides in an agar ‘sandwich’. The DNA is lysed and slides placed in an 
electrophoresis buffer. Then broken DNA strands move towards the anode forming a 
tail which has the appearance of a Comet. The greater the tail length and width, the 
greater the extent of DNA damage. Depending on the pH of the electrophoresis buffer, 
single or double strand breaks can be measured. Cells can be examined immediately 
after treatment, or left for some time to allow DNA repair to take place. Damage was 
measured with the Kinetic Image Analysis system using KOMET 4 software.   
 
5.2.2.2.1 Chemical preparation 
 
Different concentrations of TiO2 NPs suspensions (10, 30 and 50 µg/ml) were prepared 
through sonication then, particle size was measured by a nano-sizer, 80 µM (2.72 
µg/ml) of H2O2 was also prepared as a positive control (Pc) (detailed in section 2.2.1.1).  
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5.2.2.2.2 Treatment of lymphocytes 
In this ex vivo/in vitro study of DNA damage and repair in lymphocytes from healthy 
and lung disease patients, the lymphocytes were isolated according to the protocol 
(detailed in section 2.2.1.2) within 2 hours of blood extraction. The lymphocytes were 
then treated with different concentrations of TiO2 (10, 30 and 50µg/ml) as well as a 
negative control of untreated lymphocytes (Nc) and 80 µM (2.72 µg/ml)
 
of H2O2 (Pc)  
then incubated for 30 minutes at 37ºC. The Comet assay was then carried out using the 
Comet pH ≥ 13 system (detailed in section 2.2.2). 
 
5.2.2.3 Cytokinesis-block micronucleus assay 
Cytogenetic damage can be measured as micronuclei in cells after chemical treatment 
(Fenech, 2007).  The greater the number of micronuclei, the greater the effect on the cell 
genome. Cells have a fixed chromosome number depending on the species and man has 
46. A small amount of blood can be used to make the micronucleus preparations. A 
brief general description of the method as follows: a blood culture was prepared from 
each (coded) sample in 25 cm3  cell culture flasks, each culture consisted of 500 µl of 
whole blood added to 4.5 ml fresh medium of RPM1 1640 with Glutamax-I which 
contains 20% fetal bovine serum (Gibco) and 1% penicillin-streptomycin solution. 
(P/S), and this fresh medium allows the cells to grow. 130 µl of phytohaemagglutinin 
(PHA), a mitogen, was added to reach a final concentration of 2.5%, added because 
lymphocytes need to be stimulated to divide and proliferate. Cultures were then left in 
an incubator whilst the chemicals 50 µl  of TiO2 at 2 different concentrations (5 and 10 
µg/ml) and 50 µl  of MMC were added as a positive control to reach a final 
concentration of 0.4 µM (Meynard et al., 2007) at time 24 hours. Cytochalasin B at a 
final concentration of 6µg/ml was added to cell cultures at 44 hours which prevents the 
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cells undergoing cytokinesis, so that binucleated cells are formed (Fenech, 2007).  
Incubation is continued until 72 hours. They were fixed with a 3:1 methanol: acetic acid 
fixative and stained with Giemsa.  Each sample was treated in duplicate flasks with 
TiO2 as well as positive and negative controls.  
 
Two slides were prepared from each culture (a total of 4 slides per sample). Micronuclei 
were counted using a 100X oil immersion objective on a light microscope.  A total of 31 
patients (13 lung cancer, 10 COPD and 8 asthma) and 15 controls were used in the 
CBMN assay; 5 samples were excluded for technical reasons (refer to section 2.2.3.7). 
 
5.2.2.4 Immunoblotting for ras oncoprotein detection 
 
In general, a standard amount of protein from lymphocyte culture lysates, that were 
obtained from 20 chest disease patients and 6 healthy control blood samples was 
quantitated using the Bio- Rad DC method and separated by gel electrophoresis, 
transferred to a nitro-cellulose membrane by Western blotting and detected by 
chemiluminescence (Anderson et al., 1998a).  A monoclonal ras antibody was used as a 
primary antibody and horse–radish peroxidase–conjugated sheep anti-mouse 
immunoglobulin as the secondary antibody. Optical densities (OD) of the peak of the 
protein bands were calculated and values of two standard deviations above negative 
control means were considered positive. A pan–ras antibody, which can detect proteins 
produced by all three members (Harvey, Kirsten and N- ras) of the ras gene family was 
used.  Lymphocyte cultures and protein extraction method are detailed in chapter 2 
section (2.2.3.4, 2.2.2.7.3).  For ras p21 detection; the individuals whose lymphocytes 
used were shown on table (5.2).  In brief 6 healthy controls, 4 asthma, 8 COPD and 8 
lung cancers were used in this study. 
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5.2.2.5 Statistics 
For the Comet assay the Olive tail moment (OTM) and % tail DNA parameters were 
used in the treated and untreated lymphocytes in addition to the negative (Nc) and the 
positive control H2O2 of the respiratory disease patient groups and  healthy control 
groups. The Olive tail moment (OTM) and % tail DNA parameters have been used in 
this study as the use of two different Comet parameters was recommended (Kumaravel 
et al., 2009).   The results shown are the means of two independent experiments per 
patient or healthy control.  One hundred cells were scored in each experiment to 
enhance the statistical power. SPSS 15 for windows was used.  The Kolgomrov-
Smirnov was used to examine the OTM and % tail DNA data for normality of 
distribution.  The data was found to have a normal distribution and accordingly, the 
parametric ANOVA test was applied.  Groups were compared in 2 different ways; in the 
first each group was compared to its own untreated control and in the second each 
patient group or confounder was compared to its parallel healthy control sample. 
 
For CBMN the nuclear division index (NDI) can be used as an indicator of the 
cytostatic effect of TiO2 and it was calculated according to the formula: NDI= (M1+ 
2M2 + 3M3) / N; where M1, M2 and M3 presented mono-nucleated, bi-nucleated and 
multi-nucleated cells respectively while N represented the total viable cells scored . The 
nuclear division index (NDI) was tested with the Chi square (χ2), and the number of MN 
in 1000 binucleated cells was compared between the untreated and treated for each 
sample using the graph pad 2x2 contingency (Fisher exact test) for the P value.  For ras 
p21 immunoblotting Image J software for windows was used to quantify western blots 
to compare the OD of the bands (Chiang et al., 2009; Neirynck et al., 1991). 
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5.3 Results 
5.3.1 Comet assay in lymphocytes from respiratory disease patients and controls: 
Groups were compared in 2 different ways; in the first, each group was compared to its 
own untreated control and in the second each patient group or confounder was 
compared to its parallel healthy control sample. The Olive tail moment (OTM) and % 
tail DNA of the healthy controls and patient group lymphocytes treated with different 
TiO2 concentrations were then analyzed by ANOVA and the following results obtained: 
table 5.3 and 5.4 and figures 5.1(A-E): In all reported experiments the positive control, 
H2O2, was always statistically significant p > 0.001.  This indicated that the system and 
whole experiment had worked satisfactory. 
 
5.3.1.1 Patient and control groups  
In figure 5.1 A and tables 5.3 & 5.4, the means of the OTM and % tail DNA showed 
that TiO2 produced genomic damage which increased in a concentration dependent 
manners in both respiratory disease patients and controls lymphocyte cells. When OTM 
data were used to compare the whole patient group and the control group, and TiO2 
treated lymphocytes to the untreated lymphocyte control, results showed that TiO2 
increased in a concentration dependent way DNA damage in both groups to varying 
extent with the exception of the lowest TiO2 concentration (10 µg/ml) which did not 
induce significant damage in healthy controls (ns).  However, the patient group had 
more DNA damage (p > 0.001) with exception of 10 µg/ml of TiO2 that caused less 
significant damage to patient lymphocytes with (p < 0.05).  Moreover, with the % tail 
DNA diameter, all control samples treated with different TiO2 concentrations were not 
statistically significant (ns), and for the patient group only TiO2 at a concentration of 50 
µg/ml 
 
was significant (p < 0.01).  
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When the patient groups compared to the control group (table 5.3 & 5.4) the means seen 
in fig 5.1.A generally showed that, the respiratory disease patient groups had a higher 
basal DNA damage.  This was confirmed when the two untreated controls groups were 
compared with each other (p < 0.01).  When comparing each patient’s sample with its 
parallel control sample, patient samples showed statistically significant higher DNA 
damage for both OTM and % tail DNA parameters simultaneously.  The statistical 
significance for the negative control (Nc) versus TiO2 10 µg/ml was (p < 0.01) and 
versus TiO2 concentrations of 30 and 50 µg/ml the significance was at p < 0.001.     
  
5.3.1.2 Analysis of confounding factors: 
5.3.1.2.1 Lung cancer, COPD, asthma and healthy controls 
Figure 5.1B shows the lung disease patients namely lung cancer, COPD and asthma 
compared to the healthy control group.  The trend of the histogram shows more DNA 
breakage in lung cancer and COPD groups compared to the asthma group of patients 
and healthy controls. On comparing the OTM of each group of lymphocytes treated 
with different TiO2 concentrations to un treated lymphocyte controls by ANOVA, lung 
cancer and COPD groups showed identical as well as higher DNA damage (p < 0.001) 
at all TiO2 concentrations with exception of the lowest concentration (p < 0.05), while 
the asthma group showed less damage than the controls and DNA breakage occurred 
only at the high concentration of 50 µg/ml (p < 0.001).  The OTM controls group 
showed significant DNA breakage (p < 0.01) but less than in COPD and lung cancer 
patient.  However, % tail DNA of both lung cancer and COPD recorded less DNA 
damage than on OTM and in both cases and 10 µg/ml
 
did not induce any DNA damage 
to both.  However asthma patients showed the % DNA statistical significance similar to 
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COPD (p < 0.05) and , with the % tail DNA parameter all control samples treated with 
different TiO2 concentrations were not statistically significant (ns). 
 
When each of the patient groups (lung cancer, COPD and asthma) were compared to 
their equivalent control group sample (table 5.3 & 5.4), the COPD group showed higher 
basal DNA damage at (p < 0.001) followed by lung cancer at (p < 0.01) while asthma 
group showed no difference in basal damage compared to the control for both OTM and 
% tail DNA. All groups showed identical significance for OTM and % tail DNA with 
exception of asthma which showed less damage with the % tail DNA parameter.  
 
5.3.1.2.2 Gender 
Histogram 5.1C and tables 5.3 and 5.4 shows that when the data for each group of 
treated samples were compared to data for untreated samples in the same group, the 
following result was reported:  The highest DNA damage was for OTM of male patients 
compared to other groups.  Male controls and female patients and female controls 
showed lesser value for OTM. However the % tail DNA for the male and female 
subgroups showed that female patients had the highest DNA damage.  No damage was 
induced by TiO2 in both male and female controls DNA when % tail DNA was 
examined.  However when male and female patient groups were compared to male and 
female controls (table 5.3 & 5.4), the male patient group had higher damage than female 
patients with the exception of TiO2 lowest concentration where there was more 
genotoxic damage to female DNA (p < 0.001).  Male and female patients showed 
identical results for OTM and % tail DNA. 
 
5.3.1.2.3 Age 
 
In figure 5.1D and tables 5.3& 5.4, TiO2 treated lymphocytes showed increasing 
damage with age for OTM with patients over 65 expressing the highest DNA damage 
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followed by patients of 50-65 then the other groups.  However for % tail DNA controls 
50-65 showed higher damage than patients over 65 and only the highest concentrations 
caused DNA damage to the patients over 65 (p < 0.05) , controls less than fifty 
expressed no DNA damage for % tail DNA.  However, patients less than fifty were the 
only group that had damage (p < 0.001) when their lymphocytes were treated with TiO2 
(50 µg/ml).  When the three patient groups compared to the two controls, the two oldest 
patient groups expressed similar results except that the over 65 had higher basal damage 
and patients < 50 had no significant basal damage reported also; the lower dose was not  
genotoxic to patients < 50. 
 
5.3.1.2.4 Smoking habit 
Figure 5.1 E and tables 5.3 and 5.4 demonstrate that all lymphocytes of smoker’s and 
non smoker’s categories showed an upward trend in DNA damage that indicates an 
increasing genotoxicity in lymphocytes treated with different TiO2 concentrations with 
the smoking patients showing the greatest DNA damage which was identical in both 
Comet parameters and the non smoking controls had the lowest damage with the non 
smoking patients in between.  When the Comet data for smoking and non smoking 
patients were compared to their corresponding non smoking controls, the results showed 
that for both Comet parameters, used in our statistical analysis, non smoking and 
smoking patients had similar baseline damage however, smokers developed more DNA 
damage after TiO2 exposure. 
 
5.3.1.2.5 Ethnicity 
Figure 5.1F and tables 5.3 & 5.4 demonstrated statistically significant differences 
between the Asian and Caucasian populations.  The Asian patients show statistically 
significant less damage than the Caucasians (P < 0.05).  The Caucasian controls do not 
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differ from the Asian controls.  Generally, there was agreement between OTM and % 
tail DNA. 
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Figure 5.1A Histogram showing the means of Olive tail moment and % tail DNA in peripheral blood lymphocytes of the healthy controls 
compared to the DNA damage in the respiratory disease group of patients in the Comet assay after treatment with different TiO2 concentrations 
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(10, 30 and 50 µg/ml), as well as the negative control of untreated lymphocytes (Nc) and the positive control of 80 µM (2.72 µg/ml)
 
H2O2 (Pc) 
for 30 minutes. Bars indicate standard errors.  Not significant: ns, *p < 0.05, ** p < 0.01 and ***p < 0.001 
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Figure 5.1B Histogram showing the means of Olive tail moment and % tail DNA in lymphocytes of healthy controls, lung cancer, COPD and 
asthma patient groups in the Comet assay after treatment with different TiO2 concentrations (10, 30 and 50 µg/ml), as well as the negative control 
of untreated lymphocytes (Nc) and the positive control of 80 µM (2.72 µg/ml)
 
H2O2 (Pc) for 30 minutes. Bars indicate standard errors.  Not 
significant: ns, *p < 0.05, ** p < 0.01 and ***p < 0.001 
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Figure 5.1C Histogram showing the means of Olive tail moment and % tail DNA in the peripheral blood lymphocytes of male healthy controls, 
female healthy controls, male patients and female patients groups in the Comet assay after treatment with different TiO2 concentrations (10, 30 
and 50 µg/ml), as well as the negative control of untreated lymphocytes (Nc) and the positive control of 80 µM (2.72 µg/ml)
 
H2O2 (Pc) for 30 
minutes. Bars indicate standard errors.  Not significant: ns, * p < 0.05, ** p < 0.01 and *** p < 0.001 
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Figure 5.1D Histogram showing the means of Olive tail moment and % tail DNA in lymphocytes of healthy controls aged < 50 and 50-65, 
patients aged < 50, 50-65 and > 65 years old in the Comet assay after treatment with different TiO2 concentrations (10, 30 and 50 µg/ml), as well 
as the negative control of untreated lymphocytes (Nc) and the positive control of 80 µM (2.72 µg/ml)
 
H2O2 (Pc) for 30 minutes. Bars indicate 
standard errors.  Not significant: ns, *p < 0.05, ** p < 0.01 and ***p < 0.001 
 
0
5
10
15
20
25
30
35
40
45
50
Nc 10 30 50 Pc Nc 10 30 50 Pc Nc 10 30 50 Pc Nc 10 30 50 Pc Nc 10 30 50 Pc
Concentrations in µg/ml
O
T
M
 
&
 
%
 
t
a
i
l
 
D
N
A
OTM % tail DNA
Patients >65
(D)
Controls < 50 Controls 50-65 Patients < 50 Patients 50-65
ns
ns ns ns
ns ns
ns
ns
ns
ns
ns ns
ns
ns
ns
*
*
*
*
*
*
*
*
*
*
*
*
*
*
* *
*
*
*
*
*
*
*
* *
*
*
*
*
*
*
*
*
*
*
*
*
*
* **
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
O
T
M
 
&
 
%
 
t
a
i
l
 
D
N
A
*
*
*
*
*
*
*
*
*
*
*
*
*
*
* *
*
*
*
*
*
*
*
* *
*
*
*
*
*
*
*
*
*
*
*
*
*
* **
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
140 
 
 
Figure 5.1E Histogram showing the means of Olive tail moment and % tail DNA in lymphocytes of non smoker healthy controls, non smoker 
and smoker patient groups in the Comet assay after treatment with different TiO2 concentrations (10, 30 and 50 µg/ml), as well as the negative 
control of untreated lymphocytes (Nc) and the positive control of 80 µM (2.72 µg/ml)
 
H2O2 (Pc) for 30 minutes. Bars indicate standard errors.  
Not significant: ns, *p < 0.05, ** p < 0.01 and ***p < 0.001 
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Figure 5.1F Histogram showing the means of Olive tail moment and % tail DNA in lymphocytes of Caucasian patients and controls, and Asian 
patients and control groups in the Comet assay after treatment with different TiO2 concentrations (10, 30 and 50 µg/ml), as well as the negative 
control of untreated lymphocytes (Nc) and the positive control of 80 µM (2.72 µg/ml)
 
H2O2 (Pc) for 30 minutes. Bars indicate standard errors.  
Not significant: ns, *p < 0.05, ** p < 0.01 and ***p < 0.001 
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Table 5.3:  Means ± SD of the Olive tail moment (OTM) in lymphocytes of healthy controls and respiratory disease patients divided according to confounding 
factor.  In each group the means of OTM of treated lymphocytes was compared with the means of OTM of the negative control of untreated lymphocytes (Nc) 
with ANOVA (*p < 0.05, **p < 0.01,***p < 001)  and n.s not significant. (◘ not significant ●p < 0.05, ♦p < 0.01, ♠p < 0.001) when patients and their confounders 
were compared with corresponding control samples.  The positive control (Pc) was 80 µM (2.72 µg/ml)
 
H2O2 was included. 
 
Group type and confounder  
Nc 
TiO2 concentrations in µg/ml  
Pc 10 30 50 
Control and patients 
groups 
Healthy controls 1.8 ± 0.7 2.3 ± 1.0 n.s 2.7 ± 1.0** 3.2 ± 1.2** 8.5 ± 3.0*** 
Patient group 3..7  ± 1.5♦ 4.3 ± 1.6*♦ 5.0 ± 2.0***♠ 6.2 ± 2.2***♠ 9.3 ± 3.2*** 
Lung cancer 3.9 ± 1.2♦ 4.8 ± 1.2*♠ 5.3 ± 1.4***♠ 6.7 ± 1.2***♠ 9.7 ± 2.9*** 
COPD 4.6 ± 1.4♠ 5.0 ± 1.4 ns ♠ 6.4 ± 1.4***♠ 6.8 ± 2.2***♠ 11.1 ± 1.2*** 
Asthma 2.6 ± 0.6◘ 3.2± 0.9 ns ◘ 3.4 ± 1.7 n.s◘ 5.3 ± 2.0***● 8.2 ± 2.3*** 
Gender Male controls 1.8 ± 0.8 2.6 ± 1.0 ** 2.9 ± 1.0** 3.2 ± 1.3** 8.7 ± 2.7*** 
Female controls 1.7 ± 0.6 1.6 ± 0.5 ns 2.4 ± 0.8 n.s 3.3 ± 0.8** 8.0 ± 3.3*** 
Male patients 3.9  ± 1.2♦ 4.7 ± 1.4 n.s♦ 5.9 ± 1.6***♠ 6.6 ± 1.7***♠ 9.8± 2.8*** 
Female patients 3.8 ± 1.5♦ 4.3  ± 1.4 ns ♠ 4.61 ± 1.90 n.s● 6.2 ± 2.1**♦ 9.85  ± 2.69*** 
Age Controls < 50  1.4 ± 0.5 2.0 ± 0.9 ns 2.2 ± 0.7* 2.6 ± 0.9*** 8.2± 3.4*** 
Controls 50-65  2.4 ± 0.6 2.6 ± 1.0 n.s 3.5 ± 0.8* 4.1 ± 1.0*** 8.9 ± 1.9*** 
Patients < 50  2.6 ± 0.6◘ 3.6 ± 0.9n.s◘ 3.4 ± 1.9 ns ● 5.0 ± 1.9***♦ 8.6 ± 2.5*** 
Patients 50-65  4.0 ± 1.6♦ 4.5 ± 1.8 ns ♦ 5.7 ± 2.0**♠ 6.5 ± 1.9***♦ 9.8 ± 3.2*** 
Patients >65  4.1 ± 1.1♠ 4.8 ± 1.0 ns ♠ 5.4 ± 1.2***♠ 6.8 ± 1.7***♠ 10.2 ± 2.1*** 
Smoking Non-smoking Controls 1.8 ± 0.7 2.3 ± 1.0 ns 2.7 ± 1.0 * 3.2 ± 1.2*** 8.5 ± 3.0*** 
Non-smoking patients 3.7 ± 1.7♦ 3.5 ± 1.7n.s● 4.5 ± 2.3*♦ 6.3 ± 2.3***♠ 8.3 ± 2.6*** 
Smoking patients 3.9 ± 1.3♦ 4.7 ± 1.2 *♠ 5.4 ± 1.6***♠ 6.4 ± 1.8***♠ 10.3 ± 2.6*** 
Ethnicity Caucasian controls  2.5 ± 0.6◘ 3.2 ± 0.8ns ◘ 4.0 ± 0.8*◘ 4.3 ± 1.1**◘ 9.7 ± 1.6*** 
Caucasian patients 4.2 ± 1.6● 4.5 ± 1.4ns ◘ 5.3 ± 1.9**♦ 6.3 ± 2.5***◘ 10.1 ± 2.8*** 
Asian controls  1.7 ± 0.6 2.5 ± 1.0 ns 2.4 ± 0.6 ns 3.4 ± 1.1** 8.9 ± 3.1*** 
Asian patients  2.8 ± 0.7 3.5 ± 1.7ns 3.2 ± 1.1ns 5.7 ± 2.0** 7.7 ± 2.1*** 
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Table 5.4:  Means ± SD of % tail DNA in lymphocytes of healthy controls and respiratory diseases patients divided according to confounding 
factor.  In each group the means of % tail DNA of treated lymphocytes was compared with the means of the negative controls % tail DNA of untreated 
lymphocytes (Nc) with ANOVA (*p < 0.05, **p < 0.01,***p < 001)  and n.s not significant. (◘ not significant ●p < 0.05, ♦p < 0.01, ♠p < 0.001) when patients 
and their confounders were compared with corresponding control samples.  The positive control (Pc) of 80 µM (2.72 µg/ml)
 
H2O2 was included. 
 
 
Group type and confounder  
Nc 
TiO2 concentrations in µg/ml  
Pc 10 30 50 
Control and patients 
groups 
Healthy controls 10.2 ± 4.7 12.4 ± 6.1  ns     13.8 ± 5.5 ns 15.3 ± 6.3 ns 34.9 ± 10.6*** 
Patient group 15.4 ± 5.3♦ 17.7± 5.4 ns ♦ 19.0 ± 5.5ns ♠ 23.3 ± 6.5**♠ 35.6 ± 9.3*** 
Lung cancer 16.8 ± 5.8♦ 19.4 ± 4.4 ns ♦ 20.1 ± 4.9 *♠ 24.9 ± 6.4**♠ 34.4 ± 9.3*** 
COPD 16.7 ± 5.5♦ 18.2 ± 5.6 ns ♦ 21.6 ± 4.5*♠ 21.9 ± 6.8*♠ 36.5 ± 9.6*** 
Asthma 12.7 ± 2.0◘ 15.6 ± 5.5 ns ◘ 15.4 ± 5.3 ns ◘ 23.1 ± 5.8*♠ 36.0 ± 8.8*** 
Gender Male controls 10.1 ± 5.0 13.8 ± 6.6 ns 13.8 ± 5.3 ns 15.7 ± 3.8 ns 36.2 ± 12.5*** 
Female controls 10.4 ± 4.1 9.69 ± 3.7 ns 13.6 ± 5.6 ns 14.4 ± 5.8  ns  32.3 ± 8.8*** 
Male patients 15.9 ± 5.7♦ 17.7 ± 4.2 ns  ◘      20.5 ± 5.2*♦ 21.5 ± 7.1*● 32.3 ± 9.2*** 
Female patients 15.9 ± 4.8◘ 18.3 ± 6.2 ns ♦ 18.5 ± 5.5 ns◘ 25.1 ± 6.2***♠ 38.4 ± 7.7*** 
Age Controls < 50  7.8 ± 4.5 10.8 ± 6.6 ns 11.2 ± 5.5 ns 12.1 ± 6.7  ns 34.7 ± 11.9*** 
Controls 50-65  13.9 ± 2.4♦ 14.8 ± 6.0 ns● 17.5 ±1 6.3**♦ 20.0 ± 3.5**◘ 35.2 ± 8.1*** 
Patients < 50  12.6 ± 1.7♦ 17.2 ± 4.0 ns ♦ 16.1 ± 2.2 ns ♦ 23.6 ± 5.4***◘ 38.5 ± 9.7*** 
Patients 50-65  16.4 ± 5.8♠ 18.4 ± 6.2 ♠ ns 20.8 ± 5.4*♠ 24.2 ± 3.5**◘ 35.3 ± 8.1*** 
Patients >65  16.3 ± 5.3♠ 17.9 ± 4.2 ♠ ns 19.6 ± 4.6 ns♠ 22.5 ± 7.8*◘ 34.6 ± 9.8*** 
Smoking Non-smoking Controls 10.2 ± 4.7 12.4 ±6.1 ns 13.7 ± 5.5 ns 15.3 ± 6.3 ns 34.9 ± 10.6*** 
Non-smoking patients 14.4 ±3.5♦  14.1 ± 3.1 ns ♦ 16.5 ± 5.2 ns ♦ 22.4 ± 6.6**♠ 30.5 ± 6.8*** 
Smoking patients 15.9 ± 5.1♦ 18.9 ± 5.0*♠ 20.2 ± 5.1**♠ 23.1 ± 9.6*** ♠ 36.8 ± 9.3*** 
Ethnicity Caucasian controls  14.8 ± 0.7◘ 17.0 ± 2.3 ns ◘ 19.3 ± 1.4**◘ 22.4 ± 2.2***◘ 40.2 ± 3.0*** 
Caucasian patients 16.1 ± 6.36◘ 17.7 ± 6.0 ns ◘ 19.5 ±6.3**● 22.9 ± 7.2***◘ 36.6 ± 11.2*** 
Asian controls  9.3 ± 3.8 14.3 ± 6.4 ns 12.2 ± 3.3 ns 15.8 ± 5.1** 35.8 ± 10.4*** 
Asian patients  13.8 ± 1.8 16.6 ± 7.0 ns 14.6 ± 3.0 ns 22.3 ± 4.8** 30.3 ± 6.0*** 
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5.3.2 CBMN assay in lymphocytes from respiratory disease patients and controls 
 
A total of 46 individuals from four groups were screened for MN, consisting of 13 lung 
cancer, 11 COPD, 8 asthma and 15 controls.  These samples were further divided to test 
for the confounding factors (age, gender and smoking habit), to determine whether these 
factors could influence our findings. All former smokers and those who never smoked 
were considered as non-smokers to increase the statistical power of detection of any 
assumed association of MN with smoking.  MMC was included as a system control and 
the responses were as anticipated indicating that the system and the whole experiment 
had worked. 
           
 Each sample was treated with two TiO2 concentrations (5 and 10µg/ml), a positive 
control (0.4µ MMMC) and a negative control of untreated cells (figure 5.2 A-F and 
table 5.5).The nuclear division index (NDI) was evaluated with the Chi square test, and 
the number of MN in 1000 binucleated cells was compared between the untreated and 
treated for each sample using the graph pad 2x2 contingency (Fisher exact test) for the P 
value.  An extra comparison was carried out between the patients’ samples and the 
healthy control untreated sample. To assess the effect of other factors such as co-
morbidity on MN frequency, patients and controls were further divided to subgroups 
according to their gender, age, smoking habit and ethnicity as shown in figure (5.2 C-F). 
 
5.3.2.1 Patients and controls 
Although, figure 5.2 A-F and table 5.5 have shown that the number of micronuclei 
increases, the difference were not statistically significant, except when the MN in 
patient samples compared to the MN of untreated control.  This showed a significant 
increase in MN induction in all patients groups including for their confounding factors. 
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In all groups as indicated in table 5.5.1 the nuclear division index (NDI) and the 
percentage bi-nucleated cells (% BiNC) which are indicators of the cytostatic state were 
within normal limits. MMC the positive control behaved as anticipated signifying that 
the system and the whole experiment were working satisfactory.  In all TiO2 treated 
samples there was an increase in NPBs and to lesser extent buds which were not 
significant. 
 
Figure 5.2A, shows  a clear difference in MN numbers between the lung disease 
patients and the healthy controls which was not significant except when comparing 
patients’ MN to those of untreated healthy controls MN the patients’ induced MN was 
significant (p < 0.05) (figure 5.2A and table 5.5.1). 
5.3.2.2 Analysis of confounding factors: 
5.3.2.2.1 Lung cancer, COPD, asthma and healthy controls 
 
Figure 5.2 B and table 5.5 the MN frequency distribution in controls and lung cancer, 
COPD and asthma patient groups, was displayed in figure 5.2B, which demonstrated an 
increasing pattern of MN induction in each of the above mentioned groups; however it 
was not statistically significant.  Thereafter, we compared MN induced by lung cancer, 
COPD and asthma patients to the MN of the untreated control of healthy individuals 
and a significant difference was reported for all patient groups, at  p < 0.01  for lung 
cancer and COPD and p < 0.05 for asthma. 
 
5.3.2.2.2 Gender  
According to gender, male and female patients showed higher MN which was 
statistically significant compared to the untreated control of the healthy persons group at 
p < 0.01 for both the male and female lymphocytes response to TiO2 concentration of 
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TiO2 10 µg/ml.  However, only male patients showed a response to (Nc) and 5 µg/ml at 
p < 0.05 (figure 5.2C and table 5.5.2). 
 
5.3.2.2.3 Age 
 In relation to age, the two older patient groups induced significantly higher MN 
compared to the untreated control of healthy individuals (p < 0.01) and was not 
significant compared to their negative controls (figure 5.2D and table 5.5.3). 
                
5.3.2.2.4 Smoking 
 The smoking and non smoking patients showed statistically significant increases in MN 
number when compared to the control of the healthy individuals for both TiO2 
concentrations.  However, the induced MN number of the smoking and non smoking 
patients was not significant compared to its counterpart untreated control (figure 5.2E 
and table 5.5.4). 
 
5.3.2.2.5 Ethnicity  
Ethnicity, as a confounder was tested on 30 Caucasian and 6 Asian patients and 10 
Caucasian and 5 Asian controls.  Caucasian patients showed the largest increase in the 
MN number compared to the other groups (figure 5.2F and table 5.5.5). Results were 
not significant unless compared to the untreated control groups.  The higher significance 
obtained was for the Asian patients for the number of MN in 1000 binucleated cells. 
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Figure 5.2A Histogram showing the means of micronuclei (MN) per 1000 binucleated cells of 
healthy controls and respiratory disease group of patients after treatment of blood cultures with 
2 different TiO2 concentrations (5 and 10µg/ml) as well as the negative control of untreated 
blood cultures (Nc) and the positive control of 0.4 µM MMC (Pc) in the CBMN assay.  
*denotes p < 0.05 and **p <0.01 when the patients group are compared with untreated 
lymphocytes of the controls group.  +denotes highly significant in both situations when 
compared with the untreated control of their own specific group, as well as with the untreated 
lymphocytes of healthy controls.  The bars indicate standard errors. 
 
 
 
 
 
Figure 5.2B Histogram showing the means of micronuclei (MN) per 1000 binucleated cells of 
healthy controls, lung cancer, COPD and asthma patients after treatment of blood cultures with 
2 different TiO2 concentrations (5 and 10µg/ml) as well as the negative control of untreated 
blood cultures (Nc) and the positive control of 0.4 µM MMC (Pc) in the CBMN assay.  * 
denotes p < 0.05 and **p <0.01 when the patient groups are compared with untreated 
lymphocytes of the controls.  +denotes highly significant in both situations when compared with 
the untreated control of their own specific group, as well as with the untreated lymphocytes of 
healthy controls.  The bars indicate standard errors. 
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Figure 5.2C Histogram showing the means of micronuclei (MN) per 1000 binucleated cells of 
male healthy controls, female healthy controls, male respiratory disease patients and female 
respiratory disease patients after treatment of blood cultures with 2 different TiO2 concentrations 
(5 and 10µg/ml) as well as the negative control of untreated blood cultures (Nc) and the positive 
control of 0.4 µM MMC (Pc) in the CBMN assay.  * denotes p < 0.05 and **p < 0.01 when the 
patient groups are compared with untreated lymphocytes of the controls.  +denotes highly 
significant in both situations when compared with the untreated controls of their own specific 
group, as well as with the untreated lymphocytes of healthy controls.  The bars indicate standard 
errors.   
 
 
Figure 5.2D Histogram showing the means of micronuclei (MN) per 1000 binucleated cells of 
age < 50 healthy controls, age 50-65 healthy controls, age < 50 patients, age 50-65 patients   and 
patients aged > 65 after treatment of blood cultures with 2 different TiO2 concentrations (5 and 
10µg/ml) as well as the negative control of untreated blood cultures (Nc) and the positive 
control of 0.4 µM MMC (Pc) in the CBMN assay.  * denotes p < 0.05 and **p < 0.01 when the 
patient groups are compared with untreated lymphocytes of the controls.  +denotes highly 
significant in both situations when compared with the untreated control of their own specific 
group as well as with the untreated lymphocytes of healthy controls.  The bars indicate standard 
errors. 
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Figure 5.2E Histogram showing the means of micronuclei (MN) per 1000 binucleated cells of 
non smoker healthy controls, non smoker patients and smoker patients after treatment of blood 
cultures with 2 different TiO2 concentrations (5 and 10µg/ml) as well as the negative control of 
untreated blood cultures (Nc) and the positive control of 0.4 µM MMC (Pc) in the CBMN 
assay.  *denotes p < 0.05 and **p <0.01 when the patient groups are compared with untreated 
lymphocytes of the controls.  +denotes highly significant in both situations when compared with 
the untreated control of their own specific group as well as with the untreated lymphocytes of 
healthy controls.  The bars indicate standard errors. 
 
 
 
Figure 5.2F Histogram showing the means of micronuclei (MN) per 1000 binucleated cells of 
Caucasian controls, Caucasian patients, Asian controls and Asian patients after treatment of 
blood cultures with 2 different TiO2 concentrations (5 and 10µg/ml) as well as the negative 
control of untreated blood cultures (Nc) and the positive control of 0.4 µM MMC (Pc) in the 
CBMN assay.  *denotes p < 0.05 and **p <0.01 when the patient groups are compared with 
untreated lymphocytes of the controls. +denotes highly significant in both situations when 
compared with the untreated control of their own specific group as well as with the untreated 
lymphocytes of healthy controls.  The bars indicate standard errors.
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Table 5.5.1: Health condition as a factor in the CBMN.   Means ± SD of  different 
CBMN assay parameters of respiratory disease patients (lung cancer, COPD,  asthma) 
and healthy controls in blood cultures treated with TiO2  (5 and 10 µg/ml) as well as a 
negative control of untreated blood cultures (Nc) and a positive control (Pc)  of 0.4 µM of 
mitomycin C (MMC). Symbols indicate level of significance when comparing each group 
to healthy individuals’ untreated controls. * implies P < 0.05, ** P < 0.01 and +denotes 
highly significant when compared each group to its own untreated control as well as to 
corresponding healthy individuals untreated control.  
 
Group type and confounder  
 
Nc 
TiO2 concentrations µg/ml  
 
Pc 5 10 
C
o
n
tr
o
l a
n
d 
pa
tie
n
ts
 
gr
o
u
ps
 
Controls group     
NDI 1.88  ± 0.03 1.84 ± 0.02 1.73 ± 0.02 1.66 ± 0.03 
%BiNC 58 .04 ± 4.42 56.35± 2.34 58.34 ± 3.45 46 ± 2.44 
BiMN 1.87 ± 1.63 4.47 ± 2.39 7.27 ± 1.69 29.87 ± 4.15+ 
Mono MN 1.93 ± 2.24 1.80 ± 1.51 3.67 ± 1.51 5.2 ± 2.56 
NPBs 0.33 ± 0.47 4.40 ± 2.95 4.80 ± 2.45 0.53 ± 0.81 
Nuclear buds 0.67 ± 0.79 2.13 ± 1.64 2.13 ± 1.5 0.72 ± 0.47 
Patients group     
NDI 1.68  ± 0.03 1.54 ± 0.02 1.67 ± 0.08 1.52 ± 0.05 
%BiNC 48.50 ± 1.68 46.40 ± 3.45 49. 60 ± 2.87 43.45 ± 3.75 
BiMN 8.54  1.40± 8.29 ± 1.55 11.03 ± 1.70* 30.90 ± 12.21+  
Mono MN 2.04 ± 0.48 3.06 ± 0.28 3.95 ± 1.33 1.21 ± 0.13 
NPBs 5.32 ± 0.06 5.39 ± 0.45 4.79 ± 6.65 5.42 ± 0.24 
Nuclear buds 2.58 ± 0.17 1.88 ± 0.73 1.96 ± 0.98 1.42 ± 0.27 
Lung cancer     
NDI 1.65 ± 0.06 1.66 ± 0.03 1,65 ± 0.03 1.55 ± 5.2 
%BiNC 54. 70 ± 2.34 52. 50 ± 4.56 56.34 ± 3.42 37.35  ± 2.34 
BiMN 9.98 ± 2.40* 9.71 ± 3.35* 14.50 ± 3.01** 28.58 ± 4.39+ 
Mono MN 2.58 ± 2.60 3.33 ± 1.75 5.83 ± 2.11 1.08 ± 1.66 
NPBs 1.08 ± 1.11 5.67 ± 1.89 5.33 ± 2.53 1.50 ± 1.85 
Nuclear buds 0.83 ± 0.99 2.58 ± 2.26 1.33 ± 1.17 1.42 ± 1.04 
COPD     
NDI 1.63 ± 0.02 1.59 ± 0.03 1.62 ± 0.04 1.38 ± 0.06 
%BiNC 49. 60 ± 2.35 52.25 ± 2.33 56 ± 3.44 46.34 ± 1.36 
BiMN 9.67 ± 2.61* 9.67 ± 3.25* 13.83 ± 1.95** 32.33 ± 4.37+ 
Mono MN 1.42 ± 1.38 3.17 ± 3.02 2.92 ± 2.66 1.17± 1.28 
NPBs 1.3 ± 1.43 5.75 ± 3.29 6.08 ± 2.69 2.58 ± 1.89 
Nuclear buds 1.17 ± 1.14 2.17 ± 2.94 3.42 ± 1.44 1.08 ± 1.11 
Asthma     
NDI 1.86 ± 0.08 1.82 ± 0.02 1.67 ± 0.06 1.42 ± 0.06 
%BiNC 45.55 ± 2.06 65.23 ± 3.44 61.44 ± 2.44 45.2 ± 5.65 
BiMN 3.75 ± 1.48 6.13 ± 2.15 9.73 ± 1.54* 31.75 ± 4.92+ 
Mono MN 2.13 ± 1.69 2.6 ± 1.87 3.1 ± 2.15 1.38 ± 1.41 
NPBs 1.375 ± 1.5 4.75 ± 2.38 3.88 ± 3.22 2.63 ± 1.49 
Nuclear buds 0.75 ± 1.09 0.88 ± 1.05 1.13 ± 1.05 1.75 ± 0.97 
 
Footnote: 
NDI: indicates nuclear division index 
% Bi NC: indicates percentage binucleated cells in 1000 scored cells 
BiMN: indicates number of micronuclei in 1000 binucleated cells 
Mono MN: indicates micronuclei in mononucleated counted in 1000 cells. 
NPBs: indicates number of nucleoplasmic bridges in 1000 cell 
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Table 5.5.2: Gender as a confounding factor in the CBMN assay.  Means ± SD of  
different CBMN assay parameters of respiratory disease patients (lung cancer, COPD,  
asthma) and healthy controls in l blood cultures treated with TiO2  (5 and 10 µg/ml) as 
well as a negative control of untreated blood cultures (Nc) and a positive control (Pc)  of 
0.4 µM of mitomycin C (MMC). Symbols indicate level of significance when 
comparing each group to healthy individuals’ untreated controls. *P < 0.05, **P < 0.01 
and +denotes highly significant when compared each group to its own untreated control 
as well as to corresponding healthy individuals untreated control.  
 
Group type and confounder   
Nc 
TiO2 concentrations µg/ml  
Pc 5 10 
G
en
de
r 
 
Healthy males     
NDI 1. 88 ± 0.02 1.88 ± 0.04 1. 72 ± 0.02 1.56 ± 0.04 
%BiNC 54.45 ± 3.22 52.28 ± 4.66 50.44 ± 6.33 38.44 ± 1.01 
BiMN 1.8  ± 1.6 6.4 ± 0.34 7.9 ± 1.37 28.87 ± 2.81+ 
Mono MN 1.93 ± 2.24 1.80 ± 1.51 3.67 ± 1.58 5.20 ± 2.56 
NPBs 1.8 ± 0.3 2.1 ±  1.65 5.21 ± 2.27 0.87 ± 0.8 
Nuclear buds 0.78 ± 0.7 1.12 ± 0.97 2.73 ± 1.35 0.81 ± 0.5 
Healthy females     
NDI 1.88 ± 0.06 1.80 ±0.02 1.74 ± 0.04 1.76 ± 0.02 
%BiNC 64.12 ± 1.24 55.45 ± 2.02 56.46 ± 0.04 48.26 ± 1.22 
BiMN 2 ± 1.67 6.60 ± 2.42 6.00 ± 1.55 30.01 ± 5.51+ 
Mono MN 2.14 ± 2.24 3.27 ± 2.49 4.09 ± 2.79 1.23 ± 1.56 
NPBs 0.60 ± 0.49 4.40± 1.36 4,22 ± 2.61 0. 0 ± 0 
Nuclear buds 0.80 ± 0.6 1.60± 1.85 1.10  ±0.73 0.4 ± 0.49 
Male patients     
NDI 1.60 ± 0.04 1.56 ± 0.02 1.62 ± 0.39 1. 70 ± 0.02 
%BiNC 52.56 ± 1.26 58.55 ± 2.22 56.64 ± 2.46 36.04 ± 1.65 
BiMN 9.56 ± 2.63* 9.69 ± 4.16* 13.38 ± 2.64** 31.69 ± 5.26+    
Mono MN 1.59 ± 1.52 2.75 ± 2.64 1.93 ± 1.86 1.36 ± 1.30 
NPBs 1.31 ± 1.40 6.06 ± 2.46 5.25 ± 2.56 1.88 ± 1.76 
Nuclear buds 1.11 ± 0.88 2.00 ± 1.84 2.50 ± 2.09 1.31 ± 1.10 
Female patients     
NDI 1.76 ± 0.02 1.52 ± 0.02 1.72 ± .0.02 1.34 ± 0.04 
%BiNC 49.70 ± 4.73 52.50 ±  1.78 46.50 ± 2.56 37.35 ± 2.87 
BiMN 6.50 ± 3.34 8.25 ± 2.22 12.44 ± 3.62** 30.91 ± 4.30+ 
Mono MN 2.00 ± 2.00 1.75 ± 1.55 3.60 ± 1.74 5.3 ± 2.28 
NPBs 1.29 ± 1.19 5.25 ± 2.54 5.25 ± 3.21 2.50 ± 1.90 
Nuclear buds 1.00 ± 1.06 1.63 ± 2.26 1.63 ± 1.69 1.44 ± 1.06 
 
Footnote: 
NDI: indicates nuclear division index 
% Bi NC: indicates percentage binucleated cells in 1000 scored cells 
BiMN: indicates number of micronuclei in 1000 binucleated cells 
Mono MN: indicates micronuclei in mononucleated counted in 1000 cells. 
NPBs: indicates number of nucleoplasmic bridges in 1000 cells 
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Table 5.5.3: Age as a confounding factor in the CBMN assay.  Means ± SD of  
different CBMN assay parameters of respiratory disease patients (lung cancer, COPD,  
asthma) and healthy controls in blood cultures treated with TiO2  (5 and 10 µg/ml) as 
well as a negative control of untreated blood cultures (Nc) and a positive control (Pc)  
of 0.4 µM of mitomycin C (MMC). Symbols indicate level of significance when 
comparing each group to healthy individuals’ untreated controls. *P < 0.05, **P < 
0.01 and +denotes highly significant when compared each group to its own untreated 
control as well as to corresponding healthy individuals untreated control.  
 
 
 
Group type and confounder 
TiO2 concentrations µg/ml  
 
Pc 
 
Nc 
 
5 
 
10 
A
ge
 
Control <50     
NDI 1.88 ± 0.03 1.74 ± 0.02 1.76 ± 0.04 1.38 ± 0.03 
%BiNC 56.34 ± 1.78 45.66  ± 1.26 48.46 ± 3.06 37.66 ± 2.86 
BiMN 1.00  ± 0.82 3.33 ± 1.63 7.11 ± 1.73 30.38 ± 4.51 + 
Mono MN 1.8 ± 2.64 2.00 ± 1.41 1.80 ± 1.17 5..00 ± 3.03 
NPBs 0.47 ± 0.33 3.44 ± 2.54 5.78 ± 2.35 0.68 ± 0.44 
Nuclear buds 0.68 ± 0.44 1.89± 1.10 2.22 ± 1.40 0.68 ± 0.56 
Control 50-65     
NDI 1..84 ± 0.04 1.64 ± 0.03 1.66 ± 0.02 1.74 ± 0.04 
%BiNC 54.22 ± 2.65 52.66 ± 2.03 49.43 ± 3.03 48.56 ± 2.34 
BiMN 3.17 ± 1.67 6.17 ± 2.34 7.50 ± 1.61 28.89 ± 3.54+ 
Mono MN 0.78  ± 1.03 1.44 ± 1.57 3.22 ± 1.40 3.78 ± 1.93 
NPBs 0.47 ± 0.33 5.83 ± 2.67 3.33 ± 1.80 0.94 ±0.67 
Nuclear buds 1.00 ± 0.82 2.50 ± 2.06 2.00 ± 1.63 0.75 ± 0.33 
Patients < 50     
NDI 1.39 ± 0.45 1.45 ± 0.03 1.52 ± 0.04 1.31 ± 0.02 
%BiNC 52.24 ± 2.05 56.45 ± 2.04 51.66 ± 1,80 47.33 ± 1.46 
BiMN 3.60 ± 1.36 7.00 ± 1.67 8.80 ± 1.33 29.33 ± 1.55+ 
Mono MN 2.31 ± 2.36 2.69 ± 2.11 3.765 ± 2.86 0.88 ± 0.93 
NPBs 1.26 ± 1 4.80 ± 2.86 4.40 ±3.01 2.80 ± 1.72 
Nuclear buds 1.20 ± 0.6 0.20 ± 0.40 1.40 ± 1.102 1.80 ± 1.17 
Patients 50-65     
NDI 1.47 ± 0.03 1.52 ± 0.02 1.67 ± 0.02 1.42 ± 0.02 
%BiNC 54.45 ± 2.45 52.26 ± 1.34 53.26 ± 3.44 42.42 ± 2.21 
BiMN 7.77 ± 3.09 8.23 ± 3.12 13.46 ± 3.1** 31.92 ± 4.98+ 
Mono MN 1.75 ± 1.64 3.50 ± 2.50 1.50 ± 1.80 4.38 ± 2.52 
NPBs 1.54 ± 1.39 5.69 ± 2.58 5.77 ± 2.91 2.77 ± 2.04 
Nuclear buds 1.04 ± 1.00 1.54 ± 1.91 1.73 ± 1.62 1.31 ± 0.91 
Patients > 65     
NDI 1.64 ± 0.02 1.76 ±0.04 1.68 ± 0.04 1.66 ± 0.02 
%BiNC 56.65 ± 2.06 53.65 ± 3.54 52.66 ± 2.64 42.26 ± 2.12 
BiMN 9.69 ± 2.52* 9.87 ± 3.33* 13.86 ± 2.50** 31.29 ± 5.16+ 
Mono MN 3.67 ± 2.43 2.33 ± 1.25 4.33 ± 1.60 7.33 ± 1.80 
NPBs 1.28 ± 1.07 5.93 ± 2.28 5.07 ±2.49 1.43 ± 1.40 
Nuclear buds 1.07 ± 0.97 2.64 ± 2.16 2.71 ± 2.19 1.29 ± 1.16 
Footnote: 
NDI: indicates nuclear division index 
% Bi NC: indicates percentage binucleated cells in 1000 scored cells 
BiMN: indicates number of micronuclei in 1000 binucleated cells 
Mono MN: indicates micronuclei in mononucleated counted in 1000 cells. 
NPBs: indicates number of nucleoplasmic bridges in 1000 cells 
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Table 5.5.4: Smoking habit as a confounding factor in the CBMN assay.  Means ± SD of  
different CBMN assay parameters of respiratory disease patients (lung cancer, COPD,  
asthma) and healthy controls in blood cultures treated with TiO2  (5 and 10 µg/ml) as well 
as a negative control of untreated blood cultures (Nc) and a positive control (Pc)  of 0.4 µM 
of mitomycin C (MMC). *P < 0.05, **P < 0.01 and +denotes highly significant when 
compared each group to its own untreated control as well as to corresponding healthy 
individuals untreated control.  
 
 
 
 
 
Group type and confounder 
 
 
TiO2 concentrations µg/ml 
 
 
 
 
Pc 
 
Nc 
 
5 
 
10 
Sm
o
ki
n
g 
Non-smoker controls     
NDI 1.74 ± 0.02 1.62 ± 0.02 1.68 ± 0.02 1.62 ± 0.05 
%BiNC 54.67 ± 3.05 55.65 ± 1.56 49.47 ± 4.28 43.36 ± 2.56 
BiMN 1.87 ± 1.63 4.47 ± 2.39 7.27 ± 1.69 29.87 ± 4.15+ 
Mono MN 2.02 ± 1.72 3.20 ± 2.14 2.40 ± 2.06 1.60 ± 1.80 
NPBs 0.33 ± 0.47 4.40 ± 2.85 4.80 ± 2.45 0.81 ± 0.53 
Nuclear buds 0.67 ± 0.79 2.13 ± 1.59 2.13 ± 1.50 0.72 ± 0.47 
Non-smoker patient     
NDI 1.77 ± 0.04 1.64 ± 0.03 1.66 ± 0.06 1.47 ± 0.03 
%BiNC 50.45 ± 3.54 49.23 ± 2.34 56.34 ± 4.87 51.65 ± 3.42 
BiMN 5.50 ± 2.99 3.32 ± 3.38 10.67 ± 2.81* 31.39 ± 5.14+      
Mono MN 1.54 ± 1.82 3.62 ± 2.31 4.00 ± 2.83 0.92 ± 1.59 
NPBs 1.33 ± 1.01 2.76 ± 2.70 5.08 ± 3.28 2.00 ± 1.67 
Nuclear buds 0.75 ± 1.16 1.83 ± 1.77 2.00 ± 1.87 1.58 ± 1.11 
Smoker patient     
NDI 1.31 ± 0,03 1.52 ± 2.56 1.67 ± 0.02 1.61 ± 0.03 
%BiNC 56.44 ± 2.65 59.56 ± 6.34 41.28 ± 4.04 38.45 ± 2.26 
BiMN 8.77 ± 3.06 9.93 ± 3.37* 13.82  ± 3.17** 31.39  ± 4.58+ 
Mono MN 2.43 ± 2.24 2.86 ± 2.39 4.43 ± 2.73 1.21 ± 1.21 
NPBs 1.23 ± 1.38 6.18 ± 2.41 5.45 ± 2.92  2.23  ± 1.93 
Nuclear buds 1.14 ± 0.75 1.86 ± 2.12 2.09  ± 1.95 1.32  ± 1.02 
 
 
Footnote: 
NDI: indicates nuclear division index 
% Bi NC: indicates percentage binucleated cells in 1000 scored cells 
BiMN: indicates number of micronuclei in 1000 binucleated cells 
Mono MN: indicates micronuclei in mononucleated counted in 1000 cells. 
NPBs: indicates number of nucleoplasmic bridges in 1000 cells 
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Table 5.5.5: Ethnicity as a confounding factor in the CBMN assay.  Means ± SD of  
different CBMN assay parameters of respiratory disease patients (lung cancer, COPD,  
asthma) and healthy controls in blood cultures treated with TiO2  (5 and 10 µg/ml) as 
well as a negative control of untreated blood cultures (Nc) and a positive control (Pc)  of 
0.4 µM of mitomycin C (MMC). *P < 0.05, **P < 0.01 and +denotes highly significant 
when compared each group to its own untreated control as well as to corresponding 
healthy individuals untreated control.   
 
Group type and confounder 
 
 
Nc 
TiO2 concentrations µg/ml  
Pc 5 10 
Et
hn
ic
ity
 
Caucasian controls     
NDI 1.83 ± 0.08 1.56 ± 0.04 1.52 ± 0.03 1.68  ± 0.06 
%BiNC 58.30 ± 3.05 46.50 ± 1.60 54.20 ± 3.45 48. 60 ± 0.02 
BiMN 3.92 ± 1.46 8.62 ± 2.85 9.84 ±3.11  30.38 ± 2.46+     
Mono MN 1.50 ± 0.48 4.63 ± 3.16 3.88 ± 2.20 0.38 ± 0.70 
NPBs 0.38  ± 0.70 2.13 ± 1.90 2.00 ± 1.87 0.63 ± 0.70 
Nuclear buds 0.38 ± 1.80 1.75 ± 1.20  4.50 ± 1.41 5.25 ± 2.73 
Caucasian patients     
NDI 1.76 ± 0.10 1.66 ± 0.03 1.56 ± 0.02 1.64 ± 0.06 
%BiNC 52 .66 ± 2.65 55.23 ± 1.26 47.88 ± 2.65 56.26 ± 2.44 
BiMN 9.96 ± 1.46 8.62 ± 2.85 12.24 ±3.11*  39.54 ± 1.25+     
Mono MN 1.7 ± 1.55 1.35 ± 1.82 2.95 ± 2.64 3 ±  2.47 
NPBs 1.46 ± 1.35 3.24 ± 1.44 5.65 ± 2.85 1.3 ±1.31  
Nuclear buds 1 ± 1.14 1.55 ± 1.35 1.82 ± 1.35 2.6 ± 1.74 
Asian controls     
NDI 1.75 ± 0.04 1.74  ± 0.03 1.88 ± 0.02 1.67 ± 0.01 
%BiNC 52.60 ± 2.35 56 .02 ± 2.42 54.35± 3.34 46 ± 2.84 
BiMN 1.67 ± 1.25 4.33  ± 2.13 7.67 ± 1.70 29.67 ± 3.45+ 
Mono MN 2.83  ± 2.54 4.00 ± 2.58  6.17 ± 2.34 0.50 ± 0.76 
NPBs 0.17 ± 0.37 2.00 ± 1.15 2.33 ± 0.94 0.33 ± 0.75 
Nuclear buds 1.75 ± 0.04 1.74  ± 0.03 1.88 ± 0.02 1.67 ± 0.01 
Asian patients     
NDI 1.65 ± 0.06 1.66 ± 0.03 1,65 ± 0.03 1.55 ± 5.2 
%BiNC 54. 70 ± 2.34 52. 50 ± 4.56 56.34 ± 3.42 37.35  ± 2.34 
BiMN 4.67 ± 1.25 8.40 ± 3.98* 10.40±1.36** 31.20 ± 5.42+ 
Mono MN 0.80 ± 0.98 4.60 ± 2.87 6.40±1.20 2.00 ± 1.10 
NPBs 1.00 ± 1.26 2.20 ± 2.14 1.60±1.85 1.20 ± 1.17 
Nuclear buds 2.40 ± 1.36 4.00 ± 3.58 2.80±2.48 1.60 ± 1.50 
 
Footnote: 
NDI: indicates nuclear division index 
% Bi NC: indicates percentage binucleated cells in 1000 scored cells 
BiMN: indicates number of micronuclei in 1000 binucleated cells 
Mono MN: indicates micronuclei in mononucleated counted in 1000 cells. 
NPBs: indicates number of nucleoplasmic bridges in 1000 cells 
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5.3.3 Ras p21 expression   
 The results of ras p21 expression are shown in table 5.6 and figures 5.3 A-D.  A total of 
20 samples were tested for ras p21 expression after treatment with different TiO2 
concentrations for 30 minutes (10, 30 and 50µg/ml) as well as a negative control of 
untreated lymphocytes.  All 6 controls and 5 asthma patients’ samples did not express 
ras p21 regardless of the fact they were treated and therefore TiO2 did not modulate ras 
p21 expression in these groups.  However, 5 COPD and 6 lung cancer patients 
expressed ras p21.  The intensity of ras p21 bands was quantified with ImageJ software 
after scanning the western blotting X ray film.  It has shown that the OD intensity of the 
bands alters in COPD patients which in some instances could be an up regulation of 
p21.  On the other hand, there is a clear ras p21 reduction in OD in cancer patients after 
treatment with different TiO2 concentrations. 
 
According to the blots of ras p21 expression as shown in figure 5.3 A-D and the OD of 
the bands in table 5.6: 
 
• None of the tested healthy controls or asthma patient groups showed clear proto 
oncogenic ras p21 expression.   
• Of the eight COPD samples (fig. 5.3C) four individuals (COPD2, COPD5, 
COPD6 and COPD8) produce clear positive response of proto-oncogenic ras 
p21 expression, 2 (COPD1 and COPD4) had faint un measurable bands and 1 
had a negative response (COPD 3).  In COPD7 the bands disappeared after TiO2 
treatment. 
• For lung cancer, six expressed measurable ras p21 bands (75%), 2 did not 
express ras p21 (negative) and in one sample (CA2) the bands disappeared 
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Figure 5.3A: Ras p21 protein expression in lymphocytes treated with different TiO2 
concentrations of (3)10 µg/ml, (4) 30µg/ml and (5) 50 µg/ml for 30 minutes, in addition to 
(1) SW 480 cell lysate (positive control) and (2) untreated lymphocytes (negative control) 
in healthy controls (Cont), 
 
 
 
 
 
Figure 5.3B: Ras p21 protein expression in lymphocytes treated with different TiO2 
concentrations of (3)10 µg/ml, (4) 30µg/ml and (5) 50 µg/ml for 30 minutes, in 
addition to (1) SW 480 cell lysate (positive control) and (2) untreated lymphocytes 
(negative control) in asthma (A) patients. 
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Figure 5.3C: Ras p21 protein expression in lymphocytes treated with different TiO2 
concentrations of (3)10 µg/ml, (4) 30µg/ml and (5) 50 µg/ml for 30 minutes, in 
addition to (1) SW 480 cell lysate (positive control) and (2) untreated  
lymphocytes (negative control) in COPD patients.  
Figure 5.3D: Ras p21 protein expression in lymphocytes treated with different TiO2 
concentrations of (3)10 µg/ml, (4) 30µg/ml and (5) 50 µg/ml for 30 minutes, in addition to 
(1) SW 480 cell lysate (positive control) and (2) untreated lymphocytes (negative control) 
in lung cancer patients (CA).  
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Table 5.6: Densitometry of ras p21 bands.  The OD obtained with ImageJ software and 
standard deviations of scanned blots of ras p21 bands in respiratory disease patients and healthy 
controls lymphocyte protein extracts untreated (Nc) and treated with different TiO2 
concentrations (10, 30 and 50 µg/ml) for 30 minutes.  All patients samples were coded * (OD 
means show ras p21 down regulation), $ (OD means show ras p21 up regulation) and – (ras p21 
not detected or immeasurable bands).  Negative responses have not been included. 
 
 
 
 
 
Group 
 
 
 
Nc 
TiO2 concentration in µg/ml 
10 30 50 
COPD 2 217.6  ± 23.9 212.6 ± 26.8 214.4 ± 15.5 187.3 ± 17.3 
COPD 5 187.0 ± 23.3 220.7 ± 14.0 223.0 ± 18.0 221.8 ± 18.3 
COPD 6$ 55.1 ± 10.1 187.0 ± 32.5 184.5 ± 40.4 178.0 ± 18.3 
COPD 7 227.0 ± 8.7 - - - 
COPD 225.8 ± 5.8 222.0 ± 7.4 222.0 ± 7.4 219.6 ± 7.3 
Lung cancer 1 222.0 ± 11.3 224.8 ± 15.6 226.6 ± 6.3 216.1 ± 9.4 
Lung cancer 3* 227.1  ± 14.8 227.0 ± 22.7 - - 
Lung cancer 4 101.4 ± 25.4 - - - 
Lung cancer 5 197.6 ± 9.3 196.7 ± 23.9 186.4 ± 32.6 
 
- 
Lung cancer 6 202.9 ± 18.0 201.5 ± 14.9 98.2 ± 32.9 197.2 ± 11.7 
Lung cancer 7* 110.5 ± 20.3 75.2 ± 12.8 54.9 ± 11.6 43.9 ± 15.4 
Lung cancer 8* 221.0 ± 22.7 217.7 ± 7.8 134.1 ± 13.9 - 
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5.4 Discussion 
This ex vivo/in-vitro genotoxicity study of nanosized anatase TiO2 was carried out on 
human lymphocyte cells from thirty six patients with different respiratory diseases 
namely lung cancer (sixteen),   COPD (thirteen) and asthma (nine) plus fifteen healthy 
individuals as a control group.  Investigations were carried out with the single-cell gel 
electrophoresis (Comet) assay and the cytokinesis-block micronucleus test.   
Various in vivo and in vitro studies have reported cytotoxic and genotoxic effects in 
lung tissues (Duan et al., 2010; Hussain et al., 2010; Kim et al., 2010; Lamoureux et al., 
2010; Larsen et al., 2010; Park et al., 2009; Schwaiger et al., 1991).  None of the 
previous studies, however, have tested TiO2 on respiratory disease patient lymphocytes.    
The Comet assay has been extensively used to measure DNA damage in isolated 
lymphocytes for oxidative DNA damage and repair capacity(Collins, 2009).  For 
genotoxicity of TiO2 NPs we used the Comet assay pH ≥ 13 as a measurement of DNA 
strand breaks to quantify DNA damage (Collins and Horvathova, 2001; Olive and 
Banath, 2006). The Comet assay have been commonly used to examine the association 
of DNA damage and repair capacity in peripheral white blood cells with risk of various 
cancers (Schabath et al., 2003; Schmezer et al., 2001).  
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In this bio-monitoring study the effect of different TiO2 concentrations (10, 30 and 
50µg/ml) on lymphocytes from respiratory disease patients and controls was examined 
in the alkaline Comet assay. The exposed lymphocytes have been shown to induce 
significant DNA strand breaks in respiratory disease patients compared to healthy 
individuals using Olive tail moment and % tail DNA.  In addition, it was observed that 
the distribution of lymphocyte DNA damage was increased with age and smoking habit.  
However the mean increased only slightly and the possibility could be that only some of 
the cells exhibited an increase in DNA migration as Tice (Tice et al., 1991) observed 
that only 10-20% of the lymphocyte cells treated with bleomycin exhibited an increase 
in DNA migration. 
In the present work, it has also observed that in the absence of photo-activation the 
lymphocytes of both controls and patients’ lymphocytes exposed to different TiO2 
concentrations showed significant increases in DNA breakage, however, the patient 
groups showed more sensitivity to the lower concentration. 
 The results indicated that TiO2 NPs at concentration levels between 10–50 µg/ml could 
cause dose dependent genotoxicity which was greater with the Olive tail moment than 
with % tail DNA.  These findings were in line to some extent with previous studies that 
reported TiO2 (anatase) in the absence of photo-activation, induced oxidative DNA 
damage to human bronchial epithelial cells (Gurr et al., 2005).  Additionally previous 
studies with TiO2 NPs have shown that, TiO2 induced cytotoxicity and genotoxicity to 
human lymphoblastoid cells (Wang et al., 2007a), induced   DNA damage to rat liver 
cells (Kocbek et al., 2010) and increased  cell death in human neural (astrocytoma U87) 
cells (Hussain et al., 2006).  Moreover, on in vivo study on mice with TiO2 NPs in the 
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drinking water, has shown that the TiO2 induced 8- hydroxy-2′-deoxyguanosine, 
induced γ-H2AX foci which is indicative of DNA double-strand breaks and 
additionally, induced micronuclei and DNA deletions (Trouiller et al., 2009).  However, 
in a separate in vitro study with TiO2 in human nasal epithelial cells, DNA strand 
breakage was not detected by the Comet assay (Hackenberg et al., 2010). 
The photo-catalytic, reactive oxygen species (ROS) generation and in vitro cytotoxic 
properties of TiO2  have previously been reported, following exposures to TiO2  of 
human dermal fibroblasts and A549 human lung epithelial cells  (Logan, 1983),  
besides, preceding studies reported genotoxic effects of TiO2 on lymphocytes however, 
the mechanism of TiO2 genotoxicity is still to be found. 
Although the tendency of TiO2 NPs to aggregate has been reported in this study (table 
4.1) the fate of inhaled NPs in still unknown. This is mostly vital because of the fast 
growth in the promising nanomedicines and NPs are increasingly used in aerosols.  
There is possibility that NPs could become disaggregated after inhalation and 
subsequently deposited in the lung alveolar space.  Thus they may enhance NPs 
inflammatory potency with subsequent recruitment of different inflammatory cells that 
could translocate to the interstitium which is anatomically the more vulnerable lung 
compartment and subsequently may lead to lung inflammation and fibrosis. 
The unique properties of nanoparticles such as their small size and large surface area 
that increases their reactivity are the main incentives behind the rapid expansion of 
nanotechnology and which is specifically true for engineered NPs.  The sizes, shapes 
and chemical compositions of NPs are diverse.  While TiO2 NPs have spherical shapes, 
carbon NPs has different shapes as nanotubes, nanowires and nanofibres. Sizes and 
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compositions additionally are different which could contribute to the variations in the 
toxicity of NPs.  
 
Numerous in vivo studies have found that exposures to nanoscale particles produce 
greater genotoxic and cytotoxic effects compared to exposure to larger sized 
particles(Donaldson et al., 2002; Hackenberg et al., 2010), mostly because of the great 
potential of NPs to escape macrophages and therefore easily pass from the air space to 
the lung interstitium or to the  blood vessels and thus either cause direct primary injury 
to the lungs such as interstitial inflammation and fibrosis, or translocate to other organs 
via the blood circulation and cause injury to other organs through oxidative stress 
production (Barillet et al., 2010; Narsimha Reddy et al., 2010).  The NPs size effect was 
reported formerly in an in vivo study that compared the effect of different ultra-fine NPs 
(carbon black, TiO2 and nickel) to their larger counterparts.  The nano sized particles 
produced more compelling lung inflammation and cytotoxicity than larger sized 
particles in rats’ lungs (Oberdorster et al., 2000; Oberdorster et al., 2005; Zhu et al., 
2006).  In addition, in a different in vivo instillation study with carbon black and TiO2 it 
has been shown that the nano forms produced more inflammation than an equal mass of 
respirable larger size particles of the same material.  Besides the NPs size’, the surface 
area as well was found to have a key role to play in the process of the resulting 
inflammation that occurred (Roller and Pott, 2006; Wittmaack, 2007). Additionally, the 
leading size effect of engineered NPs on the lungs have been frequently reported and 
found to overload the lungs at lower burdens than the larger particles (Apley et al., 
1971; Gilmour et al., 2004).  
 
Transition metals in general have been shown to generate damaging hydroxyl radicals 
inside the cell which in response forms mutagenic adducts with DNA (Schins 2002; 
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Hillegass et al., 2010).  The oxidative stress generated inside the cell may cause lipid 
peroxidation in the cell which subsequently mediates such adduct formation (Veccheit 
et al., 1976). In general, NPs seem to be capable of crossing biological membranes and 
entering the cell nucleus instead of the cytoplasm to a greater extent compared to larger 
particles of the same material, and afterwards NPs could gain access to the nucleus and 
becomes closer to the DNA and consequently could cause genotoxicity from the NPs’ 
oxidative products (Chen and von Mikecz, 2005; Geiser et al., 2005). 
 
A number of manufactured NPs have been found to encompass carcinogenic potentials. 
The potential for example of PM, asbestos and silica to cause cancer is well documented 
(Demircigil et al., 2010; Heintz et al., 2010; Olsson et al., 2010). Two mechanisms have 
been postulated for NPs’ carcinogenicity: the first is the direct genotoxic effect of the 
particles which involves the entrance of the particle to inside the cell with subsequent 
chemical and structural changes to the cell composition and therefore DNA damage, the 
second mechanism is by indirect genotoxic effects which are mediated through the 
particles’ ability to induce inflammation. However, the exact mechanism is yet to be 
confirmed and might  involve both mechanisms as well as TiO2 which has the potential 
to mediate such effects (Kocbek et al., 2010). 
 
The inflammatory mechanism of NPs’ carcinogenicity was previously proved on assays 
with carbon black which induced genotoxicity and lung tumors in rats.  Such genotoxic 
effects and mutation on alveolar epithelial cells had occurred secondarily to substantial 
lung tissue inflammation that supported the inflammatory hypothesis of NPs 
carcinogenic outcome (Driscoll et al., 1996).   
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As mentioned previously, with regard to the reported carcinogenicity of TiO2 and other 
nanoparticles on the lungs, our objectives of carrying out this study was to assess and 
compare the effects of nanoparticles in peripheral blood lymphocytes from patients with 
respiratory diseases and healthy individuals using genotoxic endpoints. 
 
In the Comet assay results have shown that in absence of UV irradiation, when each of 
the respiratory disease patient’s and healthy controls lymphocyte cells were treated with 
different TiO2 concentrations (10, 30 and 50 µg /ml) and compared to its own group 
untreated control, cells showed significantly different OTM values for all subjects.  On 
the other hand, values were only genotoxic in the treated lymphocytes of all patient 
groups (lung cancer, COPD and asthma) and smokers group for both OTM and % tail 
DNA at all concentrations.  The 30 µg/ml TiO2 caused high DNA damage to all patient 
and control groups with exception of patients aged < 50.  In this study the percentage 
tail DNA has shown less statistically significant values than the Olive tail moment. Both 
lung cancer and COPD showed less damage with the % tail DNA parameter than with 
OTM, and that the asthma subgroup showed the same pattern of significance as the 
healthy controls. For 50 µg/ml, TiO2 was highly genotoxic to all patient and control 
groups, lung cancer, COPD, all patients and all control age groups and less genotoxic to 
male and female control groups when analysed separately (P< 0.01). In addition, 
significant differences between the patient and control groups when their confounding 
factors were compared (gender, age, smoking history and ethnicity) have been reported 
in the Comet assay, where the patient groups tend to have greater responses than the 
controls with the exception of patients aged < 50 which could be due to the fact all of 
the younger patients had asthma.  
165 
 
The rationale behind the use of CBMN assay to monitor the genotoxic effects of TiO2 
on different respiratory disease patients and control because CBMN assay is a 
genotoxicity assay which provides simultaneously substantial information on different 
chromosomal damage endpoints such as chromosomal breakage, rearrangements and 
gene amplification (Fenech, 2002b). 
The measurement of micronucleus (MN) incidence in peripheral blood lymphocytes is 
broadly used in cytogenetics to estimate the presence and the scale of chromosomal 
damage in human populations exposed to genotoxic agents (Fenech et al., 1999).  The 
reliability and low cost of  the CBMN assay, has contributed to the global successful use 
and approval as a biomarker for in vitro and in vivo genome stability studies (Fenech, 
2001).  Chromosome loss, breakage and rearrangements and gene amplification play an 
important role in initiating events of the development and progression of cancer 
(Fenech, 2000; Reshmi et al., 2004), but less is known regarding the effect of TiO2 
exposure on the genome stability. We therefore focused on the effect of TiO2 to help to 
find the effect of TiO2 on the chromosomal stability of human lymphocytes. This could 
have important implication in the nanomedicines field in determination of the optimal 
concentration of TiO2 that could be used without affecting genome stability.  
 In the current study, the frequencies of all CBMN assay parameters such as 
micronuclei, nucleoplasmic bridges and nuclear buds were higher in the lung cancer and 
COPD patients and the respiratory disease group as whole than in controls without 
being statistically significant.  
The high basal DNA damage in lung cancer and COPD patients revealed in this study 
even before TiO2 treatment have been reported previously as well. For example Cheng 
was reported higher spontaneous micronuclei levels in 42 lung cancer patients 
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compared to 55 controls  (Cheng et al., 1996), beside that an investigation of genetic 
instability in lymphocyte cells of lung cancer patients with the Comet assay and 
micronucleus (MN) assay on 36 lung cancer patients and 30 controls have been 
previously carried out and the result in the MN assay indicated that the average values 
of MN in lung cancer patients were significantly higher than those of controls (El-Zein 
et al., 2006; Lou et al., 2007).  In addition, Olive tail moment in the Comet assay was 
significantly higher than the controls, however; the difference in the tail length between 
the two groups was not significant (Lou et al., 2007).  Furthermore, the basal DNA 
damage in COPD patients reported in a study measuring the genetic damage levels in 
COPD patients with CBMN and the Comet assays, revealed an increase in the basal 
DNA damage in COPD patients.  As the frequency of nucleoplasmic bridges and buds 
was increased as well, the investigators contributed the increased frequency of 
micronuclei in COPD patients to clastogenic events and DNA amplification (Maluf et 
al., 2007). 
In this study age, gender, smoking and ethnicity have been considered as confounding 
factors as recommended in previous bio-monitoring studies (Moller et al., 2000).  An 
age related increase in responses by comparison with corresponding treated and 
untreated controls have also been reported in this study.  
 
Male and female patients, as well had higher values than male and female controls 
which were increased in a concentration related manner.  This result was in line with 
previous studies, as for example, inter-individual differences in DNA damage 
assessment carried out for the evaluation of DNA damage in urinary bladder washing 
cells in the Comet assay.  The DNA migration was found to increase significantly with 
age in non-smokers (Gontijo et al., 2001).  In another study on healthy Indian male and 
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female population, the results demonstrated a statistically significant higher level of 
basal DNA damage in males when compared to females (Bajpayee et al., 2002).  In 
addition another large group study that involved 127 donors MN were increased with 
age and gender however, gender variation was mostly in people aged < 50 and women 
having higher MN frequencies (Wojda et al., 2007).  With regard to ethnicity, Asians 
had generally less damage with Comet assay than Caucasians, but with MN assay Asian 
patients had a higher level of damage.  These differences may be explained by 
difference in distribution of Asians in the groups.  In the COPD groups there were none.  
In the lung cancer groups there was one Asian patient and in the asthma groups there 
were 6 out of 9, and in the control groups 5 out of 15.  Furthermore, before treatment 
lung cancer and COPD patients showed basal values than asthma patients. 
 
Although, cigarette smoking is a recognized cause of lung cancer, and passive smoking 
is an undisputed risk factor for developing lung cancer (24% increase in risk) 10% of 
lung cancers occurred in non-smokers (Brennan et al., 2000). Oxidative stress in active 
smokers  correlates to the number of cigarettes smoked per day with decreased DNA 
repair capacity in smokers compared to non and ex-smokers (Raczka, 1981).  
 
Regarding smoking habit as a confounding factor, the present work has revealed that 
smokers showed more damage than non-smoker patients in the Comet assay that in turn 
had higher values than non smoking controls.  Furthermore smoking and non-smoking 
patients showed statistically significant increases in MN numbers when compared to the 
untreated controls of the healthy individuals, which was in line with a previous study 
that has shown smokers high basal DNA damage and low GSH cellular content which 
are the main intracellular defences against cigarette smoking (Fracasso et al., 2006),  
and in line with another study that was reported significant lymphocyte DNA damage in 
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cigarette factory workers measured in the Comet assay  in smoking workers who 
smoked one or more cigarette per day as  compared to non-smokers and Lam et al. who 
found that Smoking, male gender, age and  even passive smoking increased DNA strand 
breaks in lymphocytes of elevator factory workers (Lam et al., 2002) .  A similar 
finding was also previously reported (Fracasso et al., 2006). 
However, these findings regarding smoking habit were in contrast to some other studies 
which did not find differences in genetic damage between subjects who smoked and 
non-smokers in the Comet parameters (Betti et al., 1995; Fracasso et al., 2002; Maluf et 
al., 2001; Touil et al., 2002; Undeger et al., 1999; Garaj-Vrhovac and Kopjar, 2003). 
 
The ras proteins are guanine nucleotide–binding proteins.  They play vital roles in the 
growth control of normal and transformed cells.  Various growth factors and cytokines 
stimulate ras activation, which subsequently stimulates several downstream effectors, 
such as Raf-1/mitogen-activated protein kinase pathway. Mutated ras genes have been 
found in around 30% of human cancers, including lung, pancreatic and colon 
adenocarcinomas.  The mutated ras gene produces mutated proteins that remain in an 
active state sending uncontrolled proliferative signals (Hezel et al., 2010).  Oncogenes 
play key part in the development of many cancers because they regulate cellular 
proliferation.  Cells have been transformed in culture by ras genes (Dimri et al., 2005; 
Liss et al., 2010; Takahashi et al., 2009).  The ras genes encode the ras protein which 
consists of 189 amino acids of molecular weight of 21 kDa and are restricted to the 
inner surface of the plasma membrane. Many studies have targeted ras in the last two 
decades in order to have a better understanding of the mechanism by which mutated ras 
genes confer neoplasia in cells which could help in the production of more effective and 
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less toxic cancer therapeutics, and specifically target the defects in the cell growth 
control.  
 
Immunoblotting studies in primary colorectal tumours and colon cancer cell lines 
treated with 10 µM quercetin (a flavonoid plant, used as a nutritional supplement), have 
revealed that ras p21 expression was significantly down regulated by quercetin. Such 
findings suggested a possible chemo-preventive role for quartering in colorectal 
carcinogenesis (Ranelletti et al., 2000) and showed that ras expression could be 
modulated by chemicals. Therefore, in the current study, we tested the effect of different 
TiO2 NPs concentrations in lymphocytes of some of the study patients and controls to 
determine the ability of TiO2 to modulate ras p21 expression.  This is especially because 
ras p21 represents an important class of proto oncogene that are known to be associated 
with the development of lung cancer, particularly adenocarcinomas. Ras p21 is 
considered as a biomarker of some cancers including lung cancer because it is expressed 
in these cancers. In the present study, we found even after treatment with TiO2 for 30 
minutes lung cancer and COPD patients clearly expressed ras p21, however there was 
no expression of ras p21 in the asthma or control groups.  Thus confirms a study by 
Anderson et al on a Polish population as many of the cancers and some of the COPD 
patients expressed ras p21 without any treatment (Anderson, 1999; Anderson et al., 
1998b). 
 
Overall, this study confirms in the absence of UV irradiation, that anatase TiO2 of 
different sizes and concentrations gave positive responses in the Comet and MN assays.  
Moreover, anatase TiO2 can induce DNA damage in the Comet assay, and increase the 
number of MN and NPBs without being statistically significant except when compared 
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with the untreated control of the healthy individuals.  In addition, different levels of 
TiO2 concentrations could modulate ras p21 expression 
 
It is known from various studies (Blasiak et al., 2004; Kontogianni et al., 2007; 
Stoyanova et al., 2010), that untreated healthy control individuals have lower basal 
damage than patient groups.  Thus it is not surprising that respiratory disease patients 
also have high basal damage than the healthy controls in the present study.  It is difficult 
to disentangle the effect of TiO2 from the effect due to smoking or the primary 
respiratory disease or any other confounder.  However, in general lymphocytes from 
healthy individuals without confounding effects of smoking and respiratory disease 
show an increase of DNA damage with TiO2 in the absence of UV irradiation (see 
chapter 3) (Gopalan et al 2009).  These confounding responses could be working 
additionally synergistically or antagonistically.  Overall, responses are still increased in 
the presence of TiO2 regardless of confounding effects. 
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Chapter 6 
 
General discussion 
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Nanotechnology as defined by the Centre for Responsible Nanotechnology (USA) is 
“the engineering of functional systems at the molecular scale. It is referred to the future 
ability to construct items from the bottom up, using techniques and tools being 
developed today to make complete, high performance products” 
(http://www.crnano.org/whatis.htm). 
The U.S. National Science Foundation perspective for nanotechnology is as follows: 
“Imagine a medical device that travels through the human body to seek out and destroy 
small clusters of cancerous cells before they can spread or a box no larger than a sugar 
cube that contains the entire contents of the Library of Congress or materials much 
lighter than steel that possess ten times as much strength”. 
(http://www.scribd.com/doc/18303519/Nanotechnology-for-Communications) 
The future outlook for nanotechnology is to be a general-purpose technology (as it was 
called), because it will have significant effect on all other technologies and industries. 
The outcome as a result of nanotechnology as expected is that everything will become 
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better more effective medicines, enhanced stronger buildings, and cleaner safer water 
supply.   
Although, nanotechnology has numerous useful applications in a variety of fields, many 
of these nanoparticles are non biodegradable and their long term behaviour is not well 
understood.   In spite of the many promising useful medical applications, such as, 
imaging (Reddy et al., 2006), sensing (Lee and El-Sayed, 2006), gene delivery  and 
artificial implants, multi-functional nanoparticles for cancer therapy and for organ or 
cell specific drug delivery through nanoparticles (Dobson, 2006), toxicology studies are 
still lacking. 
 
Many of these particles can enter human tissues through different ports for example via 
the lungs after inhalation (Oberdorster, 2001), through the digestive system (Jani et al., 
1990) or through the skin (Jeong et al., 2010; Lademann et al., 1999).  Additionally, 
NPs are capable of crossing the body physiological barriers as for example the  blood–
brain barrier (Borm and Kreyling, 2004; Oberdorster et al., 2004) and the blood-testis 
barriers (Chen et al., 2009).   
 
Another undesirable effect of nanotechnology is nano-pollution, which is the waste, 
generated during manufacturing of nanomaterials or by the nano-devices it produces. 
Nano-pollution could be very hazardous due to the particles small sizes which enable it 
to float easily in the air and get access to mammalian cells, which may have not yet 
adapted to the novel nano-waste environment because most of these wastes are man-
made and do not appear normally in nature (Reynold et al., 2006). 
 
Any free radical involving oxygen is referred to as a reactive oxygen species (ROS).  
DNA damage is an important issue in carcinogenesis; it is known that any agent capable 
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of chemically modifying DNA like ROS could be carcinogenic. The hydroxyl radical 
(OH·) attacks DNA and generates modified purines and pyrimidines bases.  In healthy 
individuals, the steady level of oxidative DNA damage in normal cells is around 1 per 
106.  This could explain the age related high incidence of cancer due to adducts of 
endogenous damage by ROS (Loft and Poulsen, 1996), many of which are known to be 
mutagenic free radicals  produced in cells by cellular metabolism and by exogenous 
agents. These species react with bio-molecules in cells, including DNA. The resulting 
DNA damage caused by ROS or the oxidative damage is implicated to aging, 
mutagenesis, and carcinogenesis.  
 
Many chemicals have negative impact on the germ cells as they can affect the germ 
cells directly or indirectly through their action on the somatic cells Such effects include 
gametogenesis, fertility and offspring (Tran et al., 2007).         
 
Exposure to such toxic chemicals and environmental contamination are an important 
cause of decline in male fertility and semen quality for example, industrialized countries 
have shown a 12% decrease in semen quality over the past 50 years (Carlsen et al., 
1992).  For example, dichlorobromopropane (DBCP) a soluble chemical resulted in 
lower sperm count and spermatogonial destruction (Potashnik et al., 1978).  In addition, 
some chemicals were reported previously to preferentially accumulate in sperm cells 
compared to somatic cells with subsequent decrease in the number of sperm cells 
(Aoyagi et al., 2002).   
 
Although the general impression that only maternal factor could result in foetal 
malformations In vivo studies in rats have disapproved such conception and found that 
mutations in male germ-line as a result of mutagens exposure such as radiations, 
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cytotoxic drugs and smoking could as well subsequently lead to congenital 
malformations in the foetus and subsequently may increase the risk of cancers 
(Anderson, 2005; Brinkworth, 2000). 
 
Therefore, as a result a of  increasing use of nanoparticles, one area of concern could be 
effect of nanoparticles on the germ cells, as these could have serious implications on the 
health of future generations.  DNA damage to somatic cells can give rise to cancer but 
damage to germ cells could give rise not only to cancer, but also cause congenital 
defects in future generations. Hence it was decided to investigate the effect of ZnO and 
TiO2 (anatase form) in human sperm and lymphocytes in vitro using the Comet assay 
because they are widely used ingredients in dermatological preparations and sunscreens 
and many other products.  
 
Three different illumination conditions were used to investigate the genotoxic potential 
of the UV irradiated ZnO and TiO2 (mean particle size 40-70 nm) using the Comet 
assay in lymphocytes and sperm cells in non illumination conditions (the dark, D), with 
pre-irradiation (PI) irradiation of the cells followed by treatment with either ZnO or 
TiO2 and under simultaneous (SI) irradiation conditions in which cells simultaneously 
exposed to NPs and UV irradiation).  It has been found in the absence of overt toxicity 
both ZnO and TiO2 are capable of inducing genotoxic effects on human sperm and 
lymphocytes and the effect of ZnO and TiO2 was enhanced by UVA.  However, TiO2 
tended not to produce definite photo-genotoxic effects in sperm, although it appears to 
have definite photo-genotoxic effects with lymphocytes.   
 
In spite of the small UV dose used in this study (1.68 mj/ cm2) compared to (700 
mJ/cm2 and 750 mJ/cm2) used in another study, both results are in line together (Dufour 
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et al., 2006).  The parameters, which may have affected genotoxicity and / or photo-
genotoxicity of ZnO and TiO2 in this study include:  a) In the dark, the cellular DNA 
damage could be due to the intrinsic genotoxic properties of ZnO and/ or TiO2.  b) DNA 
damage in pre- and simultaneously irradiated cells could be due to intrinsic genotoxicity 
or as a result of the effect of the UV system per se on the cells. The probable cause of 
the induced DNA damage could be that, oxygen radicals generated from ZnO and TiO2 
and acted synergistically with UVA to exacerbate the responses, as Many toxicological 
studies over the past years have raised concerns regarding the safety of nanoparticles as 
they readily generate oxidative stress through reactive oxygen species (ROS) because a 
strong link between nanoparticles and oxidative stress has been documented (Stone et 
al., 2007; Xia et al., 2006). In addition, many investigators have shown that ROS play a 
major role in nanoparticle-induced DNA damage (Donaldson and Stone, 2003). 
However, detailed molecular mechanisms involved in the cellular responses to 
genotoxic effects are not yet fully understood. Oxygen radicals can cause single and 
double strand breaks.  However, the exact mechanism is yet to be known.   
 
The expanding industrial and medical use of nanomaterials, especially zinc oxide and 
titanium dioxide, has led to growing concern about their toxicity. Accordingly, the 
intrinsic genotoxic and cytotoxic potential of these nanoparticles were evaluated using a 
HEp-2 cell line because they are the mainstay of cancer research for determining the 
cytotoxic effects of different chemicals (Cole et al., 1994; Kusumoto et al., 1988; Lebret 
et al., 2008).   
 
Cytotoxicity of ZnO and TiO2 was tested with the mitochondrial activity (MTT) and the 
neutral red uptake (NRU) assays. The mitochondria and lysosome activity tests (MTT 
assay and NRU) indicated cytotoxicity of ZnO to HEp-2 cells treated beyond 4 h 
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reaching cell survival of < 16% after 48 hours. The highest
 
TiO2 concentration of 100 
µg/ml was found to be cytotoxic to HEp-2 cells in less than 2 hours. The genotoxic 
potential of ZnO and TiO2 in HEp-2 cells was also determined employing the Comet 
assay.  It has been found that ZnO Genotoxicity in HEp-2 cells was seen within the 
Comet assay showing a 3-fold increase in DNA damage.  On the other hand, TiO2 
treated HEP-2 cells showed a 2-fold increase in DNA damage after treatment with 
different TiO2 concentrations.  The genotoxic potential of ZnO and TiO2 in HEp-2 cells 
was also investigated in the CBMN assay, and an increase in the formation of 
micronuclei was found after treatment with different concentrations ZnO and TiO2 in 
HEp-2 cells.   
 
As the oxidative stress could be one of the possible modes suggested for ZnO and TiO2 
induced DNA damage, it is as well now considered a major cellular signalling regulator 
and it was suggested that genotoxicity mediated by ROS could be further linked to other 
pathways (Schins and Knaapen, 2007); therefore, we investigated the tyrosine 
phosphorylation pathway additionally to the induction of DNA damage.   These results 
have showed that, ZnO increased tyrosine phosphorylation of five proteins at 20, 21-22, 
25, 30, and ~80 kDa with less effect of TiO2 which showed almost similar bands pattern 
only at the highest concentration.  Accordingly, tyrosine phosphorylation is modified by 
both ZnO and TiO2 and produced genotoxic damage at two different end points in the 
Comet and CBMN assays in the absence of cytotoxicity.  Such findings could be highly 
significant as previous studies showed, that dysregulation of protein tyrosine 
phosphorylation is associated with cell proliferation and the early stages of neoplasia 
(Blume-Jensen and Hunter, 2001; Hahn and Weinberg, 2002).  On top of that, the 
increase in tyrosine phosphorylation of 21-22 kDa could be highly significant as a 
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correlation was previously found between cell transformation and tyrosine 
phosphorylation of 22-kDa protein (Glenney, 1989).   
 
Phosphotyrosine phosphatases (PTPs) are important regulators of cellular signal 
transduction pathways. They are sensitive targets of oxidative stress and may be 
inhibited in conditions, which induce intracellular oxidation. The effects of PTPs 
inactivation amplified by activation of key protein tyrosine kinases (PTKs), lead to 
initiation of phosphotyrosine-signalling cascades, which are not under normal receptor 
control. These independent signals result in the accumulation of protein 
phosphotyrosine (Parker et al., 1998).         
 
Signal transduction requires the actions of many signalling molecules, small changes in 
the activity of these molecules increased through signalling pathways. Therefore, the 
impairment of a function of a few oxidation-sensitive phosphotyrosine phosphatases 
(PTPs) may result in a shift in the balance of phosphotyrosine along a certain pathway. 
Communication between the cell surface and the nucleus might be altered along the 
signalling pathway, leading to message loss as the signal passes on. In cases of 
oxidative stress, inhibition of PTPs synergizes oxidative induction of protein tyrosine 
kinases (PTK) activity, and signalling cascades normally under receptor control are 
initiated in an independent manner. 
 
Protein tyrosine phosphatase (PTP) inhibitory effect of treated cells has previously been 
reported, for example, PTP was found to inhibit tyrosine expression of sodium vanadate 
treated cells. This resulted in a bypass of growth arrest that occurred as the result of 
genotoxic exposure which indicates a role for tyrosine phosphorylation in the regulation 
of cell survival (Bae et al., 2009).  Protein tyrosine phosphatase inhibition has also been 
previously reported in primary mammary epithelial cells, which enhanced cell survival 
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by decreasing apoptosis (Furlong et al., 2005).  Additionally, earlier in-vitro studies on 
human U937 monocytes have shown that nano-cobalt increased the transcription of 
matrix metalloproteinases (MMP-2 and MMP-9) and protein tyrosine kinase (PTK) 
signalling pathways were involved through oxidative stress (Wan et al., 2008). As a 
result, we presumed that either PTP inhibition (Bae et al., 2009) or increased 
transcription of matrix metalloproteinases (MMP-2 and MMP-9) and PTK signalling 
pathways (Wan et al., 2008) could explain our findings of increased tyrosine 
phosphorylation as the result of genotoxic insult of ZnO and the highest concentration 
of TiO2. 
 
Prior studies have shown that nanoparticles produced an effect similar to irradiation by 
inducing carcinogenesis pathways through ROS-induced DNA damage, activating p53 
and proteins related to DNA repair (Mroz et al., 2008). The acute DNA damage could 
trigger cell cycle arrest and leads to prolonged repair time or cell death (Friedberg and 
Meira, 2004). Accumulation of mutations, which are caused by excessive or incomplete 
DNA repair, is a known cause of oncogenesis (Rusyn et al., 2004).  
 
In view of that, the present investigation conclusively provides further evidence for the 
genotoxic effect of ZnO and TiO2 nanoparticles without UV irradiation in both the 
Comet assay and the micronucleus assay with induction of chromosomal damage at 
high, but non-cytotoxic concentrations.  It also provides evidence of significantly 
increased chromosomal mutations at the highest concentrations which showed no 
cytotoxic effects in the NRU and MTT assays.  
 
Here, an ex vivo/in-vitro study on human peripheral blood lymphocyte cells from thirty 
six patients with different respiratory diseases, lung cancer (sixteen),   COPD (thirteen) 
and asthma (nine) in addition to fifteen healthy individuals as a control group, was 
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carried out to investigate the effect of nanosized anatase TiO2 potential genotoxic 
effects with the single-cell gel electrophoresis (Comet) assay and the cytokinesis-block 
micronucleus test.   
 
Although inhalation is unlikely for engineered nanomaterials compared with dust 
particles, this can take place during massive production and handling of NPs.  Due to 
the chief effective deposition in the alveolar area, the crucial interactions of 
nanoparticles occur within the lung epithelial and alveolar macrophages. However, 
insufficient data currently exists on the mechanism of NPs permeability across the lung 
epithelium.  A considerable number of studies showed that some of the NPs have the 
ability to induce lung inflammatory reactions; granulomas or even tumours e.g. TiO2 in 
experimental animals.  
Various in vivo studies in rats, have reported genotoxic and cytotoxic effects induced by 
different NPs in the lung tissues.  As for example, aggregated ultra-fine TiO2 have been 
shown to induce lung tumours in rats (Oberdorster, 1996;  Bermudez et al., 2002), 
severe lung inflammations (Donaldson et al., 2002; Oberdorster et al., 2000), lung 
tumours (Heinrich et al., 1995) and progressive fibro-proliferative lesions and alveolar 
epithelial metaplasia (Bermudez et al., 2002).  As for NPs in general, in vivo and in 
vitro studies have reported cytotoxic and genotoxic effects of different NPs in lung 
tissues (Duan et al., 2010; Hussain et al., 2010; Kim et al., 2010; Lamoureux et al., 
2010; Larsen et al., 2010; Park et al., 2009; Schwaiger et al., 1991).  None of the 
previous studies, however, have tested TiO2 in the lymphocytes of respiratory disease 
patients.    
In this study the effect of different TiO2 concentrations (10-50 µg/ml) in lymphocytes 
from respiratory disease patients and controls was examined in the alkaline Comet 
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assay, then lymphocytes cells from each of the respiratory disease patients were treated 
with different TiO2 concentrations and compared to its untreated controls using the 
Olive tail moment and % tail DNA. 
 
In general, the exposed lymphocytes have been shown to induce significant DNA strand 
breaks in respiratory disease patients, and treated cells showed significantly different 
OTM values for all subjects. However for both OTM and % tail DNA, values were only 
genotoxic in the treated lymphocytes of all patient groups (lung cancer, COPD and 
asthma) and smokers group at all concentrations when compared to untreated controls.   
 
Regarding the effect of different TiO2 concentrations, the 30 µg/ml TiO2 caused high 
DNA damage
 
to all patient and control groups with the exception of those aged < 50.  
At 50 µg/ml, TiO2 NPs were highly genotoxic to all patient and control groups, lung 
cancer, COPD, all patients and all control age groups and less genotoxic to male and 
female control groups when analysed separately.   
 
In this work age, gender, smoking and ethnicity have been used as confounding factors 
as recommended in previous bio-monitoring studies (Moller et al., 2000).  Accordingly, 
in the Comet assay, significant differences between the patient and control groups have 
been found when their confounding factors were compared to each other (gender, age 
and smoking history).  It was observed that the distribution of lymphocyte DNA 
damage was increased with age and smoking habit in patient groups that tend to have 
greater responses than the controls with the exception of patients aged < 50 which could 
be due to the fact all of the younger patients had asthma who showed less or no basal 
DNA damage. Therefore, it could be reported that in the absence of photo-activation 
lymphocytes of both controls and patients’ exposed to different TiO2 concentrations 
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showed significant increases in DNA breakage.  However, the patient groups showed 
more sensitivity to the lower concentration. 
 Furthermore, In the Comet assay it has been observed that the percentage tail DNA 
reported less statistically significant values than the Olive tail moment. Both lung 
cancer and COPD showed less damage with the % tail DNA parameter than with OTM, 
and that the asthma subgroup showed the same pattern of significance as the healthy 
controls.  
Such findings were in line with previous studies in which TiO2 in the absence of 
photoactivation induced oxidative DNA damage to human bronchial epithelial cells 
(ref).  Moreover, TiO2 NPs in drinking water induced DNA double-strand breaks, 
micronuclei and DNA deletions (Trouiller et al., 2009).  Although, the photo-catalytic, 
reactive oxygen species generation and in vitro cytotoxic properties of TiO2  have 
previously been reported, following human dermal fibroblasts and A549 human lung 
epithelial cells to TiO2  (Logan, 1983).  However, the exact mechanism of TiO2 
genotoxicity is still not fully determined. 
The primary size effect of engineered NPs on the lungs have been frequently reported 
and found to overload the lungs at lower burdens than the larger particles (Apley et al., 
1971; Gilmour et al., 2004).  Such size inflammatory effect of NPs on the lung was also 
well observed in many in vivo studies in rats (Donaldson et al., 2002; Hackenberg et al., 
2010; Oberdorster, 2001; Oberdorster et al., 2000; Zhu et al., 2006).  This was mostly 
because of the great potential of NPs to escape macrophages and therefore easily pass 
from the air space to the lung interstitium or to the blood vessels and thus either cause 
direct primary injury to the lungs such as interstitial inflammation and fibrosis, or 
translocate to other organs via the blood circulation and cause injury through oxidative 
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stress production. Additionally, the surface area as well was found to have a key role to 
play in the process of the resulting inflammation that occurred (Roller and Pott, 2006; 
Wittmaack, 2007).  
Although the tendency of TiO2 NPs to aggregate have been noticed in this study (table 
4.1), we do not have the knowledge regarding the fate of inhaled NPs in general which 
is vital because of the fast growth in nanomedicines and NPS are increasingly used in 
aerosols. Thus, NPs could become disaggregated and deposited in the lung alveolar 
space following inhalation that could enhance their inflammatory potency with 
subsequent recruitment of different inflammatory cells and subsequently may lead to 
lung inflammation and fibrosis. 
In general, NPs could be capable of crossing biological membranes and entering the cell 
nucleus instead of the cytoplasm compared to larger particles of the same material, 
therefore, NPs could gain access to the nucleus and becomes closer to the DNA causing 
genotoxicity from their oxidative products (Chen and von Mikecz, 2005; Geiser et al., 
2005). 
 
A number of NPs have been found to have carcinogenic potential in the lungs, for 
example PM, asbestos and silica (Demircigil et al., 2010; Heintz et al., 2010; Olsson et 
al., 2010).  As a result, one of the objectives to carry out this study was to assess and 
compare the effects of nanoparticles in peripheral blood lymphocytes from patients with 
respiratory diseases and healthy individuals using genotoxic endpoints. 
The CBMN assay Was used to monitor the genotoxic effects of TiO2 in different 
respiratory disease patients and control to estimate the presence and the scale of 
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chromosomal damage endpoints such as chromosomal breakage, rearrangements and 
gene amplification (Fenech, 2002b).   
Chromosome loss, breakage and rearrangements and gene amplification play an 
important role in initiating events of the development and progression of cancer 
(Fenech, 2000; Reshmi et al., 2004), but less is known regarding the effect of TiO2 
exposure on the genome stability. It was therefore focused on the effect of TiO2 on the 
chromosomal stability of human lymphocytes. This could have important implication in 
the nanomedicines field in determination of the optimal concentration of TiO2 that could 
be used without affecting genome stability.  
In general, in the CBMN assay, the lung cancer and COPD patients showed basal 
increases in MN values and the patients group had higher values compared to controls 
without being statistically significant.  As for the confounding factors, an age related 
increase in responses by comparison with corresponding treated and untreated controls 
was reported in this study, which was in line with a previous study, that assessed an 
inter-individual differences in DNA damage by the Comet assay in which DNA 
migration was found to increase significantly with age (Gontijo et al., 2001).   As for 
gender, male and female patients, as well had higher values than male and female 
controls, which were increased in a concentration related manner without being 
statistically significant.  
Although, 10% of lung cancers occurred in non-smokers (Brennan et al., 2000), lung 
cancer is associated with cigarette smoking as well as  passive smoking with a 24% 
increase in developing lung cancer and active smokers  had decreased DNA repair 
capacity compared to non and ex smokers (Raczka, 1981). As a result, smoking habit 
have been used as a confounding factor in this study, where it was revealed that 
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smokers showed more damage than non smoker patients in the Comet assay and they in 
turn had higher values than non smoking controls.  Additionally, smoking and non 
smoking patients showed statistically significant increases in MN numbers when 
compared to the control of the healthy individuals, which was in line with a previous 
study that has shown smokers high basal DNA damage and low GSH cellular content 
which are the main intracellular defences against cigarette smoking (Fracasso et al., 
2006) , and in contrast to another studies that  revealed smoking and gender were not 
significant confounding factors (Betti et al., 1995; Fracasso et al., 2002; Maluf et al., 
2001; Touil et al., 2002; Undeger et al., 1999). 
In the CBMN assay, we observed that lung cancer and COPD patients had high basal 
DNA damage before exposure to TiO2 treatment.  Such high basal DNA damage have 
been reported previously as well in a similar study where higher spontaneous 
micronuclei levels were reported in lung cancer patients compared to controls  (Cheng 
et al., 1996), beside that on previous investigation of genetic stability in lymphocyte 
cells of lung cancer patients indicated that the average values of MN in lung cancer 
patients were significantly higher than those of controls (El-Zein et al., 2006; Lou et al., 
2007).  As for COPD patients prior studies reported an increase in the basal DNA 
damage in COPD patients with increasing values of all CBMN assay parameters (Maluf 
et al., 2007).  In addition, different levels of TiO2 concentrations could modulate ras p21 
expression.  
Future perspectives 
Engineered nanoparticles (NPs) cover a variety of classes of technological materials 
with novel properties. Such unique properties make NPs more attractive for many uses 
in pharmacology and biomedicine.    
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There is strong evidence linking NPs toxicity to their unique properties such as their 
size, surface area and other novel chemical properties that attracted the nanotechnology.  
Additionally, most of the nanomaterials react according to oxidative stress assumption, 
but possible nanomaterials connection with biological systems may result in more forms 
of damage. 
In the literature, there is a growing support that some nanomaterials are potentially 
harmful to humans; accordingly, firm industrial safety methods should be available to 
limit contact during nanomaterials manoeuvring. Moreover, given the doubt about the 
nanomaterials capability to induce significant pathogenetic effects, a toxicological 
evaluation of each nano-material should be carried out. 
Nanotechnology holds great promises for medicine, manufacturing and for the 
environment including efficient water purification and removal of toxic waste. 
Currently, nanoparticles like ZnO and TiO2 are already widely used in many consumer 
products. The variety of applications ranges from using nanoparticles within sunscreens, 
pigments, tooth pastes, antiseptic coatings, paints and the coating of spectacles to make 
products unbreakable and scratchproof. As a result, the evaluation of the toxic potential 
of nanoparticles within their substrate is imperative. However, in many cases detailed 
toxicological evaluation of nanoparticles including their genotoxic assessment is 
lagging behind the technological application of medical and consumer nano-products. 
Thus, in the very near future the focus will shift from nanotechnology towards 
nanotoxicology. Recent studies and our study have shown that under certain conditions 
nanoparticles can increase genotoxic damage within cells and potentially lead to adverse 
effects.  Nanotechnology and Nanomedicines are promising more medical benefits 
within the next years. This includes the discovery of nano-based drugs and nanoscale 
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diagnostic devices. The Cancer research has a goal of developing nanometer scale 
multifunctional nano therapeutic products which can diagnose, treat and monitor cancer 
progress. These products include contrast agents to improve cancer cells resolution to be 
detected at a single cell level. However, toxicity of nanoparticles should not be ignored. 
Therefore it is essential that deep research should be carried out for nanomedicines 
achievements to become real success.   Human’s exposure to airborne nanosized 
particles has increased considerably over the last century due to the rapidly expanding 
field of nanotechnology.  Therefore, it is probable to become another source of exposure 
through different routs primarily through inhalation then other different routs such as 
skin uptake, ingestion or injection of engineered nanomaterials.  
 
In the meantime, the current information regarding engineered nanomaterials 
prospective hazards still lacking.  Toxicology studies results of NPs and airborne ultra-
fine particles should be taken seriously as a base for nanotechnology expansion.   
Collectively, some emerging concepts of nanotoxicology can be identified from the 
results of these studies.  
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Appendix 1A) 
 
 
 
 
 
Participant Information Sheet for patients (Version 3, 07-07-09) 
 
Study title: Effect of small (nano) particles on white blood cells in patients with 
chest diseases compared to white blood cells in people without chest diseases. 
 
Reviewed by Leeds Central Research Ethics Committee (REC) 
 (REC reference number: 09/H1313/37)  
 
Invitation to the research study 
We would like to invite you to take part in a research study. Before you decide you need 
to understand why the research is being done and what it would involve for you. Please 
take time to read the following information carefully. Talk to others about the study if 
you wish to and you will be allowed around 24hours to consider this.  
(Part 1 tells you the purpose of this study and what will happen to you if you take part.  
Part 2 gives you more detailed information about the conduct of the study).  
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Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part.  
 
Part 1 
What is the purpose of the study? 
In this study white blood cells will be treated in a test tube with very small chemical 
particles to determine if patients with respiratory diseases are more at risk after 
exposure. A blood sample of around 6-8 teaspoons (40 ml) will be taken. Samples will 
be stored only for the duration of the study (about 3 years) and used for studies of a 
similar nature or to check original responses. The research is for a PhD programme. 
 
 Why have I been invited? 
 Because you are a patient at the Clinic for chest diseases and we should like to 
determine if these small chemical particles could be more harmful to you than to people 
without chest diseases. 
 
 Do I have to take part?  
It is up to you to decide.  We shall outline the study and go through this information 
sheet, which we shall then give to you.  We shall ask you to sign a consent form to show 
you have agreed to take part.  You are free to withdraw at any time, without giving a 
reason.  This would not affect the standard of care you receive.   
 
Part 2 
What will happen to me if I take part? 
A single blood sample will be taken and you will not need to attend the Clinic again for 
this research study. A brief questionnaire will need to be completed by the researchers. 
 
We shall need to access your notes so that they can be linked in an anonymous way to 
your clinical data which can be tied up with the research results. Each individual will be 
given a coded study number. 
 
The data obtained will only be available to the research team and will not be returned to 
you. Responses will be compared only on group basis i.e. collective responses from 
patients with chest diseases compared to collective responses from people without chest 
diseases. Results could be published in the form of scientific papers. The work will 
benefit the medical and scientific community at large, but will not be of direct benefit to 
you as an individual.  If, however, you would like more information, Dr BK Jacobs will 
be prepared to talk to you individually about study results. 
 
People who cannot take part in the study. 
People who are not well enough to take part will be excluded (e.g. those with anaemia) 
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Appendix 1C 
 
 
 
 
DATA COLLECTION FORM 
(To be completed by the Doctor) 
STUDY TITLE: EFFECT OF SMALL PARTICLES (NANO) ON WHITE BLOOD 
CELLS IN PATIENTS WITH CHEST DISEASES COMPARED TO PEOPLE 
WITHOUT CHEST DISEASES. 
REVIEWED BY LEEDS CENTRAL RESEARCH ETHICS COMMITTEE (REC)       
 (REC REFERENCE NUMBER: 09/H1313/37)    
                    
PATIENT NUMBER   DATE OF SAMPLE  
     
AGE       
     
SEX (PLEASE TICK) M F  CONSENT    Y / N  
ETHNIC GROUP   INFORMATION SHEET Y / N  
 
OCCUPATION  
 
 
DIET WESTERN ASIAN OMNIVORE VEGETARIAN VEGAN 
 
VITAMINS / ANTI-OXIDANTS  
(PLEASE LIST)  
  
 
PRESCRIBED DRUG USE  
(PLEASE LIST)  
  
 
RECREATIONAL DRUG USE Y/N   
  
IF YES PLEASE LIST  
MEDICAL 
 
LUNG  CANCER  
COPD                                     ASTHMA 
EXTENT    SITE  HISTOLOGY   SURGERY  
 
LUNG CANCER  
COPD  
ASTHMA  
OTHER MEDICAL CONDITIONS  
(PLEASE LIST)  
FAMILY HISTORY OF CANCER AND  
LUNG CANCER, COPD, ASTHMA   
CURRENT SMOKER  Y/N PAST SMOKER Y/N HOW MANY/MUCH PER DAY? 
CIGARETTES   CIGARS   PIPE   
ALCOHOL Y/N               UNITS PER WEEK  
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 School of Life Sciences 
 
 
 
Centre Number:  
 
 
CONSENT FORM FOR PATIENTS 
 
 
Title of Project: Effect of small (nano) particles on white blood cells in patients with chest 
diseases compared to white blood cells in people without chest diseases. (Version 3, 07- 07- 
09) 
 
Reviewed by Leeds Central Research Ethics Committee (REC) 
 (REC reference number: 09/H1313/37)  
 
       box  
 
1. I confirm that I have read and understand the information sheet (version 3, 19-
06-09) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights 
being affected.  
 
3. I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals from the NHS Trust or the 
University of Bradford, where it is relevant to my taking part in this research. I 
give permission for these individuals to have access to my records.  
 
4. I agree that the sample I have given and the information gathered about me can 
be stored at the University of Bradford, as described in the attached information 
sheet. 
 
 
5. I agree to take part in the above study. 
 
 
___________________________ ___________________ ______________________ 
 Name of Patient Date  Signature 
___________________________ ___________________ _______________________ 
Name of Person  Date  Signature  
taking consent  
 
When completed, 1 for patient; 1 for researcher site file; 1 (original) to be kept in medical notes 
 
 
Appendix 1 D) 
 
194 
 
 
 
 
Participant Information Sheet for healthy volunteers (Version 3, 19-06-09) 
 
Study title: Effect of small (nano) particles on white blood cells in patients with chest 
diseases compared to white blood cells in people without chest diseases. 
 
Reviewed by Leeds Central Research Ethics Committee (REC) 
 (REC reference number: 09/H1313/37)  
 
Invitation to the research study 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take time 
to read the following information carefully. Talk to others about the study if you wish to and 
you will be allowed around 24 hours to consider this.  
(Part 1 tells you the purpose of this study and what will happen to you if you take part.  
Part 2 gives you more detailed information about the conduct of the study).  
Ask us if there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part.  
 
Part 1 
What is the purpose of the study? 
In this study white blood cells will be treated in a test tube with very small chemical particles to 
determine if patients with respiratory diseases are more at risk after exposure. A blood sample 
of around 6-8 teaspoons (40 ml) will be taken. Samples will be stored only for the duration of 
the study (about 3 years) and used for studies of a similar nature or to check original responses. 
The research is for a PhD programme. 
 
 Why have I been invited? 
 You have been invited because you don’t have a chest disease and we should like to determine 
if these small chemical particles could be more harmful to people with chest diseases than those 
without chest diseases. 
 
 Do I have to take part?  
It is up to you to decide.  We shall outline the study and go through this information sheet, 
which we shall then give to you.  We shall ask you to sign a consent form to show you have 
agreed to take part.  You are free to withdraw at any time, without giving a reason.  
    
Part 2 
What will happen to me if I take part? 
Only a single blood sample will be taken for this research study. A brief questionnaire will need 
to be completed by the researchers. 
 
Each individual will be given a coded study number so that your clinical data is linked in an 
anonymous way with the research results. 
 
The data obtained will only be available to the research team and will not be returned to you. 
Responses will be compared only on group basis i.e. collective responses from patients with 
chest diseases compared to collective responses from people without chest diseases. Results 
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could be published in the form of scientific papers. The work will benefit the medical and 
scientific community at large, but will not be of direct benefit to you as an individual.  If, 
however, you would like more information, Dr BK Jacobs will be prepared to talk to you 
individually about study results. 
 
People who cannot take part in the study. 
People who are not well enough to take part will be excluded (e.g. those with anaemia).  
 
If you have any further questions, you could contact the research team: 
Dr B K Jacobs,  Consultant Respiratory Medicine, MB, CHB, MD, FRCP, Bradford Hospitals 
NHS Trust, Bradford Royal Infirmary, Duckworth Lane, Bradford, BD9 6RJ.  
Telephone: 01274-366 832 
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 School of Life Sciences 
 
 
 
Centre Number:  
 
 
CONSENT FORM FOR HEALTHY VOLUNTEERS 
 
 
Title of Project: Effect of small (nano) particles on white blood cells in patients with chest 
diseases compared to white blood cells in people without chest diseases. (Version 3, 07-07-
09) 
 
Reviewed by Leeds Central Research Ethics Committee (REC) 
 (REC reference number: 09/H1313/37)  
 
 Please 
initial 
       box  
 
6. I confirm that I have read and understand the information sheet (version 3, 19-
06-09) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
7. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights 
being affected.  
 
8. I agree that the sample I have given and the information gathered about me can 
be stored at the University of Bradford, as described in the attached  
 
9. Information sheet. 
 
10. I agree to take part in the above study. 
 
___________________________ ___________________ ______________________ 
 Name of Volunteer Date  Signature 
 
 
___________________________ ___________________ _______________________ 
Name of Person  Date  Signature  
taking consent  
 
When completed, 1 for patient; 1 for researcher site file;  
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